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ABSTRACT 
This work investigated the effects of different lifestyle strategies for reversing some of 
the lipid and lipoprotein abnormalities commonly known as an atherogenic lipoprotein 
phenotype (ALP) in groups at increased risk for CVD, such as type 2 diabetes mellitus 
(T2 DM), the overweight and obese. These strategies included a low glycaemic index 
(GI) diet, energy restriction, a low carbohydrate Atkins diet, and increased exercise level. 
The diets were tested either alone or in combination to examine the potential for additive 
effects on outcome measures. 
The effects of a low GI diet, alone and in combination with energy restriction, were 
investigated in overweight/obese T2 DM patients in Kuwait (Chapter 4). For this 
purpose, the glycaemic and insulinaemic indices of some staple foods in the Kuwaiti diets 
were determined to provide data from which low GI foods could be selected (Chapter 3). 
A standard WHO procedure was used for determining the glycaemic index (GI) and 
insulinaemic index (II) of seven types of bread and a type of white rice that are consumed 
extensively by the Kuwaiti population. Six of the breads in the Kuwaiti diet were shown 
to have GI values that fell within an intermediate GI range, which was comparable to the 
GI values of similar foods reported in the literature. The exception to this was a brown 
pita bread which gave a high GI value and a relatively higher II value compared with 
glucose. Iranian bread also had a high II value compared to that of the glucose standard. 
In Chapter 4, the effects of two low GI diets, with and without energy restriction, were 
examined on markers of CVD risk in overweight/obese T2 DM patients and compared 
with a control diet, in a6 week, randomised controlled trial. The average GI of the diet 
was reduced by 12 units in the intervention groups. An additive effect of weight loss in 
the energy-restricted low GI diet group was not shown because of the limited amount of 
weight loss in this group (3% reduction from baseline weight); a direct result of poor 
compliance. Both intervention groups produced similar effects that included a decrease 
in the concentration of plasma triacylglycerol (TAG) and increase in high density 
lipoprotein cholesterol (HDL-C). Glycaemic control, as measured by fructosamine 
levels, improved significantly in the low GI group compared to the control. Lowering the 
GI of the diet also resulted in a significant decrease in the proportion of small, dense LDL 
(sdLDL) and an increase in HDL2. 
Chapter 5 compared the effects of a low-carbohydrate, `Atkins' diet either alone, or in 
combination with an exercise programme, to provide evidence for the potential of 
exercise to modify the effects of this type of diet over 6-months in a randomised trial. 
Participants all together in this study had a 6.4% reduction in body weight. The low- 
carbohydrate diet had some significant beneficial effects on the components of an ALP, 
in particular, decreasing plasma TAG, increasing both HDL-C and HDL size, and 
decreasing the proportion of sdLDL. Hyperinsulinaemia was unaffected by the 
consumption of a low carbohydrate diet. The favourable changes in lipids with the low 
carbohydrate diet were associated with weight loss as a result of decreased energy intake. 
This study was however unable to differentiate between the effect of exercise and the low 
carbohydrate diet on an ALP, probably because of poor compliance to the exercise 
program. 
Taken together, both of the intervention studies resulted in reductions in metabolic risk 
factors for CVD, including a decrease in plasma TAG and increase in HDL-C across the 
two studies. Poor compliance to the energy-restricted diet in the low GI study in Kuwait, 
and to exercise regimens in the Atkins study did not allow any further interpretation of 
these experimental approaches. The promotion of the dietary approaches used in this 
thesis should be considered for the management of obesity and/or T2 DM and their 
associated CVD risk factors. 
ABBREVIATIONS 
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CHAPTER 1 
Chapter 1 
INTRODUCTION 
I. I. General introduction 
Despite recent advances in the identification and modification of coronary risk 
factors, cardiovascular disease (CVD) remains a leading cause of premature death 
worldwide especially in developing countries such as Kuwait. CVD is associated 
with multiple risk factors, the most notable of which being overweight, obesity, and 
type 2 diabetes mellitus (T2 DM). In addition to contributing independently to CVD 
risk, these conditions are often associated with abnormalities of plasma lipids and 
lipoprotein concentrations that have been collectively called an atherogenic 
lipoprotein phenotype (ALP). Typically an ALP includes moderately elevated plasma 
triacylglycerol (TAG), low concentrations of high density lipoprotein cholesterol 
(HDL-C), and a predominance of atherogenic smaller denser LDL particles. A 
reduced incidence of this collection of lipid abnormalities has a significant beneficial 
quantitative impact on CVD morbidity and mortality. 
A considerable range of studies increasingly suggest that an ALP can be favorably 
influenced by dietary modifications. Although initially designated neutral in their 
action on lipids, carbohydrates are now recognized as nutrients that play a major role 
in lipid abnormalities and CVD risk that are associated with obesity and T2 DM. 
There has been growing evidence of the role of carbohydrate quality (glycaemic 
index; GI), in the management of the dyslipidaemia of these conditions. Interest in 
the measurement of the GI of carbohydrate-rich foods has also grown considerably on 
the strength of evidence that carbohydrates classified as low GI carbohydrate are 
digested and absorbed slowly and lead to a lower glycaemic response and better 
metabolic risk profile than rapidly absorbed carbohydrates. 
There is universal agreement that weight reduction is an essential part of dietary 
therapy for dyslipidaemia in obesity and T2 DM. It has consistently been shown that 
when weight reduction is achieved (and maintained) in these individuals a sustained 
decrease in TAG (Howard, 1993) and increase in HDL-C (Gardner et al., 2000) is 
achieved especially when combined with other lifestyle factors such as exercise 
(Halle et al., 1999). A weight reduction of only 5-10% significantly reduces the risk 
associated with obesity and T2 DM (Wing et al., 1987a). 
The following review of the literature will summarise the prevalence, incidence, and 
pathophysiology of obesity and T2 DM. The review will also focus on the current 
literature concerning the effects of GI, weight loss, Atkins diet, and exercise on lipid 
and lipoprotein abnormalities. Normal lipid and lipoprotein physiology will be 
reviewed briefly as a base from which these different effects will be examined. 
1.2. Cardiovascular disease (CVD) 
1.2.1. Prevalence 
CVD is the disorders of the heart and/or blood vessels. It includes coronary heart 
disease (CHD), cerebrovascular disease, and peripheral vascular disease. CVD is the 
most common cause of death around the world. In the US alone, the prevalence of 
CVD among the adult population of 20 years and over is 37.1% (Rosamond et al., 
2007). In the UK, CHD is the most common cause of premature death causing 22% 
of premature deaths in men and 12% premature deaths in women (British Heart 
Foundation, 2005a). In Kuwait, CHD is now the most common cause of adult death, 
with mortality from the disease increasing by 50% in the decade from 1972 to 1981 
(Radovanovic, 1994). CHD represents a major cause of disability and is associated 
with enormous health care expenses with both direct and indirect costs. The cost of 
CHD for the UK economy is estimated to be a total of 7,900 million pounds annually 
(British Heart Foundation, 2005a). 
1.2.2. Risk factors 
CHD is a multi-factorial disease with a combination of modifiable and non- 
modifiable risk factors (Table 1.1). CHD is caused by atherosclerosis, a process 
associated with elevated serum total cholesterol (T. Cholesterol) and low density 
lipoprotein cholesterol (LDL-C) and low concentrations of high density lipoprotein 
cholesterol (HDL-C) (Anderson et al., 1991; Wilson et al., 1998; NCEP ATP-III. 
2001). Chronically elevated glucose concentrations are also known to contribute to 
the development of atherosclerosis in people with diabetes, independent of other risk 
factors (Selvin et al., 2005). The risk factors for CHD are defined by guidelines and 
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classifications from different organizations in Europe (Wood et al., 1998; Balkau et 
al., 1999) and the United States (NCEP ATP-III, 2001). The early identification and 
modification of these risk factors is essential to reduce morbidity and mortality rates 
from CHD (Abate, 2000). 
Table 1.1. Modifiable and non-modifiable risk factors of CVD (WHO, 2005). 
Modifiable Non modifiable 
Raised systolic BP Age 
Raised diastolic BP Gender 
Smoking Family history of premature CVD 
Hyperlipidaemia Previous cardiovascular events 
Left ventricular hypertrophy Premature cerebrovascular events 
Hyperglycaemia 
Renal disease 
Microalbuminurea 
Obesity 
Physical inactivity & sedentary lifestyle 
1.2.3. Metabolic syndrome 
A prominent and important risk factor for CVD is the metabolic syndrome of insulin 
resistance. In 1988, Reaven (1988) introduced the term `syndrome X', with insulin 
resistance as a common denominator for the syndrome. The metabolic syndrome is 
characterized by a constellation of metabolic risk factors, including abdominal obesity 
and an atherogenic dyslipidaemia consisting of elevated triacylglycerol (TAG), a 
predominance of small, dense LDL (also known as small dense LDL-III or sdLDL-C), 
low concentrations of HDL-C, elevated blood pressure, insulin resistance (with or 
without glucose intolerance), and prothrombotic and proinflammatory states. The 
first definition for the identification of the metabolic syndrome by the WHO (WHO, 
1999) was quickly followed by other definitions from the European Group for the 
Study of Insulin Resistance (EGIR; 1999), the National Cholesterol Education 
Program adult treatment panel III (2001) and the International Diabetes Federation 
(IDF; 2005). These definitions are presented in Table 1.2. 
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In the US about 22% of men and 24% of women aged >20 years have the metabolic 
syndrome, including diabetes (Ford et al. , 
2002). In Kuwait, the prevalence of the 
metabolic syndrome was 32.8% among 609 males and females according to the 
NCEP ATP-III guidelines (Al-Shaibani et al., 2004). Prevalence is also significantly 
affected by age, with 26% being between the ages 30-40y and 34.4% between the 
ages 40-60y. 
Individuals with the metabolic syndrome have a 3-fold elevated risk for coronary 
artery disease (CAD) and stroke (Isomaa et al., 2001). In addition to having an effect 
on CAD, the components of the metabolic syndrome have also been closely 
associated with the development of T2 DM. In a study of 1,918 Pima Indians, insulin 
resistance was strongly associated with diabetes in a four year follow-up (Hanson et 
al., 2002). Also, body size and the lipid factors significantly predicted diabetes. The 
most common combinations of components of the metabolic syndrome seen in 
diabetics are obesity in combination with hypertension or dyslipidaemia, which is 
seen in about 50% of patients with T2 DM and in 10-20% of subjects with normal 
glucose tolerance (Isomaa et al., 2001). 
1.3. Lipoproteins; structure and metabolism in relation to metabolic syndrome 
Lipids are by definition insoluble in aqueous media such as plasma and are thus 
transported in blood as multi-molecular complexes called lipoproteins. There are four 
major classes of lipoproteins mainly synthesised in the liver and in the intestine (Jain 
et al., 2007). These classes are chylomicrons, very low density lipoprotein (VLDL), 
low density lipoprotein (LDL), and high density lipoprotein (HDL) that differ in their 
hydrated density as a result of a decreasing proportion of hydrophobic lipids in their 
central core (cholesterol esters and triacylglycerol (TAG)) relative to protein in their 
surface coat (apoproteins; apo). Apoproteins and phospholipids are amphipathic 
molecules that act as an interface between plasma and the hydrophobic core lipids, 
and in effect, render these lipids soluble in plasma (Figure 1.1). In addition, 
apoproteins play an important role in stabilizing the structure of the lipoprotein and in 
acting as ligands for specific receptors, and thus determining the physiological 
behavior of lipoproteins (Jain et al., 2007). 
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Figure 1.1. Structure of a lipoprotein illustrating the hydrophobic core of TAG and 
cholesterol esters surrounded by amphipathic coat of apolipoprotein, phospholipids, 
and cholesterol. 
Following a meal, the small intestine produces apo B-48 containing chylomicrons 
(Tso et al., 1984; Jain et al., 2007) which have the primary function of transporting 
dietary TAG and cholesterol from the intestinal lumen to sites of storage and 
metabolism (Schaefer & Levy, 1985). On entry to the blood stream, chylomicrons 
rapidly undergo lipolysis via the action of endothelial bound, lipoprotein lipase (LPL; 
Figure 1.2) and lose much of the TAG and acquire cholesteryl esters from other 
lipoproteins via the action of cholesteryl ester transfer proteins (CETP). These 
remnants are taken up by the liver via receptors that bind apo E. VLDL containing 
apo E, C-II, and B-100, are relatively large particles produced in the liver and have 
the function of transporting endogenous TAG and cholesterol to the peripheral tissues. 
VLDL particles are much smaller than chylomicron particles and therefore carry 
significantly less TAG than do chylomicrons. The catabolism of VLDL is similar to 
that of chylomicrons in that VLDL-TAG is lipolysed by LPL leaving cholesterol-rich 
remnants. Chylomicron remnant particles are considered to be particularly 
atherogenic (Karpe et al., 1994). In fact, both chylomicrons and VLDL remnants 
possess the potential to cause cholesterol deposition in the arterial wall (Williams, 
1998). While all chylomicron remnants are removed by the liver, VLDL remnants 
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can have two fates; about 50% are normally removed directly by the liver. whereas 
the other 50% is converted to LDL via the action of a close relative of LPL in the liver 
hepatic lipase (HL). 
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Figure 1.2. Exogenous and endogenous lipid synthesis. Dietary (exogenous) fat is 
absorbed into chylomicrons. In endogenous lipid synthesis the liver synthesizes TAG 
and cholesterol esters and packages them to VLDL. LPL hydrolyze the TAG in 
chylomicrons and VLDL which are further hydrolyzed by LPL to form IDL and then 
LDL. Fatty acids generated from TAG hydrolyses are a source of energy or fat 
storage. 
LDL, an end product of VLDL metabolism, is composed of about 50% cholesterol 
and is the major carrier of cholesterol to peripheral tissues. LDL shows structural 
heterogeneity and exists in the plasma of all humans as a small number of discrete 
subclasses (Griffin, 1997). These subclasses may be classified according to their 
particle size, density, and flotation properties; the latter provides the most useful 
description of LDL structural heterogeneity (Griffin, 1995). Three major classes of 
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LDL cholesterol exist; LDL-I, LDL-II, & LDL-III (Griffin, 1995). LDL-III 
represents a common marker of increased risk of CHD (Rizzo & Berneis, 2006a). 
In contrast to LDL particles that deliver cholesterol to peripheral tissues, it is the apo- 
A-I containing HDL particles that help transport cholesterol to the liver from 
peripheral tissues (Jain et al., 2007; Link et al., 2007). The concentration of plasma 
HDL is often low (<lmmol/1) in people with T2 DM and the metabolic syndrome, 
patients with hypertriglyceridaemia, patients with sedentary lifestyle and smokers 
(NCEP ATP-III, 2001). As with LDL, HDL can be further subdivided into two 
principal subclasses; HDL2, which has a density range of 1.063-1.125g/ml and HDL3, 
which represents the range 1.125-1.210g/ml (Anderson et al., 1978). 
The enzymes LPL and HL and lipid transfer protein CETP are key players in the 
metabolism of the major plasma lipoproteins. CETP mediates the transfer of 
hydrophobic lipids between VLDL, LDL and HDL, shuttling cholesterol esters from 
LDL and HDL to TAG-rich lipoproteins (chylomicrons and VLDL) in an equimolar 
exchange. As VLDL becomes rich in cholesterol esters both LDL and HDL can 
become transiently enriched in TAG, that on passage through the liver is hydrolyzed 
by HL, resulting in a smaller denser, LDL and HDL particles (Grundy, 1997). 
1.4. Type 2 diabetes mellitus 
Diabetes mellitus is associated with an elevated risk of CVD; the risk of CHD is 2.5-3 
times higher in patients with diabetes and more likely to lead to mortality or 
prolonged morbidity (Gaede et al., 2003; Li et al., 2007b; Stamler et al., 1993). An 
important supporting line of evidence for the association of CVD risk factors with T2 
DM came from the United Kingdom Prospective Diabetes Study (UKPDS) (Turner et 
al., 1998). This study analysed the strength of the relationship between various CVD 
risk factors and risk of myocardial infarction in patients with T2 DM and established 
LDL-C as the strongest predictor of CHD followed by diastolic blood pressure, 
smoking, HDL-C and finally, glycaemic control as assessed by HbA lc 
concentrations. The same study showed that a1 mmol/1 increase in LDL-C. 
corresponded to a 57% increase in risk of a cardiovascular event as compared with an 
increase in risk of 15% for every 10mmHg increase in systolic blood pressure and an 
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increase in risk of 11 % for every 1% increase in HbA 1c (Turner et al., 1998). In 
addition, the risk of morbidity and mortality from stroke is also particularly high in 
individuals with diabetes (Idris et al., 2006). 
1.4.1. Prevalence and incidence 
The prevalence of T2 DM has been increasing dramatically worldwide (King et al., 
1998; Mokdad et al., 2001; Mokdadet et al., 2003). It is rapidly becoming a serious 
emerging public health concern not only in adults, but now more frequently in 
children and adolescents (Sinha et al., 2002; Pinhas-Hamiel et al., 1996). Over the 
next 20 years, the prevalence of diabetes is forecast to increase by 42% among adults 
living in the developed world and by 170% among adults in developing countries. 
Around 300 million people age 20 and older will have diabetes by the year 2025 
(King et al., 1998). In 2001,7.9% of US adults were diagnosed with DM which 
represents an increase of 61 % since 1990 (Mokdad et al., 2003). The disease was 
shown to affect approximately 9.6% of adults aged 20y and older in the US in 2005 
(U. S. Department of Health and Human Services, 2005b). In the UK, it is estimated 
that newly diagnosed T2 DM cases will rise to 19% above current levels by the year 
2023 (Bagust et al., 2000). 
As with CHD, diabetes is associated with substantial cost and economic 
consequences. In the US alone, the total annual economic cost of diabetes in 2002 
was estimated to be $132 billion, or one out of every 10 health care dollars spent 
(American Diabetes Association, 2003). In the UK, large increases in healthcare 
demand and economic burden due to diabetes are expected in the next 40-50 years 
(Bagust et al., 2000). 
1.4.2. Kuwait: background and T2 DM 
Kuwait is typical of a traditional society that has undergone a very rapid 
modernization. The country occupies the north western corner of the Arabian Gulf 
and stretches over 17,818 km2. The population in 2006 is approximately 2,418,393 
among which 1,127,039 are Kuwaiti citizens (Ministry of Planning, 2003). A few 
decades after the discovery of oil (1940s), a nation of fishermen and traders was 
transformed into one of the richest and developed nations in the world. 
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This sudden transformation has led to significant improvements in lifestyle and 
standards of living and associated with this, a considerable transition in dietary 
intakes. With these dramatic changes food became subsidised. The country no,, w- 
depends heavily on imported produce which has created a greater abundance of food 
and dietary diversity (Al-Hooti et al., 2002). As such, Kuwait is an interesting 
example of a developing country with rapid rises in diet-related diseases (Abdella et 
al., 1996; Al-Adsani et al., 2004; Al-Asi, 2003; Al-Kandari, 2006; al-Muhtaseb et al., 
1991; Al-Shaibani et al., 2004; Jackson et al., 2002; Akanji, 2002; Abdella et al., 
1998; Radovanovic, 1994) such as T2 DM which is emerging as a leading chronic 
disease. The prevalence of diagnosed T2 DM in Kuwait in 1995 was 7.6% (Abdella 
et al., 1996). By 1998, the overall prevalence had escalated to 14.8% (Abdella et al., 
1998). The disease presents at a relatively young age with a prevalence of 5.7% in the 
age group 20-39 and 18.3% in the age group 40-59 (Abdella et al., 1998). Despite the 
increased prevalence of T2 DM in Kuwait, little attention has been paid to public 
health nutrition and the therapeutic modification of diet. 
1.4.3. Pathophysiology of T2 DM 
The majority of patients with T2 DM are insulin resistant as compared to 
appropriately matched individuals with normal glucose tolerance (Reaven, 1995). 
Insulin resistance is an extremely common pathophysiological determinant for the 
development of T2 DM and dyslipidaemia (Reaven, 1995). A hypothesis that 
explains insulin resistance of T2 DM was postulated by Reaven (1988). This 
hypothesis states that as a result of chronic insulin resistance, compensatory 
hyperinsulinaemia develops to maintain glucose homeostasis. As a result, pancreatic 
hypersecretion of insulin fails and this is why T2 DM eventually develops. It has also 
been suggested that the most fundamental defects in insulin resistant individuals are 
hyperinsulinaemia, enhanced VLDL secretion and hypertriglyceridaemia (Lewis & 
Steiner, 1996). The Paris Prospective Study (Fontbonne & Eschwege, 1991), an 11 
year study in 7028 diabetic and non diabetic men, found that CHD mortality was 
strongly associated with concentrations of fasting insulinaemia, increasing stepwise 
from the lowest to highest quintile of insulin concentration. Besides insulin 
resistance, abdominal obesity represents a major contributor to the pathogenesis of T2 
DM (Ritchie & Connell. 2007). Several theories, which are not mutually exclusive, 
have been put forward to explain the role of insulin resistance in abdominal obesity. 
Among these theories is the portal theory (Frayn et al., 2005). This theory states that 
since abdominal fat drains into the hepatic portal circulation, increased abdominal fat 
deposition is often associated with increased lipolysis and elevated plasma 
concentrations of non-estrified fatty acids (NEFA) which in turn can cause hepatic 
insulin resistance. Alteration in adipokine secretion by increased abdominal fat has 
also been proposed as a mechanism that links abdominal obesity with insulin 
resistance (Ritchie & Connell, 2007) since the latter may be considered as an 
inflammatory condition (Pittas et al., 2004). 
1.5. Obesity 
1.5.1. Prevalence and health consequences 
Obesity is a major modifiable risk factor for CVD and increases the risk of 
developing conditions, such as T2 DM, dyslipidaemia and hypertension that, in turn, 
further increase CVD risk (Abate, 2000; Bjorntorp, 1992; Eckel & Krauss, 1998; 
Ferrannini et al., 1997; Li et al., 2007a). Individuals who are overweight or obese 
(specifically central obesity) are at greater risk for insulin resistance (Austin et al., 
1990; Formiguera & Canton, 2004; Sowers, 2003). In an examination of the inter- 
relationships between body mass index (BMI), energy intake, and physical activity to 
CVD mortality, obesity and lower levels of physical activity were independently 
associated with decreased CVD survival (Fang et al., 2003). 
Using a BMI of 25-30 kg. m2 as overweight and BMI>30 kg/m2 as obese, most of the 
states in the US have obesity prevalence rates equal to or greater than 25%, with 3 of 
those having a prevalence equal to or greater than 30% (U. S. Department of Health 
and Human Services, 2005a). In the UK, 41% of men and 33% of women are 
overweight. An additional 25% of men and 20% of women are obese (Foods 
Standard Agency & Department of Health, 2004). Obesity is associated with 
increased risk of T2 DM. In the Nurses' Cohort Study, for an increase of 20-35 kg, 
the relative risk of developing T2 DM diabetes was 11.3, and for an increase of more 
than 35 kg, the relative risk was 17.3 (Colditz et al., 1990). 
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In Kuwait, the prevalence of obesity (Figure 1.3) may be increasing in both men 
(32.8%) and women (47.9%) of 20 years and older (WHO Regional Office for the 
Eastern Mediterranean, 2005). A comparison of two cross sectional samples studied 
in the year 1980-1981 and 1993-1994 for the prevalence of obesity showed that the 
frequency of overweight and obesity increased significantly among males and 
females between these two periods (Al-Isa, 2003). The prevalence of obesity 
increased by 15.4% and by 8.4% among men and women respectively. A recent 
study of the prevalence of obesity in Kuwait (Al-Kandari, 2006) indicated that most 
of the obese individuals, in a sample of 212 men and 212 women, were grade 2 
obesity (30<BMI<40). In addition, 71.2% of this sample was obese with obesity 
increasing with age and being more prevalent in women. In the same study, the high 
prevalence of obesity was found to correlate with the level of education, eating 
regularly at restaurants, and with the availability of a family cook and the 
socioeconomic status of the family. Obesity, in a T2 DM Kuwaiti population, was 
also found to be a significant risk factor for CHD (Abdella et al., 1998). In general, 
more than one third of patients with T2 DM are obese (Franz, 2004). Beside CHD, 
there are numerous other diseases that are either caused or made worse by the 
presence of obesity (O'Brien & Dixon, 2002); T2 DM parallels the epidemic of 
obesity and is at the top of the list of these diseases (Table 1.3). 
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Figurel. 3. Overall trends in obesity in the world from 1980-1998 (British Heart 
Foundation. 2005b). The diagram shows Kuwait with one of the highest prevalence 
rates for obesity with more than I% increase in obesity each year. 
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Table 1.3. Obesity-associated health risks (O'Brien & Dixon, 2002) 
T2 DM 
Hypertension 
Dyslipidemia 
Ischemic heart disease 
Stroke 
Cardiomyopathy 
Obesity hyperventilation syndrome 
Asthma 
Obstructive sleep apnea 
Gallstones 
Nonalcoholic steatohepatitis 
Urinary incontinence 
Osteoarthritis: knees, hips, feet 
Lower back pain 
Infertility 
Polycystic ovary syndrome 
Obstetric complications 
Fetal abnormalities 
Depression 
Cancer: breast, bowel, prostate 
Venous ulcers 
Accident prone 
Gout 
Gastroesophageal reflux 
Skin disorders 
1.5.2. Abdominal obesity 
BMI provides an indication of total body fat content but does not take account of the 
distribution of body fat (Sowers, 2003). It therefore provides a useful marker of 
being overweight or obese but not central obesity. The pattern of fat distribution, as 
assessed by waist circumference, can be used as an alternative definition of obesity 
and is particularly important for cardiovascular risk assessment (Bjorntorp, 1992; 
Frayn, 2001; Li et al., 2007a; Ritchie & Connell, 2007). It is notable that in the last 
15 years, the prevalence of abdominal obesity has been increasing continuously with 
increased obesity (Li et al., 2007a). In 1956, Vague introduced the idea of systematic 
evaluation of the role of fat distribution on risk for obesity-related morbidity (Vague. 
1956). Vague coined the term android and gynoid obesity. In this study, android 
obesity was found to be more frequently associated with diabetes mellitus, coronary 
artery disease than gynoid obesity (Vague, 1956). Beside the finding that obesity is 
strongly predictive of CAD, the Framingham Heart Study (Diabetes Prevention 
Program Research Group, 2002) also demonstrated that the risk for CVD is 
significantly increased when abdominal obesity (waist circumference > 102 cm in men 
and >88 cm in women) is present. 
Central obesity is characterized by greater deposition of fat in the central part of the 
body, and has been shown to correlate with insulin resistance (Frayn, 2001; Ritchie & 
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Connell, 2007; Frayn et al., 2005; McFarlane et al.. 2001). This is, as previously 
mentioned, because increased body fat, particularly abdominal fat, is associated with 
increased lipolysis and elevated plasma concentrations of NEFA (Frayn et al., 2005; 
Jensen, 1989). NEFA can interfere with the cellular mechanisms of insulin signaling 
and down regulate cellular sensitivity to insulin (Shulman, 2000). Since the risk for 
developing T2 DM is high in overweight and obesity, assessing weight and waist 
circumference in these individuals is particularly useful for identifying those at risk 
(Sharp et al., 2003). In Sharp's study, all the anthropometric indices that were 
measured were positively correlated with total cholesterol (T. Cholesterol). insulin. 
glucose, TAG, and systolic and diastolic blood pressure and negatively correlated 
with HDL-C. Reduction in central abdominal fat has also been linked to a less 
atherogenic lipid profile (Klein et al., 2004; Norris et al., 2005). 
1.6. Dyslipidaemia in T2 DM and obesity 
The increased progression of atherosclerosis in diabetes is most likely to be the result 
of the impact of the major CVD risk factors that are more prevalent in diabetes, 
namely obesity and dyslipidaemia (Resnick & Howard, 2002). The Framingham 
Heart Study (Garge, 1994) found that dyslipidaemia was common in adults with 
diabetes and considered it to be an independent risk factor for CVD in this 
population. The key characteristics of T2 DM dyslipidaemia are moderate 
hypertriacylglycerolaemia, increased postprandial lipaemia a predominance of small 
dense LDL (sdLDL) and decreased HDL (especially HDL2) concentrations (Table 
1.4; syvanne & Taskinen, 2005; Rizzo & Berneis, 2006a; Rizzo et al., 2007; Austin et 
al., 1994; Griffin & Zampelas, 1995). This collection of lipoprotein abnormalities 
frequently presents as a subclinical dyslipidaemia that is referred to as an atherogenic 
lipoprotein phenotype (ALP). This ALP is not restricted to persons with T2 DM; it is 
also common in obese individuals with insulin resistance (Grundy, 1997; Rizzo & 
Berneis, 2005). An ALP is found in 50-75% of patients with T2 DM (Beckman et al., 
2002). Although an increased production of plasma apo B has not been universally 
accepted as being part of the definition of ALP, increased LDL particle number has 
emerged in recent years as a major source of increased CVD risk (Ahmed et al., 
2007, Griffin et al., 1999; Griffin et al., 2000; Wagner et al., 2002). 
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Table 1.4. Characteristics of ALP (Griffin & Zampelas, 1995). 
Parameter Fasting plasma concentration 
TAG 
sdLDL-III (density 1.044-1.060g/ml) 
HDL cholesterol 
HDL2 (large HDL particle diameter 
9.7-12.9nm) 
Enhanced postprandial lipaemia 
Cholesterol ester enriched VLDL and 
CM remnants 
Insulin resistance 
1.5-2.3 mmol/1 
>40% of total LDL plasma 
<1 mmol/1 
<10% total HDL 
1.6.1. Pathophysiology of an ALP 
1.6.1.1. Increased TAG rich lipoproteins 
TAG-rich lipoproteins include several species of lipoproteins that are either newly 
secreted or modified in the circulation (which are called remnant lipoproteins). As 
stated before, remnant lipoproteins are formed by LPL in the circulation. During the 
catabolism of TAG- rich lipoproteins the cores of these lipoproteins are reduced in 
TAG content but are enriched in cholesterol esters via the action of CETP (Morton & 
Zilversmit, 1982). An elevated concentration of TAG-rich lipoproteins in the 
postprandial phase is a common feature of insulin resistant states, such as obesity and 
T2 DM, that may directly predispose to CHD (Grundy, 1999). A moderate rise in 
plasma TAG (>1.5mmol/1) influences LDL size and density through a cycle of lipid 
exchange (Taskinen et al., 1996; Griffin et al., 1994). This concentration of plasma 
TAG allows enhanced CETP mediated exchange of cholesteryl ester from LDL and 
HDL for TAGs from VLDL and chylomicrons, leading to enrichment of LDL and 
HDL with TAG. Hydrolysis of core TAGs by HL, which is often increased in T2 
DM (Baynes et al., 1991), results in the formation of sdLDL and small dense HDL 
(sdHDL; Figure 1.4). 
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Figure 1.4. Mechanism of generation of sdLDL and sdHDL in obesity and T2 DM 
(Ginsberg, 2000). Insulin resistant adipocytes fail to suppress the release of NEFA 
into the circulation in the postprandial phase leading to increased NEFA uptake by the 
liver for TAG synthesis. This in term may stimulate the assembly and secretion of 
apo B and VLDL. The result is an increased number of VLDL particles and increased 
concentration of TAG in the plasma. This can accelerate neutral lipid exchange and 
promote a net transfer of TAG to LDL and HDL, leading to two outcomes: a 
cholesterol rich VLDL remnant particle that is atherogenic, and a TAG-rich 
cholesterol depleted HDL particle. The triglyceride-rich HDL particle can undergo 
further modification including hydrolysis of its TAG by HL thereby leading to the 
formation of sdHDL particles. Increased concentrations of VLDL TAG also enhance 
the transfer of TAG into LDL in exchange for LDL cholesteryl ester. The TAG-rich 
LDL can be hydrolysed by HL to the form sdLDL particles. 
The increase in plasma TAG for VLDL assembly in the liver in insulin resistant states 
may be derived from three main sources; an increased flux of NEFA from adipose 
tissue to the liver, hepatic uptake of VLDL and chylomicron-derived remnants, and 
increased hepatic lipogenesis (Ginsberg et at., 2005). After the original exclusion of 
plasma TAG as a risk factor for CHD as a result of its association with other risk 
factors such as HDL, raised plasma TAG has re-emerged as an independent risk 
factor for CHD. This was largely due to the results of a meta-analyses of 17 
prospective population studies, which established raised plasma TAG as an 
independent risk factor for CHD in a total of 46,413 men and 10.864 women 
(Hokanson & Austin. 1996). 
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1.6.1.2. Role of sdLDL in CVD 
Evidence for the role of sdLDL in CVD has been derived from cross sectional, 
prospective and clinical intervention studies (Gardner et al., 1996; Griffin et al., 1990: 
Griffin et al., 1994; Grundy, 1997; Rosenson, 2004; Wood et al.. 2006; Austin et al.. 
1988). Indeed, elevated concentrations of these particles has been associated with a3 
to 4-fold increase in the risk of acute myocardial infarction (Rizzo & Berneis, 2005, 
Austin et al., 1988). The NCEP ATP-III (2002) has therefore recognized a 
predominance of small dense sdLDL (LDL-III; Figure 1.5) as an emerging 
cardiovascular risk factor. Austin and colleagues (1990) were the first to investigate 
the clinical relevance of sdLDL. They analysed the LDL of 301 subjects by using 
non-denaturing gradient gel electrophoresis. In this study, two distinct phenotypes 
were identified; phenotype `A' which was characterized by predominance of large, 
buoyant LDL particles, and phenotype `B' which consisted of a major peak of sdLDL 
particles. Phenotype `B' was specifically associated with increased plasma TAG and 
apo B and a decreased HDL-C and plasma apo A-I. While the majority of healthy 
subjects have LDL particles that are large and buoyant, about 30-35% of Europeans 
have a predominance of sdLDL particles. Phenotype 'B' has been associated with a 
number of other metabolic changes including raised intermediate density lipoproteins 
(IDL) (Austin et al., 1990) and reduced insulin sensitivity (Reaven, 1995). 
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Figure 1.5. Plasma LDL subclasses of normal and ALP subjects (Griffin & 
Zampelas, 1995). 
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The activity of CETP and endothelial lipases LPL and HL have been identified as 
major metabolic determinants of LDL particle size (Griffin & Zampelas. 1995). In 
order to evaluate the roles of these proteins in determining LDL subfraction 
distribution in T2 DM, a study of 137 patients with T2 DM (75 male & 62 female) 
and 140 matched controls (80 male & 60 female) was conducted (Krauss, 1998). The 
findings of this study supported the hypothesis that plasma TAG influences the 
formation of sdLDL particles through a cycle of lipid exchange via the action of 
CETP as described earlier (Section 1.6.1.1). Kinetic studies also indicated that the 
amount and type of VLDL secreted from the liver may determine the size of LDL 
formed in the circulation (Tan et al., 1999). More specifically, LDL derived from 
large VLDL was shown to be similar to sdLDL with respect to its lower fractional 
catabolic rate and longer residence time in plasma, suggesting that sdLDL may be the 
product of larger, TAG-rich VLDL particles (Packard et al., 2000). 
Small, dense LDL has been associated with increased risk of atherosclerosis through 
several inter-related mechanisms. sdLDL binds to the arterial wall with greater 
affinity than native LDL (Demant & Packard, 1998). sdLDL is also more susceptible 
to glycation and oxidative modification (Yu et al., 2007) which contributes to their 
increased atherogenicity in diabetic patients (Wagner et al., 1989). Along with IDL, 
oxidized LDL can readily be taken up by arterial wall macrophages that thereby 
become foam cells (Wagner et al., 2003). Postprandial lipaemia has also been 
implicated in generating increased atherogenicity through sdLDL (Griffin & Fielding, 
2001). 
Recent findings from several primary and secondary prevention trials have indicated 
that raised plasma apo B is a better index of atherosclerotic risk than LDL-C, 
essentially because raised apo B provides a marker for an increased number of 
circulating LDL particles (Gotto et al., 2000; Ahmad et al., 2007). In addition, LDL- 
C: apo B ratio is an important tool to detect phenotype `B' in T2 DM patients (Wagner 
et al., 2002). The ratio of apo B: non HDL-C (a measure of total cholesterol minus 
HDL-C) is also essential for the identification of dyslipidaemia that confers high 
CVD risk in patients with T2 DM (Wagner et al., 2002). While raised apo B (>1.3 
g/1) is characterized by an abundance of sdLDL, a predominance of sdLDL (as >50%; 
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phenotype 'B') may not always be found in association with raised number of LDL 
particle (LDL apo B) (Griffin et al., 1999). 
1.6.1.3. Low HDL cholesterol concentration 
The concentration of plasma HDL-C is a major predictor of CVD risk (Rosenson, 
2004; Gardner et al., 2000; Link et al., 2007). Large prospective studies have shown 
that low HDL-C independently increases the risk for coronary artery disease (Gordon 
et al., 1977; Link et al., 2007). In a follow-up study of risk factors in 229 T2 DM 
patients who had no history of CHD and stroke, low HDL-C was an independent risk 
factor for the development of CHD (Gordon et al., 1977). In addition, HDL-C has 
been shown to be a better discriminator of CHD than LDL-C and for every 0.026 
mmol/l increase in HDL-C, CHD is reduced by 3% (Castelli, 1988). 
Among other factors, it has been suggested that any benefit underlying elevated HDL 
cholesterol concentrations could be mainly attributed to the larger, more cholesterol- 
rich HDL2 subfraction (Gardner et al., 2000; Gofman et al., 1966). The Kuopio 
Ischemic Heart Disease Risk Factor Study (Gofman ei al., 1966) also indicated that 
the cardioprotective effect of elevated HDL cholesterol concentrations may be 
attributed to the HDL2 subclass. HDL2 levels have also been inversely correlated with 
abdominal fat, plasma insulin concentrations, and glucose intolerance (Ostlund et al., 
1990). The weaker association between smaller HDL3 and CVD risk is thought to 
arise from the shorter half-life, lower TG: CE ratio and lower anti-oxidative activity of 
these smaller particles (Hansel et al., 2004). 
HDL particles in subjects with T2 DM are small and have a low free cholesterol 
content (Syvanne et al., 1995; Link et al., 2007; Syvanne & Taskinen, 2005). In 
insulin resistant individuals, HDL-C and apo A-I concentrations are reduced as a 
result of the action of CETP mediated transfer of cholesteryl ester from HDL to TAG 
rich lipoproteins (Link et al., 2007). Non-HDL-C has also been shown to represent a 
useful CVD risk marker for predicting the risk for CVD in T2 DM (Lu et al., 2003). 
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1.7. Dietary management of CVD risk in T2 DM and obesity 
The clinical management of diabetes, insulin resistance, hypertension, obesity, and 
other risk factors aims to substantially reduce the risk of CVD. Similarly, weight loss 
and glycaemic control are key goals for reducing CVD risk in diabetes. Clinically 
significant weight loss of 5-10% of body weight has beneficial effects not only on 
blood lipids (Wing et al., 1987a; Wing et al., 1994; Blackburn et al., 2001; Wood, 
2006) and risks associated with obesity (Blackburn et al., 2001; Krauss et al., 2006) 
but also on insulin sensitivity and glycaemic control (Krauss et al., 2006; Wing et al., 
1987a; Wing et al., 1994; Heilbronn et al., 2002). It has been suggested that 
glycaemic control alone is not sufficient to reduce CVD risk in many patients 
(Schernthaner et al., 1983). The UKPDS data indicated that HbAIc ranked below 
LDL-C and HDL-C as risk factors for CAD and below LDL-C and diastolic blood 
pressure as a determinant of risk for fatal or non fatal myocardial infarction (Turner et 
al., 1998). Therefore, the treatment of dyslipidaemia in patients with T2 DM is 
essential. This is also indicated through the guidelines of NCEP ATP-III (2001) and 
the American Diabetes Association (2004b). 
Dietary modification in T2 DM represents a simple tool for treatment and prevention 
of CHD. Epidemiological and experimental studies have identified many nutrients 
that either protect against or stimulate one or more of the risk factors for CHD (Wood 
et al., 1998; Frost et al., 1999; Wood, 2006). Epidemiological studies have clearly 
shown that diets high in fat and especially saturated fat are associated with insulin 
resistance (Mayer-Davis et al., 1997) and hyperlipidaemia (Tanasescu et al., 2004). 
Substitution of dietary saturated fat with a diet enriched in polyunsaturated fatty acid 
(PUFA) in an isoenergetic diet resulted in increased insulin sensitivity and reduced 
LDL-C (Summers et al., 2002) but these effects were not necessarily related to 
increased PUFA or decreased saturated fat intake in the PUFA group. In addition, 
diets enriched with PUFA have not always been associated with insulin sensitivity 
(Mayer et al., 1993). High monounsaturated fatty acid (MUFA) diets have also been 
advocated as dietary alternatives to improve insulin sensitivity (Vessby et al., 2001). 
However, within individuals with a high fat intake (37% of energy), beneficial effects 
on insulin sensitivity were not seen. The replacement of energy from saturated fat 
with carbohydrate stimulates hepatic synthesis and secretion of VLDL and TAG 
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leading to an increase in TAG-rich lipoproteins and lower HDL-C concentrations 
(Abbasi et al., 2000; Liese et al., 2007; Liu et al., 1983). It has therefore been 
suggested that the quality of dietary carbohydrate should be considered as a 
potentially modifiable factor that together with weight control and exercise may play 
a role in CVD prevention and treatment in diabetes (Jenkins et al.. 2002). 
1.7.1. Glycaemic index of carbohydrates 
In (1936) Conn and Newburgh noted that different carbohydrate containing foods 
with the same macronutrient composition elicited different glycaemic responses. In 
1981 Jenkins introduced the term glycaemic index as a means of quantifying the 
glycaemic response to different dietary carbohydrates for the dietary management of 
diabetes. Therefore, in determining the potential metabolic effects of a diet, the 
physiological assessment of foods, represented by the glycaemic index (GI), is a 
useful supplement to chemical analysis of their dietary fibre content and composition. 
High GI carbohydrate-rich foods have been proposed to increase hunger and elevate 
NEFA concentrations, leading to an increased risk of CVD (Wolever, 1990a). 
Consequently, the WHO (1998) recommends the classification of dietary 
carbohydrate according to the GI and endorses the usefulness of GI in dietary 
planning. 
1.7.1.1. Definition of glycaernic index (GI) and load (GL) 
GI is a measure of the postprandial glucose response as a result of the consumption of 
carbohydrate-rich food and provides a standardized comparison of the 2 hour 
postprandial glucose response of a carbohydrate with that of white bread or glucose 
(FAO/WHO, 1998). It is defined as the incremental area under the blood glucose 
response curve elicited by a 50 g of available carbohydrate in portion of a 
carbohydrate-rich food, expressed as a percentage of the glucose response to 50 g of a 
reference material (usually 50 g of glucose in solution or white bread) in the same 
subject. The GI can therefore be calculated by using the following formula 
Incremental area under 2-h plasma glucose curve for test food 
GI containing 
50 g available CHO x100 = Incremental area under 2-h plasma glucose curve for 50 g glucose 
'Y) 
As such, low GI (LGI) carbohydrates (GI<55%) are those that are digested and 
absorbed slowly and lead to a low glycaemic response, whereas HIGH GI foods 
(GI=70% or more) are rapidly digested and absorbed and exhibit a high glycaemic 
response. A medium GI food will have a GI of 56-69% (Figure 1.6). Much of the 
carbohydrates present in the Western diet contain refined polysaccharides, such as in 
bread and baked products, and sugars, found in juices and sodas. These have a HIGH 
GI, causing glucose and insulin to increase substantially (Ludwig, 2007). Other types 
of carbohydrates found in certain whole grains, beans, nuts, and vegetables have a 
lower GI and cause less of a postprandial increase in serum glucose and insulin. 
The International Table of Glycaemic Index Values (Foster-Powell et al., 2002) was 
first published in 1995, and has been since updated to include the GI values for over 
750 different types of foods (Ludwig, 2007). These tables provide the GI for each 
food with either glucose or white bread used as the reference food. Along with the GI 
values, the tables include values for the glycaemic load (GL) of certain carbohydrate- 
rich foods. The GL concept was first introduced in 1997 (Salmeron et al., 1997a; 
Salmeron et al., 1997b) to quantify the overall glycaemic effect of a portion of food. 
It is the product of dietary GI and total dietary carbohydrate, therefore it is 
representative of the quantity as well as the quality of carbohydrate consumed and 
provides a useful measure of the total glycaemic effect (Salmeron et al., 1997a; 
Salmeron et al., 1997b). The higher the GL, the greater the elevation in glycaemic 
and insulinaemic response (Foster-Powell et al., 2002). 
Data from the Framingham offspring cohort study demonstrated that the intake of 
whole grain was inversely associated with insulin resistance, as measured by the 
homeostasis model assessment of relative insulin resistance (HOMA-IR), and a lower 
prevalence of the metabolic syndrome (McKeown et al., 2004). In this study, dietary 
GI, but not the GL, was positively associated with HOMA-IR and the prevalence of 
the metabolic syndrome. Consistent with this, Brand-Miller (2004) showed that the 
GI of carbohydrate rich foods was significantly associated with disease risk more 
often than the GL of the diet. Accordingly, there is accumulating evidence that a diet 
with a predominance of foods that elicit low glycaemic responses, induces modest 
clinically beneficial effects in diabetes (Salmeron et al., 1997a; Salmeron et al., 
1997b: Opperman et al., 2004), CVD risk (Opperman et al., 2004; Liu et al., 2000, 
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Frost et al., 1999), and certain forms of cancer (Augustin et al.. 2003). while the role 
of this diet for the management of obesity has recently been debated (Pawlak et al., 
2002; Raben, 2002). 
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Figure 1.6. Glycaemic response after ingestion of pasta, wholemeal bread, and white 
bread (Frost & Dornhorst, 2000). Pasta has a relatively lower 2h postprandial 
response compared with white and wholemeal breads. 
1.7.1.2. Factors affecting GI 
The increase in plasma glucose after a meal is determined by the rate of absorption of 
a carbohydrate which, in turn, is controlled by the rate of gastric emptying, and rate of 
hydrolysis in the gastrointestinal tract (Augustin et al., 2002). The latter two 
processes are affected by the composition of the food, the tertiary structure, and the 
susceptibility of the starch molecules to enzymatic digestion (Jenkins et al.. 1988a). 
The GI of carbohydrate-rich food provides an indication of the rate at which 
carbohydrate-rich foods are digested (Jenkins et al., 1981). One of the other factors 
that affect the rate of glucose absorption from a carbohydrate-rich food and hence the 
GI value is the proportion of amylose to amylopectin (Avenell et al.. 2004b). 
Amylose is a linear molecule with D-glucose units linked in by al-4 linkages. 
Amylopectin has both al-4 and al-6 linkages (Behall et al., 1988), and is thereby a 
branched structure (Figure 1.7). The rate of absorption is affected by the ratio of the 
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two types of starch (Behall et al., 1988). The higher the proportion of amylopectin. 
the higher the GI, because amylopectin is more easily hydrolyzed in the gut than is 
the single stranded amylase (Annison & Topping, 1994; Miller et al., 1992). For 
example, much of the variation in the GI of different rice brands is due to the 
variation in this ratio (Miller et al., 1992). Rice varieties that contain a higher 
proportion of amylose have been shown to have a slower rate of digestion and 
produce lower GI (Juliano & Goddard, 1986; Miller et al., 1992). 
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Figure 1.7. Structure of A; amylose and B; amylopectin. The ratio of amylose to 
amylopectin affects the rate of carbohydrate absorption and the GI. 
In addition, studies have shown that diets rich in soluble non-starch polysaccharides 
(NSP), such as guar gum and ß-glucan, produce lower postprandial blood glucose and 
insulin concentrations (Miller et al., 1992). When Wolever (1990a) studied the 
dietary fibre content and composition of 25 foods and related them to their GI, total 
dietary fibre was significantly related to GI (r=-0.461, p<0.05). Soluble NSPs are 
found in pulses, vegetables, whole fruits, oats, and barley. They form gelatinous gels 
in the stomach and delay gastric emptying and enzyme digestion. These, plus other 
factors that might affect the GI of the carbohydrate-rich foods are listed in Table 1.5. 
1.7.1.3. Aspects of the practical measurement of GI 
A frequent criticism of the GI is that it is subject to significant inter and intra 
individual variation (Brouns et al., 2005). However, Wolever (2006) emphasized that 
most of the variation appears in the plasma glucose response as assessed by 
incremental area under the curve elicited by a carbohydrate meal. This is reduced 
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when expressed as a ratio compared with the response to 50g glucose, as in the 
measurement of GI. Feeding experiments have shown that variation in glycaemic 
response to a single food between different individuals is small. For example, in 
determining the GI of 5 foods in 47 subjects (Wolever, 2006), about 50% of the 
variance of the AUC of glucose was due to variation between subjects, 25% was due 
to day to day variation within subjects, and 25% to variation between foods. When 
expressed as GI, the total variance was reduced by 45%, by a reduction in the between 
subjects variation (Wolever, 2006). 
Table 1.5. Factors affecting the GI of a carbohydrate rich food (Augustin et al., 
2002). 
Factors that affect the GI Factors that decrease GI Factors that increase GI 
Nature of the starch T Amylose/Amylopectin JAmylose/Amylopectin 
Nature of monosaccharide Fructose Glucose 
components Galactose 
Viscous fibre TGuar Guar 
TP -Glucan J ß-Glucan 
Cooking/ Food processing Parboiling Extruding 
Cold extrusion Flaking 
popping 
Particle size Large particles Grinding (small particles) 
Ripeness and food storage Unripeness Ripeness 
Cooling 
a-Amylase inhibitors TLectins ILectins 
TPhytates jPhytates 
Nutrient starch interaction TProtein Protein 
TFat 
, 
Fat 
T High levels 
Low levels 
The measurement of the GI of foods has also been criticised in terms of its wide 
variation and precision between different labs. For instance, the GI values reported 
by different laboratories vary widely for some foods such as potato (Wolever et al., 
1994a; Fernandes et al., 2005; Henry et al., 2005) and rice (Miller et al., 1992; Foster- 
Powell et al., 2002). In addition, the results of the most recent GI testing of 33 
commercially available foods in the UK (breakfast cereals, breads, pasta, rice and 
potatoes) were different from previously published values of similar foods (Aston et 
al., 2007). However, this variation can usually be explained by real differences 
between the foods in terms of their processing and cooking methods, as well as other 
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factors that were described in Table 1.5. It is noteworthy that the between laboratory 
standard deviation (SD) for GI value was 9 in a recent inter-laboratory (28 
laboratories around the world) study of GI (Wolever et al., 2007). An expert panel 
from the WHO (FAO/WHO, 1998) brought consensus to GI measurement as part of a 
global discussion on the role of dietary CHO in nutrition. This discussion provided 
guidelines and a reference methodology for the future testing of GI. More relevant GI 
methodological considerations regarding the number of subjects, sex, subject status, 
and pre-test conditions, carbohydrate test dose, blood sampling procedures, sampling 
times, test randomisation and calculation of glycaemic response (IAUC), have been 
reviewed more recently in light of the standardised GI testing methodology of the 
WHO (Brouns et al., 2005). The GI testing methodology of this review provided 
detailed and evidence-based guidelines for the measurement of GI. The method was 
standardised to improve quality control within laboratories and thus increase 
confidence in the measurement of GI (Brouns et al., 2005). 
Although the GI and the carbohydrate content of foods are the strongest determinants 
of the variation in the mean glycaemic responses to different carbohydrate rich foods 
(Wolever et al., 2006), the presence of other constituents in the food, such as fat and 
protein, influences the total glycaemic response (Lovejoy et al., 1998; Nuttall et al., 
1984). The term insulinaemic index (II) of foods was introduced to further elucidate 
this, ranking the impact of carbohydrates on postprandial plasma insulin instead of 
plasma glucose (Holter et al., 1997). The II of food provides additional information 
in the dietary management of diabetes (Bornet et al., 1997; Miller et al., 1992). 
However, although many studies have reported `II' values beside the GI when 
assessing the physiological effects of food (Indar-Brown et al., 1992; Larsen et al., 
2000; Ostman et al., 2001; Abdelgadir et al., 2005; Flint et al., 2006), and despite the 
high correlation between the two measures (Holter et al., 1997), the clinical 
usefulness of this food parameter is questionable as it varies in different groups of 
people (Wolever et al., 1998; Wolever, 2006). In mixed meals, particularly in milk- 
based meals, large inconsistencies between glycaemic and insulinaemic responses 
have been noted both in normal and diabetic subjects (Gannon et al., 1986). 
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1.7.1.4. Effect of GI on glycaemic control 
There is compelling evidence to show that controlling postprandial gl`ycaemia is 
important for macro and microvascular risk reduction in both type 1 (Diabetes 
Prevention Program Research Group, 2002) and T2 DM patients (UKPDS, 1998). 
For example, a 1% reduction in mean HbAlc (a measure of glycaemic control) is 
associated with a 21% reduction in severe end points related to diabetes such as 
mortality, heart failure, stroke, retinopathy, amputation and myocardial infarction 
(Stratton et al., 2000). Therefore in 2004 the American Diabetes Association 
recommended keeping glycaemic control, as assessed by HbA lc concentrations, to 
<7% (AHA, 2004). 
The body of evidence to support a beneficial effect of low glycaemic index (LGI) 
diets on glycaemic control is very strong. For example, a meta-analysis of the 
randomized controlled trials that have examined the efficacy of the GI on overall 
blood glucose control indicated an additional benefit of using a LGI diet over that 
observed when total carbohydrate was considered alone (American Diabetes 
Association, 2004b). Glycated proteins, including both HbAlc and fructosamine, 
were reduced by 7.4% on the LGI diet. Specifically, there was a 0.4% reduction in 
HbAlc in diabetics who followed a LGI diet compared to high GI diets, whilst 
fructosamine concentrations were also lowered by 0.2 mmol/l. Measurement of 
plasma fructosamine is favoured as a short term marker of glycaemic control in 
studies that last for 6 weeks as the effect is reported to change maximally in 4-6 
weeks (Jones et al., 1983). The longer the consumption of LGI foods, the larger the 
decreases in fructosamine concentrations (Brand-Miller et al., 2003a). Even when the 
improvement in glycaemic control was not significant (Heilbronn et al., 2002), the 
consumption of a LGI diet in T2 DM patients was associated with a 2-fold reduction 
in HbAlc compared with subjects consuming a HIGH GI diet. Another recent meta 
analysis (Opperman et al., 2004) of 16 studies that investigated the effect of LGI diets 
compared to HIGH GI diets on CVD risk, indicated an overall significant reduction in 
fructosamine concentrations in subjects receiving the LGI diet (-0.1 mmol/l; p=0.05). 
Mean HbA 1c was also decreased significantly by 0.27% (p=0.03). A selection of 
studies on the effects of LGI diets on glycaemic control are summarized in Table 1.6. 
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1.7.1.5. Effect of LGI diet on obesity 
The role of GI on appetite and body weight regulation has been a recent topic of 
debate (Raben, 2002; Pawlak et al., 2002). Some researchers have suggested that 
LGI foods are potentially beneficial in terms of weight management through their 
satiating qualities. Much of the evidence for this came from the WHO (1998) which 
reported that the consumption of a high fibre diet was beneficial with respect to 
weight management. For example, a prospective cohort study of 74.091 US female 
nurses, aged 38-63 years (Liu et al., 2003), reported that women who consumed more 
whole grains consistently weighed less than women who consumed less whole grains. 
Over a 12 years period, those with the greatest increase in intake of dietary fibre 
gained an average of 1.52 kg less than those with the smallest increase in intake of 
dietary fibre, independent of body weight at baseline. In this study, weight gain was 
inversely associated with the intake of high fibre, whole grain foods and positively 
related to the intake of refined grain foods. In addition, intervention studies such as 
the study by Slabber et al. (1994), indicated that women (n=30) who followed a LGI 
diet lost 9.4 kg as compared to 7.4 kg for those who followed a HIGH GI diets. 
These studies have therefore led to the conclusion that LGI foods typically induce 
higher satiety than HIGH GI foods, and are followed by a lower intake of energy 
intake at subsequent meals and therefore promote weight loss (Ludwig, 2000; Holt & 
Bared Miller, 1994). The proposed explanation for this GI-induced satiety is based 
on the slower rate of digestion and absorption of LGI carbohydrates which results in a 
prolonged stimulation of nutrient receptors in the GI tract. This leads to prolonged 
feedback to the satiety centre in the brain through signals such as cholesystokinin and 
glucagon like peptide-I (Lavin et al., 1996). These gut hormones are known to 
decrease appetite and regulate energy metabolism (Neary et al., 2004). 
On the other hand, many studies have not shown beneficial effects of LGI diets on 
weight management. These studies are summarized in Table 1.7. Based on the 
presented studies, there is no evidence at present that low GI foods are beneficial 
compared to high GI foods with regard to long term body weight control. It is 
reasonable to conclude that while LGI diets improve metabolic cardiovascular 
factors, they do not reduce weight unless they are part of an energy-restricted diet. 
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Table 1.7. Studies against the role of GI in weight loss. 
Gý 
O ý/ 
Body weight changes 
Study n Body Type Diets wo 
ýöU 
Bouche et al. 5 11 M Overweight Ad Libitum NS 0.5 
(2002) LGI vs. HIGH 
GI 
O 
L 
Týý 
-0.3 
Frost et al. 12 51 F Overweight LGI vs. HIGH NS -0.1 -2.1 
(1994) +M GI foods 
Jimenez- 2 8 F+ T2 DM Ad Libitum NS -0.5 0.0 
Cruz et al. M patients LGI vs. HIGH 
(2003) GI 
Kabir et al. 4 13 M T2 DM LOT Vs. NS Not Not shown 
(2002) patients HIGH GI shown 
breakfast 
Luscombe et 4 21 F Overweight LGI vs. HIGH NS -0.9 -0.6 
al. (1999) +M GI foods 
Raatz et al. 24 29 F Obese Energy NS -1.8 -1.6 
(2005) +M controlled 
HIGH GI, 
LGI, LF 
Raben et al. 2 20 F Normal Ad Libitum T 0.2 -0.7 
(1997) weight LGI vs HIGH 
GI 
Sloth et al. 10 45 F Overweight Ad Libitum NS -1.9 -1.3 
(2004) +M LGI vs HIGH 
GI 
Tsihlias et 24 72 F Normal LGI vs. HIGH NS 0.5 -1.7 
al. (2000) +M weight & GI breakfasts 
overweight 
UIrihPVPr 
of A is F+ Overweight Hvnocaloric NS -1.8 -2.5 "Y V! V Y Vl L! Výý-- -- - -ý-- J1 
al. (1992) M& obese LGI vs. HIGH 
GI 
F female, M male, NS not significant, LF low fat 
ý1 
1.8.1.6. Effect of GI on insulin sensitivity 
The GI of the diet has been shown to influence both glucose and insulin secretion 
(Ludwig, 2007). High GI diets have been linked with hyperinsulinaemia (McKeown 
et al., 2004; van Dam et al., 2000) which, in turn, may downregulate insulin 
receptors, reducing insulin efficiency, therefore resulting in insulin resistance. This 
condition acts in a vicious circle of increased glucose and insulin secretion (Figure 
1.8) (Augustin et al., 2002). 
High glycemic index foods 
1 Glucose 
Insulin receptor 11 Insulin 
down-regulation 
Figure 1.8. Potential mechanism for the relationship between high GI foods and 
insulin resistance (Augustin et al., 2002). 
Several studies have examined the effects of LGI diets on hyperinsulinaemia and 
insulin resistance. In a3 week study in women with increased risk of CHD, a diet 
with LGI was associated with increased insulin sensitivity (Frost et al., 1998). In 
another study (Jarvi et al., 1999) with a randomized cross over design, the effect of a 
LGI diet on insulin sensitivity was evaluated in 20 T2 DM patients. Insulin 
sensitivity was measured by the euglycemic hyperinsulinaemic clamp technique. 
Peripheral insulin sensitivity increased significantly after the consumption of the LGI 
diet. The incremental area under the curve for both blood glucose and plasma insulin 
was also lower by 30% compared to the high GI diet. These, and other studies 
(Dumesnil et al., 2001) have reported improved insulin sensitivity with low compared 
with high GI diets. 
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The influence of LGI diets on insulin sensitivity is thought to be regulated by NEFA 
concentrations (Wolever et al., 1995). High GI carbohydrates stimulate high insulin 
concentrations as a result of their rapid absorption. This is followed by a rapid 
glucose fall, often to below baseline values. This situation results in a counter- 
regulatory response with the release of NEFA in the late postprandial phase to a level 
well above that observed after a low GI meal, creating an insulin resistant 
environment. The improvement in insulin sensitivity seen in patients with CHD 
(Frost et al., 1998) or T2 DM (Jarvi et al., 1999; Wolever et al., 1992) on diets with 
LGI has been attributed to a greater suppression of release of NEFA. 
However, some investigators have suggested that the fibre content of the diet is more 
closely related to insulin sensitivity than the GI. In the Insulin Resistance 
Atherosclerosis Study (Liese et al., 2005), 979 adults with normal or impaired glucose 
tolerance were studied for associations between carbohydrates, fibre intake, GI and 
GL, insulin sensitivity and fasting insulin. In this study, no association was observed 
between GI and insulin sensitivity or fasting insulin after adjustment for demographic 
characteristics, family history of diabetes, energy expenditure, and smoking. In 
contrast, fibre was positively associated with insulin sensitivity and inversely with 
fasting insulin. Therefore the extent to which fibre in a food is responsible for effects 
attributable to GI remains to be determined. 
1.7.1.7. Effect of GI on an ALP 
The results from studies on the effect of dietary GI on lipid markers of CVD with 
regard to plasma TAG and HDL-C, have, to date, been equivocal. This is probably 
due to a combination of factors including limited sample size, different designs, poor 
compliance, or due to the presence of confounding factors such as the fibre content of 
the diet. Although one of the largest cross sectional analysis of metabolic risk factors 
in 394 men in the Dutch town Zutphen (van Dam et al., 2000) found no association 
between GI and blood concentrations of T. Cholesterol, HDL-C, TAG, insulin or 
glucose, many other prospective and intervention studies have highlighted the 
potential of a LGI diet in improving the ALP. 
Frost et al. (1999) found a negative relationship between the GI of the diet and HDL- 
C for both men and women in a cross sectional nutritional survey of 1420 British 
JJ 
adults, using a multiple regression model. This relationship was also found to be 
more pronounced in women. The same study indicated that the GI of the diet was a 
stronger predictor of HDL-C than dietary fat intake. The concentration of HDL-C is 
expected to improve with a LGI diet since this diet is associated with reduced hepatic 
gluconeogenesis and suppression of NEFA release (Rizkalla et al., 2002). In accord 
with the original findings of Frost et al (1999) were the results of the Third National 
Health and Nutrition Examination Survey of 13,907 adults (Ford & Liu, 2001). This 
study indicated that a difference in dietary GI of 15 units corresponded to a difference 
in HDL-C of 0.06 mmol/1. 
The effect of LGI diets on plasma TAG has also been inconsistent. While many 
studies have shown no association between the GI of the diet and plasma TAG (Frost 
et al., 2004; Jimenez-Cruz et al., 2003; Sloth et al., 2004), others have reported a 
significant fall in plasma TAG with a reduction in dietary GI (Dumesnil et al., 2001; 
Fontvieille et al., 1992; Jarvi et al., 1999; Holter et al., 1997; Ebbeling et al., 2005; 
Wolever et al., 1992; Jenkins et al., 1985). Even when the consumption of a LGI diet 
was for a short period of time (only 6 days), a decreased concentration of plasma 
TAG was observed in centrally obese men with raised baseline TAG concentrations 
(Dumesnil et al., 2001). A recent-meta analysis (Opperman et al., 2004) of 
randomized controlled trials (published in 1981 and 2003), with both crossover and 
parallel designs, showed decreases in plasma TAG in response to a LGI diet in six 
studies, though this finding was not significant due to the short duration of the studies. 
In the same meta-analysis, mean LDL-C showed a non-significant decrease after a 
LGI diet (0.15%, p=0.06). This decrease was greater in individuals with T2 DM as 
compared with healthy subjects and subjects with CHD. T. Cholesterol was also 
significantly lower in the LGI diet groups (-0.33 mmol/l; p<0.0001), with greater 
reductions being evident in those with raised baseline levels. 
A putative mechanism to explain the TAG-lowering effects of a LGI diet was first 
described by Ludwig (2002). The explanation holds that between 2-4 hours after a 
HIGH GI meal, blood insulin concentrations are higher than after a LGI meal with 
similar nutrients leading to postprandial hypoglycaemia. After 4-6 hours, counter- 
regulatory hormones are released due to the hypoglycaemia which stimulates lipolysis 
and elevated circulating NEFA. The increased circulating NEFA increases TAG re- 
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estrification and VLDL syntheses and production in the liver. The raised plasma 
TAG induced by high GI carbohydrate, might also cause the remodeling of 
lipoproteins, shifting LDL towards smaller, denser particles and reducing both HDL 
concentration and size (Ginsberg et al., 2005; Ludwig, 2007). 
Studies on the effects of LGI diets on LDL and HDL subclasses are limited (Dumesnil 
et al., 2001; Jarvi et al., 1999; Wolever et al., 2003; Rizkalla et al., 2004; Luscombe 
et al., 1999) and show inconsistent findings. Whereas the study of Luscombe et al 
(1999) in 21 obese T2 DM patients indicated no changes in sdLDL or sdHDL, 
Dumesnil et al (2001) observed an increase in LDL size. In contrast, Wolever (2003) 
found that a modest, long term reduced carbohydrate diet with increased fibre intakes 
(LGI), decreased LDL size and increased plasma TAG. The same study also showed 
increased HDL-TAG with the intake of a LGI diet which was concomitant with the 
changes in TAG concentrations. These effects were, as the author explained, 
attributed to the increased acetate availability in the colon as a result of high fibre 
consumption. With regards to the number of LDL particles, a reduction in plasma apo 
B was associated with the consumption of a LGI diet in one study (Rizkalla et al., 
2004). While LDL particle size significantly increased in the study of Dumesnil et al. 
(2001) with the intake of LGI foods, no changes were apparent regarding LDL 
particle number. Studies on the effect of the LGI diet on lipid biomarkers are 
summarized in Table 1.8. 
ýJ 
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Table 1.8. Effect of LGI diet on markers of ALP. Values represent mean concentrations of 
blood lipids (SD) by the end of the LGI diet. 
Blood lipid concentrations in LGI diet 
groups at the end of the study (mmoVl) 
Study 
ý, sD 
Ebbeling et Parallel 12 23 healthy 10 
* T* 
al. (2005)t months obese -37 -8.5 12.2 9.7 
Giacco et al. Parallel 24 63 Ti DM 20 0 90 NM (2000) weeks . (0.48) 4.7 (0.8) 1.5 (0.4) 
Luscombe et 2x4 21 obese 
T*1' T 
at (1999) §¥ 
Crossover 
weeks T2 DM 
20 1.47 5.38 0.93 3.79 
(0.19) (0.23) (0.04) (0.21) 
Jenkins et al. Crossover 2x2 6 healthy 29 
I 
0.98 I* 1.04 0.76 
(1987) weeks (0.12) 3.97(0.40) (0.14) (0.98) 
Heilbronn et Parallel 
8 45 OW T2 32 v 1.84 
*ý 
1.26 2.91 
al. (2002) § weeks DM (0.14) 
5.01(0.17) (0.08) (0.15) 
Tsihlias et Parallel 3x6 72 T2 DM 11 
H 
2.70 J. 
* H 0.97 
1* 
2.95 
al. (2000)§ months Hyperlipidemic (0.29) 5(0.14) (0.05) (0.14) 
Dumesnil et Crossover 3x7 12 OW men 35 
I*+ 
1.31 
1 
5.04 0.92 
T 
3.52 
al. (2001) days (0.38) (1.06) (0.11) (0.97) 
Frost et al. Parallel 
12 51 T2 DM 5 
1* 1* 
T 
4.43 
(1994) weeks 1.9 (0.2) 6.2 (0.3) 1.2±0.4 0.3 
Jarvi et al. Crossover 2x24 20 T2 DM 19 1.25± 4.23 0.88 2.87 
(1999) days 0.58 (0.73) (0.28) (0.70) 
Rizkalla et Crossover 
2x4 12 T2 DM 30 1.21 4.46 1.29 2.63 
al. (2004) § weeks men (0.19) (0.29) (0.11) (0.26) 
Frost et al. Parallel 
3 61 women 14 T 1.06 J5.1 NM NM (1998) weeks 
Philippou et 
al. (2007) 
Parallel 
12 
weeks 
13 MS 7 
T 
1.0 
T 
5.5 
H 
1.4 3.7 
Bouche et al. Crossover 
2x5 
ks 11 Healthy 
35 1 50 
i* 
4 38) 9 (0 
1 01 3 35 
(2002)§ wee (0.42) . . (0.08) (0.32) 
Bellisle et al. Parallel 
12 96 women NM 1.01 
1* 
5.25 1.75 
1 
3.30 
(2007)§ weeks (0.08) (0.13) (0.06) (0.15) 
Wolever et Crossover 
2x6 6 obese T2 28 0.54 J, * NM NM 
al. (1992) weeks DM (0.19) 
. 
Decrease, T increase, -no change, NM not mentioned, OW ov erweight* Significant change from b 1 
aseline, 4- 
Significant difference than high GI period or group, NM not mentioned, § Standard error of mean was u sed, ¥ No 
change in sdLDL. t percent age changes from baseline is reported. 
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1.7.2. Effects of weight loss on CVD risk 
1.7.2.1. Energy-restricted diets 
A large proportion of obese individuals with T2 DM and dyslipidaemia experience 
positive health benefits with modest weight loss (Bosello et al., 1997; Wing et al., 
1987a; Truby et al., 2006; Dansinger et al., 2005). Modest weight loss, defined as a 
weight loss of 5-10% of baseline weight, is also associated with lower blood pressure 
(Mertens & Van Gaal, 2000). This amount of weight loss has been recommended for 
the reduction of CVD risk, and to assist patients who are unable to attain and maintain 
substantial weight reduction (Mertens & Van Gaal, 2000). With respect to T2 DM 
patients, there is evidence to suggest that weight reduction in the early stages of the 
disease might slow the progression of diabetes by improving insulin release in 
response to glucose (Goldstein, 1992). A weight loss of about 15% in normotensive, 
insulin resistant, moderately obese (BMI=32.6±1.1kg/m2) subjects has been shown to 
substantially improve insulin sensitivity in relation to the amount of weight lost 
(Yoshida et al., 2004). Moreover, in overweight, insulin resistant individuals, 
hyperinsulinaemia and insulin resistance were improved with weight loss, with the 
effect being more profound in insulin resistant individuals compared with insulin 
sensitive ones (McLaughlin et al., 2001). Studies have shown that weight loss, 
induced by energy restriction, also improves glucose tolerance and insulin action in 
overweight men with either normal or impaired glucose tolerance (McLaughlin et al., 
2001). This improvement has been related to a reduction in central body fat, as 
estimated by a reduction in waist circumference. 
With respect to the dyslipidaemia associated with metabolic syndrome, weight loss 
via energy restriction has been consistently shown to lower plasma TAG (Brinkworth 
et al., 2006; Yancy et al., 2004). Recent studies of the effect of weight loss on 
dyslipidaemia (Fernandez et al., 2004) showed that weight loss not only resulted in an 
improved lipid profile but also reduced the concentrations of plasma apo B which is 
associated with atherosclerosis and increased risk for CHD. In this investigation, a 
significant decrease in T. Cholesterol, TAG, and LDL-C was clearly demonstrated. 
Participants experienced reductions in total and LDL-C of 12% and 8% respectively, 
and a 15% reduction in TAG, while plasma HDL-C concentrations were 9% higher 
after 6 months. Plasma apo B concentrations were reduced by 8.7% and 6.5% over 3 
J% 
and 6 months respectively. The changes in plasma apolipoprotein concentrations 
were significantly associated with changes in body weight, body composition, and 
total and abdominal fat. Modest weight loss in obese subjects via an energy restricted 
diet and the loss of abdominal fat, has been shown to reduce CVD risk independently 
of T2 DM (Markovic et al., 1998). 
Weight loss can be achieved by a broad spectrum of dieting strategies. Some of these 
strategies include restrictions of portion size and energy and meal substitution. Some 
plans also minimise carbohydrate without fat restriction, or modulate macronutrient 
composition or the glycaemic load of the diet. The effect of four popular diets 
(Atkins, Zone, Weight watchers and Ornish) on body weight and CVD risk was 
assessed in a one year randomised trial in the US (Dansinger et al., 2005). All diets 
resulted in a modest but statistically significant weight loss at one year, with no 
significant difference between diets. In addition, each diet significantly improved 
several CVD risk factors. These included a reduction of LDL-C (although not 
significant for the Atkins group), and increased HDL-C as well as a non-significant 
decrease in plasma TAG over one year. In a more recent trial that used the same 
approach for testing the efficacy of four commercial weight loss diets (Atkins, 
Weight Watchers, Slim-fast, and Rosemary Conley), but this time in the UK (Truby 
et al., 2006), all diets produced significant weight loss with, again, no significant 
difference in the amount of weight lost between the four diets. Certain CVD risk 
factors were also improved with the consumption of certain diets. Since all the diet 
plans used in these studies produced weight loss and improved some markers of CVD 
risk related to obesity, this provides evidence to suggest that specific dietary plans 
may be more effective if targeted to individuals. 
1.7.2.2. Low-carbohydrate diets 
The reduction of dietary carbohydrate represents one possible strategy for weight 
management. Low carbohydrate (LC) diets provide one dietary strategy for weight 
loss. Among the numerous LC diets that have been adopted in search for an effective 
diet for weight loss is the Dr. Atkins New Diet Revolution (Atkins, 2003). This diet 
recommends two weeks of extreme carbohydrate restriction followed by a gradual 
increase in carbohydrate intake to 35g/day. It has been suggested that the reduced 
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energy intake resulting from a LC intake is not fully compensated for by an increase 
of other macronutrients (Brehm et al., 2003). Therefore the primary mechanism of 
weight loss with the Atkins diet is related to decreased energy intake. The decreased 
energy consumption with the LC diet might be due to the limited food choices within 
this diet plan, or alternatively the greater satiating potential of protein (Brehm et al.. 
2003). Furthermore, the production of ketones with the Atkins diet has also been 
proposed as a possible mechanism for the observed weight loss, since ketones are 
known to decrease appetite (Atkins, 2003). For these reasons, LC diets have been 
shown to produce greater initial weight loss than conventional weight-losing diets 
(Samaha et al., 2003; Stern et al., 2004; Foster et al., 2003). In addition, glycaemic 
control in T2 DM patients has been shown to be better with LC than with a low fat 
diet (Samaha et al., 2003). Many studies have also reported a decrease in 
hyperinsulinaemia with the intake of LC diets (Brehm et al., 2003; Samaha et al., 
2003). 
Regarding the effect on plasma lipids, LC diets generally result in a small increase in 
T. Cholesterol (Westman et al., 2002; Larosa et al., 1980; Volek et al., 2000). For 
example, T. Cholesterol and LDL-C, were shown to increase by 6% and 18% 
respectively in normolipidaemic subjects after 8 weeks on a LC diet (<10g/day) 
(Larosa et al., 1980). The increase in LDL-C, which is an established risk factor for 
CHD (Turner et al., 1998) together with the high consumption of saturated fat, 
represents one of the main concerns of consuming the Atkins diet. However there are 
some studies that have shown no significant changes in LDL-C concentrations with 
the intake of LC diets (Samaha et al., 2003; Foster et al., 2003). 
Despite the potential health risks of a LC diet as a result of its potential to increase 
saturated fat intake and LDL-C, beneficial effects on plasma TAG have been shown 
with this diet. LC diets have been shown to be highly effective in decreasing plasma 
TAG. Most of the reduction in plasma TAG is shown in individuals with baseline 
hypertriglyceridaemia, with the effect, arguably, being independent of weight loss 
(Volek et al., 2000; Sharman et al., 2002; Meckling et al., 2002; Krauss et al., 2006). 
A mechanism to explain how a LC diets exerts favorable effect on plasma TAG was 
proposed by Volek (2005). This explanation centres around the effects of insulin on 
the dyslipidaemia of the metabolic syndrome, which was recently reviewed by 
J9 
Ginsberg and colleagues (2005) and included decreased hyperinsulinaemia and 
VLDL synthesis and production. 
In contrast to the effects of LC diets on lipids, there are only a limited number of 
studies on the effects of LC diet on LDL and HDL size. Some studies have shown 
that a LC diet shifts LDL particle distribution to a larger size which results in a 
significant increases in peak and mean LDL diameter, and decreases the proportion of 
sdLDL particles (Sharman et al., 2002; Wood et al., 2006; Volek et al.. 2003; 
Sharman et al., 2004), with the effect being more profound in subjects with a 
predominance of sdLDL at baseline. Some of the short and longer term studies on the 
effects of LC diets on body weight and lipid biomarkers are presented in Table 1.9. 
1.7.3. Effect of exercise on CVD risk 
Long term success in weight management depends on a combination of energy 
expenditure and dietary modification (Avenell et al., 2004b). The NCEP ATP-III 
guidelines recommend lifestyle therapies to replace drug therapies for patients with an 
intermediate range of CHD risk. 
In a longitudinal study of 9,777 men, who were followed for 19 years, men who 
maintained or improved adequate physical fitness were less likely to die from CVD 
during follow-up than men with relatively lower concentrations of activity (Avenell et 
al., 2004b). Reduced physical activity is often associated with obesity and has 
independent effect on CVD risk. Weight loss combined with an exercise program can 
delay, and possibly prevent, the development of diabetes in insulin resistant 
individuals (Laaksonen et al., 2005). The Diabetes Prevention Program (2002) 
examined a large cohort of individuals with insulin resistance. A subset of 
participants began a lifestyle modification program with a goal of >7% weight loss 
and 150 minutes of physical activity/week. After an average follow-up of 2.8 years, 
the lifestyle intervention group achieved nearly a 60% reduction in the incidence of 
diabetes compared with the control group. Exercise has also been shown to improve 
insulin sensitivity and glycaemic control through weight loss (Diabetes Prevention 
Program Research Group, 2002). 
40 
.ýO 
O 
_ 
N tJ (J 
ry ' cD GO y N O _ C 
NW . .p W W '.. ý '.. ý 
rr c. Ii W A .P c. M ýl 
p 9' O C O 
n 
0 W ("; n [r1 G- C) i > iN ý; 
o Zý ^? öcN ö ö ? ýý fj 
IA ! 71 IA IA 
Sýt a - - :ý- 
ril 
o ' ýa Sh Ä' ^ tS ý < r TQ O .. -r. Z : 
OQ tJ 
- -t 
N `' pp 
- S 
yN 
OOS r1o O C) S 
ca. 
0 O 
oý 
l - Ö lO f 
C D P O CD S vO 
A 
(D 
v 
0 
i 
p P? w N 
0 
(1) 
7 
Q 
Oro 
n 
+ c! h) y ý 
0 
41 a\ w C' W 
JN W 00 J Oý N -- 00 -l 
cn n O 00 
ý' cn O 
ýc o" ON Lit - CO 
A "' w J cJ ö 00 P OJ 
ö - ö 
ý 
4- 4-ýo t 4- 4- 
<--- <--- <--- 
4--- <--- (- <-- +-- <---- <-- <--- 
01 CIOID -+ cýeý 
** 
* o-: oo . o" oý 
t 
-ý -. 
f 
c 
c 
X- = 
N 
ö 
ö' 
0 
Duration 
ö 
ý-, vä' ýý va ... 
Insulin 
TAG 
HDL- 
C 
To 
LDL- " 
C 
LDL 
size 
HDL 
size 
r.. 
Cý7 
cD 
O 
Ö 
cD 
C- 
O 
CD 
CD 
O 
l 
um 
O 
O 12 
e 
O 
CD 
CD O 
Z 
CD CD 
O 
41 
Exercise is well known to exert a substantial positive effect on CVD risk, especiall\ '' ith 
respect to plasma lipids and increasing HDL-C concentrations (Halverstadt et al.. 2007). 
Regular exercise is shown to be particularly helpful in men with low HDL-C, elevated 
plasma TAG, and abdominal obesity (Halverstadt et al., 2007). The effect of aerobic 
exercise, after 10 weeks of intervention, on lipid concentrations was examined in 45 
hypercholesterolemic, elderly women (Fahlman et al., 2002). In this study, subjects 
assigned to the aerobic exercise intervention experienced a 20% increase in HDL-C 
concentrations, and a 14% decrease in plasma TAG concentrations. These changes in 
HDL-C and TAG concentrations were independent of any change in body weight or 
dietary intake. Likewise, in hypercholesterolemic men, training was associated with 
modest reductions in T. Cholesterol, HDL3-C, and apo A-I and apo B concentrations. 
along with a rise in HDL2-C (Crouse et al., 1997). Although exercise training failed to 
influence the production of plasma oxidized LDL, it significantly decreased plasma 
T. Cholesterol and LDL-C concentration (Wang & Chow, 2004). In addition, 24 weeks of 
endurance exercise training resulted in an improvement in most of the lipid and 
lipoprotein measures (Halverstadt et al., 2007). This included a significant reduction in 
T. Cholesterol (2.1 ± 1.8 mg/dL, p<0.001), TAG (17±3.5 mg/dL, p<0.0001), and LDL-C 
(0.7±1.7 mg/dL, p<0.0001), with a significant increase in HDL-C subfractions (1.9±0.5 
mg/dL, p=0.01 for HDL-C3 and 1.2±0.3 mg/dL, p=0.02 for HDL2-C). The 
concentrations of sdLDL particles (103±27 nmol/L, p=0.02), and small HDL particles 
(-0.03±0.4 j mol/L, p=0.007) were also shown to be decreased, along with a significant 
increase in mean HDL particle size (0.1 ± 0.0 nm, p=0.04). 
A possible mechanism for exercise-induced reduction in plasma TAG is through 
increased LPL mediated TAG clearance and reduced hepatic VLDL secretion (Gill & 
Hardman, 2003). Since exercise attenuates carbohydrate-induced postprandial 
hypertriglyceridemia, levels of physical activity should be taken into account when 
considering nutritional strategies for reducing the risk of CVD (Gill & Hardman, 2003). 
Accordingly, the Department of Health (2005) in the UK recommends that young people 
should achieve a total of at least 60 minutes of at least moderate intensity activity each 
day while adults should aim to accumulate 30 minutes of at least moderate intensity 
physical activity on five, and preferably, all days of the week. 
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1.7.4. Effect of exercise combined with LC diet on CVD risk 
Data on the combined effects of exercise and a LC diet is very limited. Most studies on 
the effects of LC diets on markers of CVD did not consider exercise (Foster et al., 2003; 
Samaha et al., 2003; Yancy et al., 2004; Truby et al., 2006). In some cases the level of 
exercise was kept constant during the intervention by maintaining subjects' baseline level 
(Volek et al., 2004a; Wood et al., 2007; Krauss et al.. 2006), whilst other studies 
encouraged increased exercise, but no results were reported regarding this outcome 
(Brehm et al., 2003; Westman et al., 2002). In all cases, the detailed effect of exercise 
(or physical activity) with the consumption of low carbohydrate diets was not described. 
Recently, an interesting study (Layman et al., 2005) examined the effect of LC high 
protein diets combined with exercise on body weight and blood lipids in 48 women with 
a BMI of 33 kg/m` during weight loss. In this 4-way study, two isoenergetic (1700 kcal- 
7140 KJ/d) dietary treatments (high protein, reduced carbohydrates and low protein, high 
carbohydrates) containing an equal percentage total energy/d as fat (30%) were examined 
with and without exercise. After 16 weeks, subjects in the LC and exercise groups lost 
more total weight (9.3 ± 0.8 kg vs. 7.3 ± 0.5 kg for the other groups, p<0.05). The LC 
plus exercise group had the largest relative weight loss (11.2%) from baseline weight and 
the high carbohydrate group had the smallest relative weight loss (8.4%). T. Cholesterol, 
LDL-C, HDL-C, and TAG improved in all groups but changes varied between 
treatments. For example, in the high carbohydrate and the high carbohydrate plus 
exercise groups, T. Cholesterol decreased by 9.2% while LDL-C decreased by 10.4%. 
These concentrations decreased by 3.7% and 1.7% respectively in the LC and the LC 
plus exercise groups. Changes in TAG were largest in the groups consuming the LC diet. 
Plasma TAG, in the LC and the LC plus exercise groups decreased by 20.2%. In the 
high carbohydrate and high carbohydrate plus exercise groups TAG concentration 
decreased by 5.2%. The study concluded that a diet with reduced carbohydrates 
combined with exercise additively improved body composition during weight loss; the 
effects on blood lipids however, differed between dietary treatments. 
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1.8. Statement of the problem 
Obesity and an ALP are major risk factors for CVD, especially in individuals \\ ith T2 
DM that can be modified through lifestyle changes. The purpose of the current research 
was therefore to investigate the effect of two lifestyle approaches for the reduction of 
obesity and the expression of an ALP in overweight/obese individuals with or without T2 
DM. These approaches were: 
0 To examine the effects of a LGI diet alone versus a LGI combined with an 
energy restricted diet in T2 DM. 
0 To examine the effects of a LC Atkins diet as a weight loss diet alone versus 
an Atkins diet combined with a moderate exercise programme in otherwise 
healthy overweight or obese individuals. 
1.9. Overall aim 
The aim of these research studies was to examine different lifestyle approaches for the 
reduction of overweight/obesity and an ALP that confers high CVD risk in T2 DM 
and/or overweight and obesity. The effects of LGI diet were examined using patients 
with T2 DM in Kuwait. Therefore, it was essential during the first stages of the project 
to determine the GI of some staples in the Kuwaiti diet to be used during the intervention 
as data on this aspect of food was lacking in Kuwait. Once the GI of some staples foods 
in Kuwait had been determined, those foods with a LGI weres selected to test the effects 
of LGI diets in patients with T2 DM in Kuwait. 
The general objectives of the studies in this thesis were therefore as follows: 
1. To determine the GI of the most abundant carbohydrate-rich foods staple to the 
Kuwaiti diet. 
2. To examine the effects of a LGI diet as compared to a LGI diet combined with an 
energy restricted diet on modifying obesity and an ALP in T2 DM patients in 
Kuwait. 
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3. To examine the effect of a LC, Atkins diet alone compared to a LC combined 
with moderate exercise in reducing obesity and an ALP in over« eight/obese 
individuals in a UK population. 
The specific aims and objectives for each study are described in detail at the beginning of 
each chapter. 
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CHAPTER 2 
Chapter 2 
MATERIALS AND GENERAL METHODS 
The following chapter outlines the materials and general methods used for the analyses of 
blood analytes in all studies presented in subsequent chapters. Individual protocols for 
each study are fully described within each chapter. 
2.1. Materials 
2.1.1. Equipment 
Accu-Check, UK 
Soft Clix lancet device 
Alferwassermann, AL Woerden, Netherlands 
SPACE autoanalyser 
Beckman Coulter, Buckinghamshire, UK 
Optima XL l 00K Ultracentrifuge 
NVT 65 rotor 
NVT 65.2 rotor 
Ultra-Clear centrifuge tube (12m1) 
70.1 Ti rotor 
4.9 Optiseal centrifuge tubes 
Becton, Dickson and company, Oxford, UK 
Plastic syringes I ml, 5 ml, 10ml 
Vacutainer tubes 
Berthold Technologies, Hertfordshire, UK 
Luminescent plate reader Centro LB 960 
C. B. S. Scientific Company, Del Mar, California, USA 
PGGE Pore Gradient Lipoprotein Electrophoresis System. 
4-30% acrylamide gel 
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Nikon, Kingston upon Thames, UK 
DIX digital camera 
Nonlinear Dynamics, Newcastle upon Tyne, UK 
Total-Lab ID gel-scan software 
Microvette, Sarsted, Germany 
3O0µ1 with fluoride oxalate tubes 
Randox Laboratories Ltd., County Antrim, UK 
Reaction cuvettes for SPACE autoanalyser 
Sample cups for SPACe autoanalyser 
2.1.2. Chemicals and reagents 
All chemicals and reagents were of analytical grade. 
Axis shield diagnostic, UK 
Optiprep 
Bio-Rad Laboratories, Germany 
Insulin quality control serum levels 1,2 and 3 
Fisher Scientific, UK 
Glacial acetic acid, Methanol, Potassium bromide, Sodium chloride 
Molecular Light Technology Research Ltd, Cardiff, UK 
Immunochemiluminometric insulin assay 
Oxoid Ltd, UK 
Phosphate buffered saline (PBS) 
Randox Laboratories Ltd., County Antrim, UK 
Apolipoprotein Al, Apolipoprotein B, Apolipoprotein calibrator, Chemistry control level 
I and 2, Direct HDL, Direct LDL, Direct LDL/HDL calibrator, Gemcal calibrator, 
Glucose GOD/PAP test kit, Lipid control level 1,2, and 3, Multisera level 2 and 
Multisera level 3, NEFA, System diluents, TG, Total cholesterol. 
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Sigma Chemical Company Ltd, UK 
Coomassie blue R 250 
Bromophenol blue 
Sulphosalicylic acid 
2.1.3. Electrophoresis buffer 
38. l4 g Tris (trishydroxymethylaminomethane) 
17.31 g Boric acid 
3.26 g EDTA 
pH= 8.4 
This was dissolved in 3 liters of water and stored at 4°C. HCl and Sodium hydroxide 
were used to bring the solution towards the desired pH. 
2.2. Methods 
2.2.1. Anthropometric and blood pressure 
Height was measured using a wall-mounted stadiometer ("Seca" Somatometre 200 cm x 
0.1 cm). Weight was measured using a calibrated dial scales (Seca 770 high capacity 
floor scale, 148 kg x 100 g). BMI was calculated using the standard formula (weight 
[kg]/height2 [m]). Waist circumference was measured to the nearest 0.1 cm using a 
Holtain tape measure (Holtain Ltd., Dyfed, Wales). Blood pressure was measured three 
times using an electronic sphygmometer (Omron M4, Omron Healthcare, Sussex, UK) 
with the subject sitting at rest. An average of the three readings was then taken. 
2.2.2. Collection of blood 
Blood was taken by venepuncture of an antecubital vein both pre and postprandially from 
male and female volunteers. The blood was collected either into vacutainers or 
centrifuge tubes containing the following anticoagulants: K2EDTA for the determination 
of total cholesterol (T. Cholesterol), TAG, LDL-C, HDL-C, apo A-I, apo B, NEFA, LDL 
and HDL subclasses, fluoride oxalate for the determination of plasma glucose, and 
lithium heparin for plasma insulin. The blood was immediately centrifuged at 2000g for 
20 min at 40 C in a low speed centrifuge for the separation of plasma. Aliquots of plasma 
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were dispensed into appropriately labelled cryovials (1.8 ml) and stored at -80°C until 
analysis. 
2.2.3. Biochemical analyses 
2.2.3.1. Analyses using the SPACE autoanalyser 
Fasting blood samples were analysed on the SPACE auto-analyser for glucose. 
T. Cholesterol, LDL-C, HDL-C, TAG, and NEFA using colourimetric enzymatic 
procedures. Apo A-I, and apo B were analysed by immunoturbidimetric assays. Specific 
quality controls (QCs) were measured at the beginning and end of each run. Assays were 
performed only if the QCs were within the accepted limit as determined by the QC 
manufacturer. Interassay CVs were calculated using 6-12 replicates while intraassay CVs 
were calculated using 6-18 replicates. 
2.2.3.2. Assay principle: plasma T. Cholesterol 
Cholesterol esters were hydrolysed to free cholesterol and free fatty acids by pancreatic 
cholesterol esterase. The liberated cholesterol and any free cholesterol present in the 
plasma were both oxidized by cholesterol oxidase, reaction: 
cholesterol esters + HO cholesterol esterase > cholesterol + fatty acids 
cholesterol + 02 
cholesterol oxidase . cholestone -3- one + H202 
2H202+ 4 -aminantipyrine + phenol 
peroxidase 
> quinoneimine +4H, 0 
The absorbance of the quinoneimine pigment was measured bichromatically at 505/692 
nm. The within assay precision gave CVs for level 1 (low) and level 2 (high) QCs of 
2.9% and 1.6% respectively, while the between assay precision gave CVs of 3.2% and 
3.0% for the low and high quality control respectively. 
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2.2.3.3. Assay principle: plasma TAG 
The principle of the assay is similar to that for cholesterol; however, glycerol-3- 
phosphate is the substrate to be oxidized to form peroxide. 
Triacylglycerol +3 H2O `p glycerol + fattyacids 
glycerol + ATP GK glycerol -3- phosphate + ADP 
glycerol -3- phosphate + 02 GPO > dihydroxyacetone - phosphate + H, 0, 
H202 +4 aminantipyrine +4 chlorophenol POD 4 quinoneimine +4 H2O + HCl 
Where POD = peroxidase, GPO = glycerol-3-phosphate oxidase, GK = glycerol kinase, 
ATP = Adenosine-5'-triphosphate, ADP = Adenosine-5'-diphosphate. The absorbance 
was measured bichromatically at 505/692 nm and was proportional to the amount of the 
TAG present. Intra-assay precision gave CVs for level 1 (low) and level 2 (high) QCs of 
2.3% and 4.0% respectively while the inter-assay precision gave CVs of 3.0% and 3.5% 
for the low and high control respectively. 
2.2.3.4. Assay principle: HDL-C 
The assay for HDL-C consists of two steps; the first step eliminates cholesterol present in 
chylomicrons, VLDL and LDL-C with the following enzyme sequence: 
Step 1 
cholesterol ester 
cholesterol esterase 
cholesterol + 02 
cholesterol oxidase 
2 H2O, `atalas 2H, 0 + O2 
cholesterol + fatty acids 
cholestone + H202 
1 
Step 2 
Step 2 involves the release of HDL-C by detergents and measured specifically. 
cholesterol ester 
cholesterol esterase 
cholesterol + fatty acids 
cholesterol +02 
cholesterol oxidase 
cholestone + H202 
2H *- 2O2 +4- AA + HDAOS 
Peroxidase 
Quinone pigment +4 H2 0 
Where 4-AA = 4-Aminoantipyrine 
HDAOS = N-(2-hydroxy-3-sulphopropyl)-3,5-dimethoxyaniline. 
When measured at 600 nm, the intensity of the quinone imine dye product was directly 
proportional to the cholesterol concentration. Within assay precision gave CVs for level I 
(low), level 2 (medium), and level 3 (high) QCs of 4.2%, 4.9%, and 3.9% respectively. 
The between assay precision gave CVs of 6.8%, 5%, and 5.3% respectively for the low, 
medium, and high QCs respectively. 
2.2.3.5. Assay principle: LDL-C 
The principle for the measurement of LDL-C was identical to that for HDL-C; with the 
exception of the detergent in the LDL reaction being TOOS (N-Ethyl-N-(2-hydroxy-3- 
sulphopropyl)-3-methylaniline) and HDAOS for HDL. Intra and inter-assay precision 
gave CVs for level 1 (low), level 2 (medium) and level 3 (high) quality controls of 4.7%, 
3.8%, and 0.9% respectively. The inter-assay precision gave CVs of 5.7%, 4.7%, 1.8% 
for the low, medium and high QCs respectively. 
2.2.3.6. Assay principle: plasma glucose 
Glucose was determined by enzymatic oxidation in the presence of glucose oxidase 
(GOD). The resultant hydrogen peroxide reacts with phenol and 4-aminophenzone under 
the catalysis of peroxidase (POD) to produce a red - violet quinoneime dye. The 
absorbance of the dye is measured bichromatically at 505/692 nm. 
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glocose + 02 + H, 0 GOD 4 gluconic acid + H202 
2 H, 02 +4- aminophenzone + phenol POD ý quinineimine +4 H2O 
Intra-assay precision gave CVs of 1.6% for level 1 (low) QC, 1.3% for level 2 (high) QC. 
Inter-assay precision gave CVs of 0.4% for both level I and level 2 QCs. 
2.2.3.7. Assay principle: plasma apo A-I 
Apo A-I was measured turbidimetrically at 340 nm. The assay is based on the reaction of 
a sample containing human apo A-I and an antiserum to form an insoluble complex. The 
concentration of apo A-I in the sample can be determined by comparing the concentration 
with a standard curve from the absorbance of standards. Precision tests for QC and intra- 
assay CVs were 3.8%, 1.1%, and 7.3% for level 1 (low), level 2 (medium), and level 3 
(high) QCs respectively. Inter-assay precision for level 1, level 2, and level 3 QCs were 
0.7%, 1.5%, 5.3% respectively. 
2.2.3.8. Assay principle: plasma apo B 
Human total apo B was measured turbidimetrically. Apo B forms a precipitate with a 
specific anti apo B serum, which is measured turbidimetrically at 340 nm. The antigen- 
antibody complex produces a turbid precipitate, the level of which is directly proportional 
to the concentration of apo B. 
A linear standard curve was constructed from an apo B standard (Randox) using saline 
(0.9% w/v), ranging from 0.0 - 2.18 g/L. Three quality controls were employed; level 1 
(low), level 2 (medium) and level 3 (high). Precision tests were carried out on each QC 
and intra-assay CVs were 8.3%, 4.6%, and 6.8% for the low, medium and high QCs 
respectively. While inter-assay precision for the low, medium, and high quality controls 
were 8.7%, 6.0%, and 8.1 % respectively. 
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2.2.3.9. Assay principle: plasma NEFA 
NEFA was determined by the enzymatic reaction of acyl CoA synthetase and acyl CoA 
oxidase to produce peroxide; the peroxide reacts with 4-aminoantipyrine which results in 
the formation of a purple dye that absorbs at a wavelength of 550 nm. The intensity of the 
colour is directly proportional to the NEFA concentration. 
NEFA + ATP + CoA 
Acyl CoA Synthetase 
Acyl CoA + AMP + PPi 
Acyl CoA + 02 Aol ` oA Ox' 1Se 2,3 - trans - Enoyl - CoA + H, 02 
2 H202 + TOOS +4- AAP POD > purple adduct +4 H2 O 
Where 4-AAP = 4-aminoantipyrine, TOOS = N-ethyl-N-(2-hydroxy-3-sulphopropyl) m- 
toluidine. Multisera level 1 (low) and level 2 (high) quality controls were employed with 
intra-assay CVs of 5.4% and 5.6% respectively and inter-assay CVs of 4.9% and 5.4% 
respectively. 
2.2.3.10. Assay principle: plasma fructosamine 
Blood for fructosamine analyses was collected in EDTA tubes and fructosamine 
concentrations were measured quantitatively using a Randox enzymatic assay for human 
serum or plasma. The kit constitutes two reagents. Reagent 1 contains Proteinase K that 
digests the glycated protein to smaller fragments according to the following equation: 
Glycated protein proteinuse K> Glycated protein fragments 
Reagent 2 consists of Ketoamine oxidase (KAO) which oxidises the ketoamine bond of 
the fragments yielding the followings: 
Glycated protein fragments 'SA" > Amino acids + HO, 
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The reaction is colorimetric at 550nm and the amount of colour developed is directly 
proportional to the concentration of the glycated protein in the sample. 
H202 + Choromogens 
Peroxid"' 
Color + H2O 
The intra-assay %CV for level 1 (low) and level 2 (high) QC was 1.8 and 1.0 µmol/l 
respectively. The reference range for fructosamine analyses in healthy subjects was 
between 122-236 µmol/l. 
2.2.4. Lipoprotein subclasses measurement 
2.2.4.1. Gradient gel electrophoresis for the identification of HDL subclasses. 
HDL subclasses were separated using commercially available, pre-cast, non-denaturing 
polyacrylamide gradient gels, using a PGGE Pore Gradient Lipoprotein Electrophoresis 
System. The 4/30 acrylamide gels were used for resolving HDL subclasses over an 
approximate molecular weight range of 50,000-2,000,000. 
Whole plasma was adjusted to density 1.21 Kg/l by the addition of KBr. The adjusted 
plasma (1.0 ml) was transferred to a Beckman Ultra-Clear centrifuge tube (12 ml) and 
mixed with a KBr 1.21 Kg/l, 1% EDTA density solution. Tubes were housed in a 
Beckman 70.1 Ti rotor and centrifuged for 20 h at 147 000g, at 15°C. After 
centrifugation, 200 µl of the upper yellow supernatant band, containing total plasma 
lipoproteins, was aspirated and used for subsequent analysis. All pre and post-diet 
samples for each volunteer were run together, at the same time and in the same rotor. 
In the next step, a 100 µl aliquot of the band was pre-stained with bromophenol blue 
(final concentration 5% w/v bromophenol blue). After the gels had been pre-equilibrated 
at 70 V, 65 mA for 30 min, 10 gl of each sample was introduced into a separate gel well. 
Following the addition of the samples, gels were run at 20 V, 50 mA for 20 min, followed 
by 70 V, 65 mA for 30 min, and finally at 120 V, 100 mA for 24 h. Gels were then 
removed from their casing and placed in fixing solution (sulphosalicylic acid, 10% w/v) 
for 30 min, followed by protein staining for Ih (0.1% w/v coomassie blue R250, 
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methanol: glacial acetic acid: RO (reverse osmosis) water in a 5: 1: 4 ratio). Gels were 
destained with methanol: glacial acetic acid: RO water 50: 75: 874 (ml) for 2-3 days with 
regular changing of the de-stain. A Nikon DIX digital camera was used to photograph 
the gels. Photographic images were down-loaded directly by fire-wire to a PC and then 
analysed using Total-Lab 1D gel-scan software version 2.01. The software generated 
HDL subclass profiles, from which it was possible to measure electrophoretic migration 
distances of the HDL bands (Relative front, Rf). Two primary peaks were identified by 
the software that corresponded to HDL-, and smaller, less dense HDL3 subclasses (Figure 
2.1). The intra-inter assay %CV for the percentages of HDL2 were 2.9% and 0.3% 
respectively. 
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Figure 2.1. Example of a computer generated densitometric scan of electrophoresed 
plasma from one participant in the LGI diet study (Chapter 4) showing a peak magnitude 
and Rf for HDL subclasses analyses. The peak shown to the left correspond to LDL. The 
area under curve labeled I represents %HDL2 while the area under curve 2 represents 
%HDL3. 
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2.2.4.2. LDL subclasses measurement 
The separation of plasma LDL subclasses was carried out by iodixanol density gradient 
ultracentrifugation (DGUC) as previously described (Layman er al., 2005). The iodixanol 
DGUC is used specifically for the detection of the proportion of small, dense LDL-ID 
and determination of LDL subclass phenotype. In the first step, 1.52 ml plasma was pre- 
stained with 200 pl Coomassie Blue R 250 (50 g/l in PBS) and mixed with 0.4m1 
OptiprepT M which is commercially available as 60% (w/v) iodixanol. This provided a 
working sample of 2 ml with a final concentration of 12%. For the upper layer, 
`Optiprep' was mixed with PBS to provide 90g/1 iodixanol solution. An aliquot of 3.4 ml 
of this solution was dispensed into a 4.9 Beckman `Optiseal' centrifuge tube, followed by 
the careful under-layering of 1.5 ml of the denser plasma sample with a syringe and 
canunula. These tubes where then housed in a 16 pocket Beckman NVT65.2 near 
vertical rotor and centrifuged at 341 000g and 16 °C for 2.5 h in a Beckman Optima XL- 
100 Ultracentrifuge, with acceleration and deceleration program 5. All pre and post-diet 
samples for each volunteer were run together at the same time in the same rotor. 
After centrifugation, the `Optiseal' tubes were placed in a rack directly opposite to a 
vertical light box and photographed using a high resolution Nikon D1X digital camera, at 
a fixed distance from the Optiseal tubes. Photographic images of the Optiseal tubes 
containing the stained LDL bands were down-loaded via a fire-wire to a PC and analysed 
by using Total-lab ID gel-scan software. The resultant LDL subclass profiles were 
assigned Rf values to all the peaks, including the major LDL peak (Figure 2.2). Rf values 
where then converted to density by cross referencing the value to a previously determined 
densities of a blank tube as previously described (Davies et al, 2003). LDL subclasses 
were described semi-quantitatively by this method in terms of LDL peak density and the 
percentage area under the LDL curve corresponding to small, dense LDL-III (%AUCB). 
The within and between rotor CVs for LDL peak density were 0.14% and 0.02% 
respectively (n=13). While the within and between rotor CV for the %AUCB was 2.26% 
and 0.30% respectively (n=13). 
57 
A 
14-0 
N 
N 
Q) 
x 
a- 
120 
110 
100 
90 
80 
70 
60 
50 
40 
30 
20 
10 
0-- 
0.0 
Rf 
l 
n 
'LY, n xý .. 
Figure 2.2. Example of a computer generated densitometric scan of a digital photograph 
of an optiseal tube from one participant in the Atkins trial (Chapter 5) showing a peak 
magnitude and Rt for LDL subclasses analyses. The area under curve labeled I 
represents %LDL-I while the area under curve 2 represents %AUCB (LDL-III). 
2.2.5. Insulin measurement 
Blood was collected into a lithium heparin coated tubes. Insulin concentrations were 
measured quantitatively using the MLT immunochemiluminometric assay. The assay is a 
two-site immunoassay, utilizing an insulin-specific solid phase antibody immobilized on 
microtitre wells, and a soluble antibody labeled with a chemiluminescent acridinium 
ester. Both of these antibodies were mouse monoclonals. After the sample was 
incubated with the labeled antibody solution, unbound labelled antibodies were removed 
by washing. The microtitre plate luminometer measured the insulin by quantifying the 
bound luminescence. 
Wash buffer was prepared by diluting I part buffer concentrate in 9 parts RO water. All 
kit components and samples were brought to room temperature before starting the assay. 
Standards (0-200 mU/L) were reconstituted by the addition of 1.0 ml RO water. 900 µl of 
the labeled antibody concentrate was dispensed into the labeled antibody diluent and 
mixed. 
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Aliquots of 100 µl of labeled antibody solution were dispensed into appropriate 96 
microtitre wells. All samples (25 .l plasma) were run 
in duplicate. The plates ývere 
sealed and incubated for 2h at 37°C. After incubation, the plates were washed three 
times with wash buffer, using an automatic plate washer. Finally, plates were read in a 
luminometer which calculated the relative luminescence (RLU) values and converted 
them into mU/L using MicroWin 2000 software. The intra-assay precision (CVs) of 
three controls were: 4.9% for QC level 1,8.07% for level 2, and 7.6 % for QC level 3. 
The inter-assay precision for level 1,2, and 3 were 6.6%, 6.0%, and 11.7% respectively. 
The conversion factor from mU/L to pmol/L: 1mU = 7.5 pmol 
2.2.6. Calculation of the homeostasis assessment model (HOMA) 
The homeostasis assessment model of insulin resistance (HOMA-IR) was calculated as 
described by Matthews et al (1985) using the following formula: 
[Plasma insulin] (pmol/L) x [Plasma glucose] (mmol/L) / 22.5 
2.2.7. Statistical analyses 
The details of statistical analyses are specific to each study and are therefore described in 
each chapter. In general, data was coded and entered into SPSS statistical analyses 
software (SPSS, version 14 for windows, Chicago, Illinois). All outcomes were assessed 
for normality using the Kolmogorov-Smirnov test and by checking normal and detrended 
normal probability plots. Homogeneity of the variance was assessed by Levene's statistic. 
Skewed parameters were transformed and retested for normality. Geometric means were 
reported for log transformed parameters. The characteristics of the study subjects were 
expressed using descriptive statistics. Data was analysed for both between and within 
group effects. The effect of the intervention diet on all measured variables was assessed 
by one way repeated measure ANOVA. A within / between group 2-way ANOVA, with 
time as within subject factor and group as between subject factor was used to examine the 
effect of the interaction between time and diet. Pearson correlations coefficients (r) were 
determined to examine the inter-relationships between variables. A p<0.05 was 
considered statistically significant. 
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CHAPTER 3 
Chapter 3 
DETERMINATION OF THE GLYCAEMIC AND INSULINAEMIC INDICES OF 
EIGHT STAPLE FOODS IN THE KUWAITI DIET 
3.1. Introduction 
T2 DM is a major clinical problem in Kuwait with a prevalence rate of 15% (Abdella et 
al., 1998) and a link to dyslipidaemia as a common CVD risk factor (Akanji, 2002). 
Appropriate dietary advice is recommended for the management of T2 DM and its related 
risk factors. In this respect, identification of food composition is essential for T2 DM 
patient management. However, food composition alone would not predict the potential 
effect of the diet, as carbohydrate-rich foods with similar composition are known to cause 
different glycaemic responses (Rasmussen et al., 1992). 
The GI is an important parameter of food quality which classifies carbohydrate-rich foods 
on the basis of their physiological effect on blood glucose. It represents the plasma 
glucose response to a food, expressed as a percentage of the glucose response to a 
reference food, generally glucose (Jenkins et al., 1981). Since the presence of other 
constituents besides carbohydrates in the food, such as fat and protein, can influence 
blood concentrations of insulin independently of the glucose response (Lovejoy et al., 
1998), the insulinaemic index (II) of foods is another important measure that provides 
additional information on the GI in the dietary management of diabetes (Bornet et at., 
1997; Miller et at., 1992). An understanding of the physiological basis of carbohydrates 
as classified by these two food parameters, GI and II, may assist in optimizing healthy 
food choices for Kuwaiti T2 DM patients, as there is accumulating evidence on the 
therapeutic potential of LGI diets in these patients (Heilbronn et at., 2002) and in subjects 
with dyslipidaemia (Jenkins et at., 1985). The GI may provide a rationale for the 
selection of carbohydrate-rich foods for the dietary management of T2 DM patients. The 
largest published GI data base (Foster-Powell et at., 2002) contains values for over 750 
different types of food, including branded products and foods from around the world, but 
not from Kuwait. Therefore, integrating the GI concept into the Kuwaiti diet is limited 
by the lack of data. This study was the first to be undertaken for the determination of the 
GI of eight staple foods commonly eaten in Kuwait. Since both GI and 11 should be 
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considered when attempting to optimize the quality of dietary carbohydrates for 
individuals with diabetes (Miller et al., 1992), both GI and II were measured in the 
present study. 
3.1.1. Glycaemic index overview 
GI provides a mean for assessing the metabolic responses to carbohydrate-rich foods by 
ranking them according to how much they raise postprandial plasma glucose 
concentration. It is defined as the incremental area under the blood glucose curve of a 
test food compared to a reference food: glucose or white bread (Foster-Powell et al., 
2002). Based on the GI, CHO may be divided into 3 groups. LGI carbohydrates 
(GI<55%) are those that are digested and absorbed slowly and lead to a low glycaemic 
response, whereas HIGH GI foods (GI=70% or more) are rapidly digested and absorbed 
and exhibit a high glycaemic response. A medium-GI food will have a GI of 56-69%. 
Interest in the measurement of GI for research and commercial applications increased 
significantly when the FAO/WHO (1998) recommended that the bulk of the CHO should 
be from LGI food. More recently, the American Diabetes Association (2004b) 
highlighted the importance of the GI as an additional benefit over that observed when 
total carbohydrates are considered alone. While in several countries (Australia, Canada, 
Sweden) the GI concept has been integrated into the dietary guidelines and some food 
companies have marketed specifically-labeled LGI products, the GI of foods in Arabic 
countries has not received a great deal of attention, and only a few studies have 
investigated the GI of some staple Arabic foods (Miller et al., 2002; Miller et al., 2003; 
Mehio et al., 1997). In the International Tables of GI (Foster-Powell et al., 2002) of the 
GI of 750 food items, only 7 are of Arabic origin. 
3.1.2. Identification of consumption patterns of bread and rice in Kuwait 
It is recognized that the Middle East region has a special need for food consumption data 
(Harrison, 1998) and Kuwait is not exempt from this. A limited number of studies, 
however, have provided some insights into food consumption patterns in Kuwait (Kuwait 
Institute for Scientific Research, 1980; Kamel & Martinez, 1984b; Dehghan et al., 2005; 
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Dashti & Al-Awadi, 2001; Sawaya et al., 1998; Al-Hooti et al., 2002). Although food 
plays a very important social and ceremonial role in Kuwait, the country does not have a 
large food manufacturing industry. Instead, it relies heavily upon imported foods from 
all over the world, which makes food abundant and diverse. Grains and cereal grains 
including rice are some of the major imported foods in Kuwait. 
Bread is an important staple in the diet of Kuwaitis and is eaten once or more per day by 
almost 81% of this population (Kamel & Martinez, 1984). Breads, usually pita and 
Iranian bread, are eaten mainly at breakfast and dinner (Kamel & Martinez, 1984). 
45.6% of the Kuwaitis consume white pita bread at least once per day, and about 15.5% 
consume Iranian bread once/day, while only 9.4% consume a serving of brown pita 
bread/day (AlAjmi, 2004). Most of the breads consumed in Kuwait are manufactured 
locally by the Kuwait Flour Mills and Bakeries Company. These manufacturers supply 
food distributors that serve consumers in Kuwait with high quality products such as 
breads, biscuits, pasta, and flour. The flour that is produced by the company from wheat 
is used to manufacture breads that are consumed by most Kuwaitis. These breads include 
white and brown pita breads, both normal and light brands (Lebanese khubus), and white 
and brown bread (toast). On the other hand, Iranian breads are made within small 
bakeries which are distributed all around Kuwait. 
Rice, especially white rice, represents the other main source of carbohydrate in the diet of 
Kuwaitis who consume it as a main course at lunch (Kamel & Martinez, 1984). 
Peshawar white rice is a polished long-grained variety of rice, famous for its delicate 
flavor. The rice, usually cultivated in Pakistan, is imported to Kuwait and distributed by 
the Kuwait Supply Company using ration cards issued to Kuwaiti families based on their 
family size. Rice in Kuwait is cooked by different methods. The preferred method of 
preparing rice is to boil it in an excess amount of water, then drain it and leave it to 
simmer for a period of time (mashkhol). According to Kamel & Martinez (1984), 74% of 
Kuwaitis consume rice daily and a substantial proportion consume it twice a day. 
Recently, the percentage of people that consumed rice on a daily basis has been 
declining. Dehghan et al. (2005) recently observed that in a sample of 201 Kuwaitis, 
only 48% reported consuming rice once per day. This study was undertaken in an 
63 
attempt to develop a food-frequency questionnaire specifically for use in nutritional 
surveys in Kuwait. In the same study all the participants reported consuming cereals at 
least once per day. More precisely, the mean number of servings of cereals and cereal 
products consumed by participants was 5.3/day. 
3.1.3. Factors affecting the glycaemic responses to bread 
The ingredients of the bread as well as baking processes influence the glycaemic 
response to breads (Englyst et al., 1982). Consequently, the GI of the same breads varies 
widely according to its country of manufacture. In the International Tables of GI (Foster- 
Powell et al., 2002), of 750 different food items, the GI value for 95 types of bread are 
included. These GI range from LGI (barley bread 75% whole grains; 27%) to HIGH GI 
(porous French baguette; 95%). 
The baking process of bread usually involves high temperature and pressure. These 
conditions increase the availability of starch to amylase and hence increase the 
digestibility of starch in the mouth and stomach as a result of starch gelatinization and 
changes in the chemical nature of the granule structure (Fardet et al., 2006). Baking 
breads using different temperatures can therefore affect the glycaemic responses. For 
example, baking breads at a low temperature for a long period of time (similar to the 
conditions used for baking pumpernickel bread: 2 hr at 120° C) decreased the GI of a 
high-amylose barley bread by 30%, as a result of the formation of crystalline starch 
(Akeberg et al., 1998). 
Resistant starch, defined as the fraction of starch that is not digested in the small intestine 
and is fermented in the large intestine (Englyst et al., 1992), is likely to be negatively 
correlated with the GI (Annison & Topping, 1994) as it is slowly absorbed in the small 
intestine resulting in decreased postprandial glucose and insulin responses. Moreover, 
the addition of viscous soluble fibres to bread affects the GI through thickening of the 
unstirred layer at the level of the intestinal mucosa which limits diffusion and hence the 
rate of glucose absorption into the epithelial-cell, leading to decreased GI (Lund et al.. 
1989). Organic acids in breads, as additives or as natural constituents in the bread, also 
affect the GI by slowing down gastric emptying (Darwiche et al., 2001). Furthermore. 
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the addition of monoacylglycerols to prevent staling of bread slows the rate of starch 
degradation by forming a complex with amylose (Fardet et al., 2006), thereby decrease 
the corresponding GI. 
Studies have shown that the glycaemic response of wholemeal bread is similar to that of 
white bread (Foster-Powell et al., 2002). Wholemeal bread is made from white flour 
with added bran. Therefore, breads with a high proportion of whole cereal grains should 
be called wholegrain instead of wholemeal breads (Jenkins et al., 1988b). The former 
could be useful in reducing the postprandial blood-glucose profile in individuals with T2 
DM (Jenkins et al., 1988b). 
3.1.4. Factors affecting the glycaemic response to rice 
Rice is the most important staple food and the primary dietary source of CHO for over 
half of the world's population. It plays an important role in meeting energy requirements 
and nutrient intake. As with bread, rice is difficult to classify as a LGI or HIGH GI food 
because of the wide range of its GI. The GI of white rice ranges from as low as 45% to 
as high as 112% when glucose (GI = 100%) was used as the reference food (Foster- 
Powell et al., 2002). A variety of factors, both intrinsic and extrinsic, have been reported 
to influence the rate and extent of starch digestibility in rice among other starches. 
Much of the variation in the GI of rice is due to differences in the ratio of amylose to 
amylopectin. Rice varieties that contain a higher proportion of amylose have been shown 
to have a slower rate of digestion and produce lower GI and II (Juliano & Goddard, 
1986). Miller et al. (1992) clearly showed that rice with a higher amylose content of 28% 
had lower GI and II than normal amylose rice varieties with 20% amylose. In the same 
study, the GI of the rice ranged from 64 ±9 for Doongara white high amylose rice to 
93±1 1 for Pelde white rice. Rice with a high amylose content in the raw state forms more 
resistant starch on processing compared with the low and intermediate amylose rice due 
to the presence of higher amounts of the linear component of starch (Sagum & Arcot, 
2000). 
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Beside the amylose content, cooking rice affects its glycaemic response and a greater rise 
in blood glucose and insulin has been reported after the consumption of cooked as 
opposed to raw starch (Colling et al., 1981). The amount of water and the processing 
temperature used during cooking rice influence the formation of resistant starch (Sagum 
& Arcot, 2000). When rice is heated in excess water, the structure of the starch granules 
is altered by the loss of crystallization of amylopectin, followed by swelling, hydration 
and gelatinization. When starch is gelatinized and allowed to cool, the amylose 
molecules align themselves or associate with each other and form retrograded starch , 
(Sagum & Arcot, 2000) thereby increasing the level of enzyme-resistant starch through 
recrystallization (Englyst et al., 1992). 
3.2. Statement of the problem 
Integration of GI concept into the dietary management of T2 DM patients in Kuwait is 
not presently possible, as the GI of the Kuwaiti staple foods has not been tested. This 
situation prevails in the face of a high prevalence of T2 DM in Kuwait with its associated 
risk factors such as dyslipidaemia, and a considerable body of evidence on the therapeutic 
potential of LGI diets in these patients. Thus in this study the GI and II of eight staple 
foods in the Kuwaiti diet were determined. 
3.3. Objectives of the study 
1. To determine the GI and II of eight types of carbohydrate foods staple to the 
Kuwaiti diet. These foods are: white pita (WP), light white pita (LWP), brown 
pita (BP) and light brown pita (LBP), white bread (WB), brown bread (BB), 
Iranian bread (IB), and white rice (WR). 
2. To evaluate the glycaemic and insulinaemic responses in healthy volunteers after 
the ingestion of eight staple Kuwaiti foods (mentioned above). 
3. To compare the GI of some staples in the current study with those of published 
values in the International Tables of GI. 
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3.4. Study hypotheses 
1. The GI of the staples tested in the current study will have a wide range. 
2. Significantly different blood glucose and insulin responses will be elicited by 
equivalent amounts of carbohydrate from different types of food with different 
carbohydrate content. 
3. The postprandial glucose responses of the test foods will be closely related to 
their insulin responses. 
4. GI values for the different type of breads and rice determined in this study will 
substantially differ from their published values in the International Tables of GI 
(Foster-Powell et al., 2002). 
3.5. Methods 
3.5.1. Test foods 
The eight test foods included seven types of bread, staple to the Kuwaiti diet, and a type 
of white rice. The following breads were examined for their glycaemic and insulinaemic 
responses; white pita (WP), light white pita (LWP), brown pita (BP), light brown pita 
(LBP), white bread (WB), brown bread (BB) and Iranian bread (IB). With the exception 
of IB, all breads were produced locally by the Kuwait Flour Mills & Bakeries Company. 
IB is usually made in small Iranian bakeries. The white rice examined in this study was 
the same as that provided by the Kuwait Supply Company to all Kuwaiti families. The 
rationale for choosing the specified test breads and rice was to study eight carbohydrate- 
rich foods that are extensively consumed by the general Kuwaiti population, including T2 
DM patients. 
Portion sizes of WP, BP, WB, BB, IB and WR were determined by the commercial 
analysis of moisture, ash, protein, fat and total dietary fibre (Leatherhead International 
Limited, UK). Available carbohydrate was calculated by difference. The portion size of 
LWP and LBP breads was determined from the nutritional information on package labels 
as they were the only types of bread with such labels. Table 3.1 summarizes the nutrient 
composition of the test foods. 
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Table 3.1. Weight (g) and composition of bread portions containing 25g available 
carbohydrate (Available carbohydrate=total carbohydrate by difference - total dietary 
fibre). 
WP" LWPI BPt LBP1 WBT BB1 IB' WR' 
Weight 44.80 43.86 53.41 48.83 54.35 62.97 46.12 86.20 
Protein 4.8 5.4 5.8 6.7 5.8 6.7 4.7 2.8 
Moisture 12.5 N/A 15.1 N/A 19.1 17.8 13.5 48.7 
T. Fat 0.63 0.22 1.12 0.34 2.1 2.4 0.92 0.4 
Ash 0.89 N/A 1.4 N/A 1.0 1.1 0.7 0.5 
Dietary fibre 1.12 0.22 5.0 1.12 1.5 3.7 1.2 1.0 
Total Carbohydrate 26.1 25.3 30.0 26.2 26.5 28.7 26.2 25.8 
'Nutrient composition based on analyses (Leatherhead International Limited). t Nutrient composition based on food label. 
N/A Not available 
3.5.2. Preparation of test foods 
All breads were purchased the night before the test, weighed to the desired amount, 
packed into plastic bags and freshly consumed on the day of the study. Because of the 
low carbohydrate density of the breads, the available carbohydrate content of the test 
portion was lowered to 25g to prevent delivery of an over sized meal. Breads were cut 
into portions, each containing 25g carbohydrate. Crust ends of the WB and the BB were 
sliced off and discarded. 
Rice was boiled in excess salted water in a covered pot for 10 minutes and strained. The 
rice was then simmered for a short period of time (5-8 min). The cooked rice was 
prepared the night before the test, kept in the fridge and microwaved before consumption. 
All test foods were taken with a standardized amount of water (250 ml). 
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3.5.3. Recruitment 
The study was approved by the University of Surrey Ethics Committee (EC 204/37 
SBMS). Volunteers were recruited for the study by invitation posters placed at a local 
supermarket in Kuwait (Dasma Co-operation). Subjects responded sporadically over the 
recruitment period which lasted for the month of October 2005. A minimum of 10 
subjects were required for testing each type of bread to provide sufficient power and 
precision for the GI measurement (Brouns et al., 2005). The study cohort consisted of 7 
females and 7 male subjects. Each subject needed between 6-9 weeks to complete the 
study. 
3.5.4. Study participants 
Volunteers were interviewed before the study commenced using a screening 
questionnaire to assess suitability for participation. Inclusion criteria included being male 
or a non-pregnant healthy female aged 20-70 years and being willing and able to comply 
with the study protocol and give informed consent. Exclusion criteria included a 
gastrointestinal condition affecting digestion or absorption of nutrients, the use of drugs 
affecting gastrointestinal motility or nutrient digestion or absorption, hepatitis, surgery or 
infection within the last three months. 
3.5.5. Study design 
In a randomized crossover design, the control and test foods were fed in random order on 
separate occasions. The study protocol was standardized using the WHO criteria (1998) 
in line with recent European recommendations (Brouns et al., 2005). To determine the 
GI, each of the 14 volunteers consumed 25g of the test food or the standard (25g of a 
glucose anhydrous solution) after a 12-14 hours overnight fast (Figure 3.1). Finger-prick 
capillary blood samples were taken at 15-30 minute intervals over the next 2 hours after 
the meal (at 0,15,30,45,60,90,120 min). Time 0 was taken as the beginning of the 
first bite or sip. Prior to blood sampling, subjects were encouraged to warm their hand to 
increase blood flow. Fingers were punctured with an Accu-Check Soft Clix lancet device 
(UK). Blood was collected in 300µl with fluoride oxalate tubes (microvette, Sarsted, 
Germany). 
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Volunteers consumed eight different types of food in random order, with a minimum of 
two days between test breads. Subjects were randomly assigned to test different foods, 
therefore not all the subjects tested the same food (Appendix 1). To control for the 
variation in fasting blood glucose concentrations on the day of the test, subjects were 
asked to eat the same meal the evening prior to each test meal. Participants were also 
asked to abstain from exercise and heavy activities 24 hours prior to testing. Volunteers 
tested each type of food on two separate occasions while they tested the reference food 
(glucose) on three separate occasions. They were asked to ingest the breads within 10-15 
min and the 250 ml glucose solution within 5-10 min. 
Repeated twice for each test food and three times for the standard (glucose load) 
Finger prick 
Test food 
*16 
ý 
or 
glucose load FBG ýýý f11 
0 15 30 45 60 90 120 
Postprandial time (min) 
FBG Fasting blood glucose 
300 µl capillary blood 
Figure 3.1: Schematic presentation of the study day protocol. Each volunteer (n=14) 
ingested the test food twice and the glucose load three times. A fasting capillary blood 
sample was obtained by finger prick and at intervals of 15,30,45,60,90, and 120 min 
after the ingestion of the test food or the standard food (glucose load). 
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3.5.6. Determination of glycaemic/insulinaemic responses and GI/II 
Plasma glucose and insulin response curves for the two-hour test period were produced 
by taking the mean of duplicate measures of blood glucose and insulin concentration at 
each time point for each volunteer, for each bread tested. A mean glucose / insulin for 
the 10 volunteers for each time point was then used to construct the response curve 
The GI and II were determined from plasma glucose and insulin response curves 
produced over the two-hour test period. The GI was calculated from the incremental area 
under the curve (IAUC) for glucose after the consumption of a test food divided by the 
IAUC after the consumption of a control food containing the same amount of 
carbohydrate. The insulin response (II) was calculated from the IAUC of the insulin 
response after consumption of a test food divided by the IAUC after consumption of a 
control food containing the same amount of carbohydrate. In both cases the `control food' 
was 25 g of glucose. Hence, the GI and II of each diet were calculated for each person 
using the following equations: 
GI - 
Incremental area under 2-h plasma glucose curve for test food 
x100 Incremental area under 2-h plasma glucose curve for glucose 
II - 
Incremental area under 2-h plasma insulin curve for test food 
x100 Incremental area under 2-h plasma insulin curve for glucose 
In this calculation, blood glucose/insulin values that were lower than the first value (at 0 
min) were ignored. The IAUC of glucose and the IAUC of insulin responses for the 
standard (25 g glucose) were derived from the mean of the three IAUC for each 
volunteer. IAUC calculations were taken from Brouns et al. (2005) and incorporated into 
an Excel macro. 
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For the calculation of individual GI and 11 values, the IAUC was calculated separately for 
each food in every volunteer to indicate the total increase in blood glucose and insulin 
after the intake of test food. This was calculated as the sum of the trapezoids between the 
blood glucose curve and the horizontal line. Since each bread was tested twice in each 
volunteer, an average GI value was calculated from these two determinations. Then the 
GI for each test food was calculated as a mean of the respective average GI for each 
individual. Glycaemic indices are classified as high (70 to 100), intermediate (55 to 69), 
or low (55 and lower). 
3.5.7. Laboratory analyses 
Blood samples were immediately centrifuged (Eppendorf centrifuge 5810 R) and plasma 
glucose concentrations were measured in the Amiri hospital in Kuwait using an 
automated glucose oxidase method (Beckman Synchron CX®3 system). The rest of the 
plasma was stored in -80°C in the Amiri hospital and shipped later on dry ice to the 
University of Surrey for the determination of plasma insulin. 
The synchron CX3 system determines glucose concentration by an oxygen-rate method 
employing a Beckman oxygen electrode. 10µL of the sample is injected into a reaction 
cup containing a glucose oxidase solution. The rate of oxygen consumption which is 
directly proportional to the concentration of glucose in the sample, is determined through 
electronic circuits 
G! u cos e oxidase 
/3 -D- glucose + 0, > gluconic acid + H, 02 
H, O 
Hydrogen peroxide is then destroyed in the presence of catalase without yielding oxygen 
by the addition of ethanol to the reagent according to the following reaction 
H202 + Ethanol ("'°`°SQ 4 Acetaldehyde + H2O 
In order to ensure the complete destruction of peroxide, iodide and molybdate are added 
to the enzyme reagent causing the following reaction 
H202 + 2H+ + 21- 
h1olybdale 
> I2 + H2O 
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Three levels of controls were used at the beginning and end of each assay. The intra- 
assay coefficients of variation for the low, medium, and high quality controls were 
calculated to be 2.8% (low QC), 2.2% (medium QC), and 2.4% (high QC). The inter- 
assay coefficient of variation were 4.4% (low QC), 2.7% (medium QC), and 2.1% (high 
QC). 
Insulin was measured using immunochemiluminometric assay as described in section 
2.2.4 
3.5.8. Statistical analyses 
Statistical analyses were performed using SPSS version 14 (SPSS for Windows, 
Chicago, Illinois). Results were plotted as glucose and insulin curves and expressed as 
means ± SEM unless otherwise specified. Mean IAUC values for glucose and insulin, 
were calculated, according to Brouns et al. (2005) ignoring any areas below the fasting 
level. Normality was assessed using the Kolmogorov-Smirnov test. Leaven's test was 
used to investigate the equality of variance in different treatment groups. As 
homogeneity of variance was verified, data were tested by ANOVA. To compare the 
responses to different foods, a 2-way ANOVA with factors for food type (between 
subjects) and time (within subject) was used. A one sample t-test was used to compare 
the GI and II of the different breads with the standard glucose load. Pearson's correlation 
coefficient was used to examine relationships between variables of interest. Differences 
were considered statistically significant if p<0.05. 
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3.6. Results 
3.6.1. Characteristics of subjects 
The demographic and clinical characteristics of the subjects are shown in Table 3.2. All 
subjects consumed each of the test foods on two separate occasions and the standard 
glucose load three occasions (19 occasions). The subjects completed a total of 202 tests. 
An additional nine tests were repeated when the concentration of fasting blood glucose 
exceeded the normal reference range (>7 mmol/1), and it was assumed that this 
represented a non-fasted value. 
Table 3.2. Characteristics of subjects values are means (SD) 
Characteristics 
Number of subjects 14 
Male/female 7/7 
Mean age (years) 35 (10.8) 
Mean weight (kg) 65.14 (9.4) 
Fasting blood glucose (mmol/1) 5.2 (0.7) 
Fasting blood insulin (pmol/1) 11.8 (8.5) 
Mean blood glucose concentration before ingestion of the test food on the 19 occasions 
was 5.2±0.07 mmol/l (n=94). There was no statistically significant difference between 
fasting plasma glucose (p=0.99) or fasting plasma insulin (p=0.60) for any of the tests at 
baseline. 
3.6.2. Glycaemic and insulinaemic indices (GI & II) of test foods 
The GI and II values for the foods are presented in Figure 3.2 (see Appendix 2). The GI 
of the BP was significantly higher than the GI of LWP bread (p=0.026), with no 
significant difference between the rest of the foods, although the GI of these foods varied 
from 58.6% to 76.4%. All tested breads and rice had a significantly lower GI than the 
glucose standard (GI=100). The 11 of BP bread, on the other hand, was significantly 
different from the II of WP (p=0.042) and LWP (p=0.022). Except for IB which had a 
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higher II than that of glucose, none of the food tested in the current study had a 
significantly different 11 from that of the glucose standard. There was a trend in the 
differences in 11 between BP and the glucose standard. Correlation analyses indicated 
that there was a significant association between the GI and the II of foods tested 
(r--O. 238, p=: O. 034). 
\° 0 ý. ý 
c 
U 
WP LWP BP LBP WB BB IB WR Control 
Figure 3.2: Glycaemic and insulinaemic index for the 8 foods (n=10). Values represent 
means ± SEM. *Significantly different from the control p<0.05, **p<0.005, and 
***p<0.0005. ''i Represent a trend in the difference between the food and the control. 
Differences between a&b and c&d are significant, p<0.05. 
3.6.3. Glycaemic and insulinaemic response data 
Mean blood glucose concentrations following ingestion of the eight foods in normal 
subjects at each time point are shown in Figure 3.3 and Figure 3.4 (see Appendix 3). The 
mean blood glucose concentration was similar before ingestion of each test food, varying 
from 5.1 + 0.2 to 5.3 + 0.3 mmol/l. The consumption of glucose standard. BP, WP. LBP, 
and WR resulted in a mean peak glucose concentration at 30 min after ingestion while 
plasma glucose concentration peaked at 45 min postprandially for LWP, WB, BB and the 
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IB. The highest peak was obtained with the 25 g glucose load at 45.7% above basal 
level, followed by white bread (36.2% increase), and the lowest was with the light white 
pita bread (25.7%). 
Patterns of mean postprandial blood glucose increments are shown in Figure 3.5 and 3.6. 
The control (25 g glucose) and the white rice had relatively early negative blood glucose 
increments compared with the breads. The glucose showed a high early blood glucose 
increment peak and was followed by a rapid decline. The brown pita and the white 
bread, on the other hand, had relatively higher incremental levels which were maintained 
above the baseline level before it decreased at a later stage. The other breads showed the 
same pattern of postprandial glucose increments. There was a significant effect of time 
and significant interaction between time and food type (p<0.0005) with no significant 
effect of bread on mean plasma glucose increments (p=0.122). 
Mean plasma insulin concentrations following ingestion of the eight foods in normal 
subjects are shown in Figure 3.3 and Figure 3.4. Mean insulin concentration was similar 
before the ingestion of test foods (11.86±0.87 pmol/l (SEM), p=0.603). The consumption 
of the glucose load, LWP, and WR resulted in a mean peak insulin concentration at 30 
min after ingestion, while plasma glucose concentration peaked at 45 min postprandially 
for WP, BP, LBP, WB, BB and the IB. A two-way ANOVA, with time and food type on 
plasma insulin increments, indicated that there was a statistically significant effect for 
time (p<0.0005) and a trend for an interaction between time and food type on insulin 
levels (p=0.079) with no significant effect of food type (p=0.414). 
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Figure 3.3: Mean plasma A: glucose, B: Insulin responses in 14 healthy volunteers after 
the ingestion of 25g glucose load and the ingestion of pita breads (white, brown, light 
white, and light brown; n-10). Values are means + SEM. Error bars have not been 
shown if they are smaller than the symbol or overlap other bars. 
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Figure 3.4: Mean plasma A: glucose B: insulin responses in 14 healthy volunteers 
after the ingestion of 25g glucose load and the ingestion of white, brown, and 
Iranian breads and white rice (n=10). Values are Means + SEM. Error bars have 
not been shown if they are smaller than the symbol or overlap other bars. 
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Figure 3.6: Mean plasma A: glucose B: insulin increments for food types vs. time for: 
white, brown, and Iranian breads and white rice. Values are Means ± SEM. Error 
bars have not been shown if they are smaller than the symbol or overlap other bars. 
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3.6.4. Comparisons of GI with published values 
A comparison was made between the GI values calculated from the current study and 
those that were available for similar foods from the International Tables of GI. Four out 
of the eight foods tested in this study were compared with published GI values for similar 
foods from a different country origin (Table 3.3). The GI of these foods was comparable 
to their previously published values. 
Table 3.3 Comparison between GI values derived from the current study and published 
values in the International Tables of GI. 
GI % 
Food Type 
Current study 
International Tables of 
GI 
White pita bread 59 57 
White bread 68 70 
Brown bread 64 71 
White Rice 62 69 
81 
3.7. Discussion 
3.7.1 Glycaemic and insulinaemic indices of tested foods 
The GI values of the carbohydrate rich staples were determined in the present study using 
a standard protocol (Brouns et al., 2005). The primary objective of this study was to 
establish the GI of some staple foods in the Kuwaiti diet, that had been previously 
reported by others (Kamel & Martinez, 1984; Al-Hooti et al., 2002) that could then be 
used to investigate the effects of lowering the GI in T2 DM patients (Chapter 4). The 
results of the analyses of the 24-hour recalls collected previously from individuals with 
T2 DM (Chapter 4; pilot study) were also used to identify the staples in the diet of these 
patients. The glycaemic index of foods is similar in normal and diabetic subjects 
regardless of the individuals' glucose tolerance status (Jenkins et al., 1981; Wolever et 
al., 1998). Therefore results of the GI testing of the food in this study can be applied to 
other individuals, including T2 DM patients. Studies have shown an association between 
dietary GI and the risk of CVD in T2 DM patients (Jenkins et al., 1988a). 
Using published criteria (Foster-Powell et al., 2002), it is possible to classify brown pita 
as a high GI bread. The rest of the breads in this study (WP, LWP, LBP, WB, BB, and 
IB) and the white rice can be designated as having an intermediate GI value despite the 
observation that WP bread and LWP had relatively lower GI values (59% and 56% 
respectively). These GIs were comparable or lower than many other types of breads 
consumed worldwide (Foster-Powell et al., 2002). For example, the GI of white Turkish 
bread, bagel, and French baguette are 87%, 72% and 95% respectively. 
The II of the breads on the other hand could not be distinguished from the glucose 
reference, with Iranian bread having an even higher 11 than the glucose reference 
(p=0.032), and the brown pita bread having a higher II that was approaching significance 
compared to the glucose reference (p=0.053). The II was usually higher on the relative 
scale than the GI of the breads. This was difficult to explain as the amount of fat and 
protein in these breads were negligible. Both fat and protein in the diet increases insulin 
responses to a carbohydrate load (Lovejoy et al., 1998; Nuttall et al., 1984). These 
breads might therefore possibly induce a higher glycaemic response in T2 DM patients as 
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insulin secretion in these individuals is subnormal (Weyer et al., 1999). Howe` er, the 
overall association between the GI and the II was positive. In general. the insulinaemic 
index is less clinically useful than the GI as it varies in different groups of people 
(Wolever et al., 1998). 
When the breads where compared statistically for their measured GI. brown pita bread, 
interestingly, had a higher GI value than the light white pita bread. This finding was 
unexpected as many studies have shown that the GI of wholemeal bread is similar to that 
of white bread (Foster-Powell et al., 2002). A possible explanation might lie in the 
presence of fibre in the brown pita rather than the type of fibre per se. In manufacturing 
these pita breads, the bran which is added to the wheat flour consists of insoluble fibre 
inclusions. It is possible that these constituents disturb the gluten network of the bread 
and favor digestion, thereby increasing the bread's GI. The other possible explanation is 
that the addition of bran to the wheat flour in manufacturing brown pita necessitates 
intense kneading to incorporate the fibre satisfactorily. Intense kneading is known to 
have a positive effect on the rate of digestion, therefore increasing the GI value (Fardet et 
al., 2006). While the relatively higher GI value (68%) of the light brown pita as 
compared to the other white pitas (GI of white pita=59% and light white pita=56%) is 
consistent with this idea, further GI testing of wholemeal breads will be necessary to 
substantiate these explanations. Moreover, the physical structure of the starch (porous 
texture with highly gelatinized starch) rather than the nature of the raw material 
influences the bread's glycaemic response (Fardet et al., 2006). Therefore, the variation 
observed among some breads in this study in terms of their GI could be due to the baking 
process itself which plays an important role in determining the texture of the food. In 
manufacturing breads, it would be preferable to use wholegrain flour with the entire 
wheat fraction (bran, germ, and endosperm) which usually slows down the digestive 
process of starchy foods. The effect of fat and protein on the GI of the staples in the 
current study cannot be determined as the amount of fat and protein present in the test 
foods may not be sufficient to affect their overall glycaemic response. For example. a 
number of studies (Gannon et al., 1988; Nuttall et al., 1984) have indicated that about 20- 
30g dietary protein is required to stimulate insulin and decrease glycaemic responses of 
the carbohydrate food. 
83 
The results of this study could lead to beneficial health effects if the relativel\ low GI 
breads are substituted for the high GI brands. This involves replacing brow n pita bread 
with light white pita or white pita breads. The importance of this arises from the finding 
that even with small changes in the GI of the diet, a significant reduction of CVD risk 
will follow (Liu et al., 2000). With the exception of the white and light white pitas, the 
GI of white rice in this study was relatively lower than the breads (GI=62%). Therefore, 
rice can be substituted for the other breads that are commonly consumed in Kuwait, 
especially at lunch, as the majority of people prefer rice dishes at lunch. The rice 
however should not be replaced with Iranian breads in the diet of T2 DM patients as these 
breads have a significantly higher insulinaemic index than the rest of the breads tested in 
the present study. The least-eaten bread among individuals with T2 DM in Kuwait, as 
determined by a 24-h dietary recall (Chapter 4), was reported for light white pita (3.8%; 
GI=56%), while the highest consumption was reported for the light brown pita 
(GI=68%). This was in line with the general perception among diabetic patients that 
wholemeal bread contains higher dietary fibres than the white bread and would be 
expected to have a lower glycaemic response. This study did not support the patient 
perception that the brown pita had a lower glycaemic response than the white light pita. 
However, studies on whole cereal grains showed a reduction of the postprandial glucose 
profile with the consumption of wholegrain bread (Jenkins et al., 1988b). 
Individuals with diabetes have a limited range of low GI foods available, especially in 
terms of cereal products (Bjorck & Elmstahl, 2003; Jarvi et al., 1999). Of the hundreds 
of cereal products listed in the GI tables, only 16 have a GI <70. Results of this study 
clearly showed that most of the breads consumed generally in Kuwait by both the normal 
and the diabetic population are in an intermediate GI range. This finding prompts the 
speculation that the high prevalence of diabetes among Kuwaitis might be related to the 
quantity (glycaemic load; GL) rather than the quality of carbohydrate they consume. 
However, such a sweeping conclusion cannot be made. Indeed, examining the effect of 
GL on glycaemic response is important, as both the GI and GL determine the individual's 
glycaemic response to a food or meal (Sheard et al., 2004). The GL is the product of the 
GI of a food and its total available carbohydrate content. With respect to GL, a stepwise 
elevation in postprandial plasma glucose and/or insulin concentrations was associated 
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with stepwise increases in the GL in healthy individuals (Brand-Miller et al., 2003b). 
Also, it should be remembered that these foods are seldom eaten alone but rather as part 
of a mixed meal or consumed as components of a complex diet. The glycaemic and 
insulinaemic responses produced by these staples could therefore be affected by the 
addition of fat and protein to the diet, the presence of which affects gastric emptying and 
insulin secretion (Nuttall et al., 1984; Welch et al., 1987). However, many studies 
support the predictability of the GI in mixed meals (Wolever & Jenkins, 1986; Wolever 
& Bolognesi, 1996). 
3.7.2. Glucose and insulin responses to test foods 
The second objective of this study was to compare the pattern of plasma glucose and 
insulin responses to the different test foods. This was examined through plotting the 
measured plasma glucose/insulin increments vs. time for each food to obtain the 
corresponding curves. The glycaemic and insulinaemic responses to the reference food 
(glucose) were assessed three times in each individual to reduce the effect of the within- 
individual variation in glucose tolerance. 
When depicted graphically, the plasma glucose and insulin increments show that the 
glycaemic responses were different from the control. However, this difference did not 
reach statistical significance. In hindsight, this was not unexpected once the GI of the 
staples was determined in the first part of the study. In view of the narrow range of GI 
values for the staples, it was predictable that the glycaemic responses of the test foods 
would not be significantly different. The source of carbohydrate would affect 
postprandial glucose responses only if the GI values of different foods differed by a 
sufficiently large amount. Furthermore, other factors such as the variation between and 
within subjects might affect the ability to detect differences in plasma glucose or insulin 
responses to different foods. 
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3.7.3. Comparison of GI values with published values 
Since the breads examined in the current study have never been tested previously, it was 
important to calibrate the study with breads tested in other countries. Consequently, three 
of the breads tested in this study (white pita bread, white bread, and brown bread) in 
addition to the white rice were compared to values that have been previously published 
by other countries in the International Tables of GI (Foster-Powell et al., 2002). The GI 
of the test foods were closely related to previously published values. This gives 
confidence that the International Tables of the GI are a reliable resource for researchers 
as well as for clinicians and dietitians in Kuwait for the dietary management of T2 DM. 
However, the preamble to these tables reinforces the need for testing local foods in some 
countries, as the GI varies considerably for different varieties of breads. Therefore, these 
tables should be used for planning diets for people with T2 DM only if the measurement 
of the GI of local products is not feasible. 
The GI value of brown pita has not been published by any country in the International 
Tables of GI. However, one recent study of the GI and GL of commercial foods (Henry 
et al., 2005) was the first to determine the GI of brown pita (wholemeal pita) in the UK. 
According to this study, the GI calculated for brown pita was 56%, which placed it 
among medium GI foods, whereas in our study, brown pita was classified as high GI 
bread (76%). This difference was larger than the 10-15%© which others (Wolever et al., 
1991) have ascribed to errors in the measurement of GI. This large difference in GI is 
difficult to explain given the host of factors that could contribute to this variation, 
including different baking conditions and fibre content of the wholemeal bread tested in 
these studies. 
White rice is the other major staple in the Kuwaiti diet. The GI of the rice tested in this 
study compared well with the published values (Henry et al., 2005; Foster-Powell et al., 
2002). However, in the present study, only one cooking method of rice was examined 
(boiling in excess water and straining). The other most common way in Kuwait of 
cooking rice is by boiling it in a lesser amount of water (machbos). The GI of cooked 
rice using this method should also be tested as the process of boiling consistently 
decreased the amount of amylose in all rice varieties (Sagum & Arcot, 2000), thereby 
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affecting their GI. Overall, Kuwaiti people commonly boil foods in too much «ater for 
too long a period of time (Kamel & Martinez, 1984). Since the classification of rice into 
a high or low GI rice depends mainly on the amylose content of commercial varieties 
(Miller et al., 1992), determination of the GI of different brands that are commonly 
consumed in Kuwait is necessary, as consumers will have no way of knowing the 
amylose content of any rice from the food label (if present). Indeed, rice needs to be 
tested locally, brand by brand (Foster-Powell et al., 2002). Beside the amylose content, 
starch digestibility in rice is generally influenced by several other factors, such as the 
degree of gelatinization during cooking, the granule particle size, starch-protein 
interactions, amylose/lipid complexes and the level of resistant starch (Sagum & Arcot, 
2000). Moreover, rice in Kuwait is almost always eaten with a protein source, so 
examining the glycaemic response of rice in the context of a mixed meal rather than as an 
individual food (as in this study) will allow the examination of the possible confounding 
effects of fat and protein. 
3.7.4. Potential practical implications of the study 
A major practical implication from the findings of this study is to encourage the use of GI 
for better planning the diet of T2 DM patients in the context of disease management in 
Kuwait. As the study is the first to test the physiological effect of staples in Kuwait, 
these findings should provide valuable evidence to support changes in dietary 
recommendations for these staples in T2 DM. In planning diets in these individuals, the 
International Tables can be used as a representative tool for selection of carbohydrate 
foods of low GI values. A low GI diet plan can be applied by following the 2005 Dietary 
Guidelines for Americans (Department of Health and Human Servises & J. S. 
Department of Agriculture, 2006) and the recommendations of the WHO/FAO (1998); 
that is, the GI should be used to compare foods of similar composition within food 
groups. However, further studies are needed to identify low GI staples in Kuwait and 
promote their usage. The production of palatable low GI breads that combine several 
factors, including the intact cereal grain, using baking conditions that favor a lower 
glycaemic response (long time/low temperature) and the generation of organic acids 
through sourdough fermentation should be encouraged by bread manufacturers 
in 
Kuwait. Lowering of the GI was seen when including a, ß-glucan rich barley genotype 
in 
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flat-baked bread products (Liljeberg et al., 1996). It should be remembered though. that 
the nutritional quality of breads should not be based on the GI parameter solely. Adding 
fats to bread, for example, to lower its GI should not be encouraged as high consumption 
of fat is related to CHD risk (Wijendran & Hayes, 2004). The use of minimal processing 
conditions might also be useful to maintain starch crystallinity and reduce the amylase 
availability and GI of cereal flakes (Fardet et al., 2006). Since the majority of the people 
in Kuwait (65.9%) use food within at least one day (ALAjmi, 2004); a greater 
understanding of the influence of storage conditions and times on the formation of 
retrograde starch is required. 
It is undoubtedly easy for people in Kuwait to switch from the brown pita bread to breads 
made with wholegrain flour or intact cereal grain such as the new multigrain bread which 
has recently been marketed by the Kuwait Flour Mills and Bakeries Company. Besides 
having the lowest G1 of these breads, they have the beneficial effect of lowering LDL-C 
(Sloth et al., 2004), the strongest predictor of CHD in T2 DM patients (Turner et al., 
1998). 
Since the glycaemic response to mixed meals can be reasonably predicted from the GI of 
constituent foods (Wolever & Bolognesi, 1996), and provided that the GI of the 
individual foods is comparable with those of the International Tables of GI, then 
integration of information on GI into the Kuwaiti diet, including the mixed meal concept, 
should be achievable. 
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3.8. Conclusions 
To conclude, most of the breads, with the exception of brown pita bread consumed in 
Kuwait, were shown to have a medium GI value. The concept of GI as a mechanism of 
exchange of one source of carbohydrate for another can therefore be simply applied bý 
replacing brown pita with white or light white pita breads. This simple change could 
have major implications in the dietary management of T2 DM and its associated CVD 
risk factors. 
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CHAPTER 4 
Chapter 4 
INVESTIGATION INTO THE EFFECTS OF A LOW GLYCAEMIC INDEX 
DIET IN ENERGY BALANCE AND AS COMPARED WITH ENERGY 
RESTRICTION ON MODIFYING AN ALP IN OVERWEIGHT/OBESE T2 
DM PATIENTS IN KUWAIT 
4.1. Introduction 
T2 DM is a major clinical and public health problem among the Kuwaiti population of 20 
years of age and older with an overall prevalence rate of 14.8 % (Abdella et al., 1998). 
T2 DM is associated with elevated risk of CVD and the risk of coronary heart disease 
(CHD) is 3-fold higher in patients with diabetes and more likely to lead to mortality and 
prolonged morbidity (Stamler et al., 1993). The National Cholesterol Education Program 
Adult Treatment Panel III (2001) defined diabetes as CHD `risk equivalents' and 
recommend equally aggressive treatment as those used for the secondary prevention of 
CHD. Typically, T2 DM is associated with a dyslipidaemia that increases the risk of 
CHD. T2 DM dyslipidaemia is characterized by high TAG concentrations, 
predominance of sdLDL-C and decreased concentrations of HDL-C (Goldberg, 2001). 
This triad of abnormalities in plasma TAG, LDL and HDL is collectively known as the 
atherogenic lipoprotein phenotype (ALP). Glycaemic control alone in T2 DM patients is 
not sufficient to reduce CVD risk (Schernthaner, 2005). The UKPDS showed that HbAI, 
ranked below LDL-C and HDL-C as risk factors for CAD and below LDL-C and 
diastolic blood pressure in determining risk for fatal or non fatal myocardial infarction 
(Turner et al., 1998). Therefore, the NCEP ATP-III (2001) guidelines placed emphasis 
on lipids and lipoprotein abnormalities as they can be modified though diet and lifestyle 
changes. To date, the most effective dietary approach for the treatment of this ALP 
remains controversial. In a low fat diet, replacement of saturated fat, which is considered 
atherogenic, with carbohydrates adversely increases plasma TAG concentrations 
especially in individuals with an ALP (Abbasi et al., 2000). An alternative approach is 
therefore to replace high glycaemic index (GI) foods with less refined lower GI foods. 
The GI is a degree to which a food will raise the plasma glucose concentration. It 
compares a test food, gram for gram of available carbohydrates with a standard test meal 
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(Jenkins et al., 2002). Carbohydrate-rich diets with a high GI cause a high postprandial 
glucose and insulin response (Jenkins et al., 2002; Wolever. 1990b) and are associated 
with decreased insulin sensitivity (Frost et al., 1998). Moreover, high GI diets have been 
shown to raise plasma TAG and lower HDL, whereas diets containing low GI (LGI) 
foods tend to lower plasma TAG (Dumesnil et al., 2001) While randomized, controlled 
trials have shown that glycated haemoglobin was reduced by 0.43% points on a low-GI 
diet (Brand-Miller et al., 2003a), the detailed effects of a LGI diet on the ALP; a 
phenotype with a high prevalence in T2 DM patients in Kuwait, have not been previously 
tested. 
There is universal agreement that weight reduction is an essential part of dietary therapy 
for dyslipidaemia in individuals with T2 DM. It has been consistently shown that when 
weight reduction is achieved (and maintained) in T2 DM patients, a sustained decrease in 
TAG concentrations is observed (Howard, 1993). Many studies have also shown an 
increase in HDL-C as well as an improvement in the ratio of total to HDL-C in T2 DM 
patients with weight reduction (Ginsberg et al., 2005b). In overweight or obese 
individuals with T2 DM, a weight reduction of 5-10% is associated with metabolic 
improvement in glycaemic control, insulin sensitivity and CVD risk factors (Blackburn, 
1995; Ditschuneit et al., 2002; Wing et al., 1987a). Results from the Women Nurses 
Health Study (Liu et al., 2000) suggest that the effect of dietary GI is more important in 
individuals with a greater degree of obesity, as there was no association of dietary GI 
with CHD in persons with a body mass index of <23 kg/m2. Therefore, any dietary 
advice for T2 DM patients should take their degree of obesity into account. Despite the 
fact that weight reduction is an important therapeutic goal for the reduction of CHD risk 
in T2 DM in Kuwait (Al-Adsani et al., 2004), available data is insufficient to construct 
dietary guidelines for risk reduction in this population. 
4.2. Statement of the problem 
Inspite of the high prevalence of CVD risk factors in T2 DM patients in Kuwait, and 
despite the evidence that these risk factors are modifiable through the manipulation of 
dietary GI, this has never been investigated previously in Kuwait. Therefore, the primary 
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aim of the current study was to investigate the efficacy of a LGI diet in improving an 
ALP as a CVD risk profile in T2 DM patients in Kuwait. In addition, it is unclear 
whether energy-restricting the diet in addition to lowering its GI will confer additional 
benefits to those observed during energy balance especially in individuals with increased 
CVD risk such as T2 DM patients. Therefore, a secondary aim of the present study was 
to compare the efficacy of the LGI diet with energy restriction as compared to energy 
balance. 
4.3. Objectives of the study 
To examine, in overweight/obese individuals with T2 DM in Kuwait, two dietary 
approaches for the reduction of an ALP as a major CVD risk factor within this 
population. These approaches are a LGI diet and a LGI combined with an energy- 
restricted, weight-losing diet. 
Specifically: 
1. To investigate the effect of a LGI diet compared to high GI diet on glycaemic 
control and ALP as markers of CVD risk in overweight/obese patients with T2 
DM in Kuwait primarily TAG concentrations. 
2. To compare the efficacy of a LGI diet to that of LGI diet combined with an 
energy-restriction with respect to the expression of an ALP in order to predict 
the most effective dietary approach for CVD risk reduction in Kuwaiti 
overweight/obese T2 DM patients. 
3. To investigate the effect of a LGI diet on self-reported appetite and food 
intake in overweight/obese individuals with T2 DM using a subjective 
appetite rating system (VAS) and 24-hour dietary recall. 
4. To demonstrate the applicability of LGI dietary advice and its potential use as 
a management tool for CVD risk reduction in Kuwaiti overweight/obese T2 
DM patients. 
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4.4. Study hypotheses 
1. A LGI diet will produce significant improvement in glycaemic control and in the 
expression of an ALP in overweight/obese patients with T2 DM in Kurt ait. 
2. An energy-restricted LGI diet will further enhance the improvement in glycaemic 
control and the expression of an ALP in T2 DM Kuwaiti patients compared to 
LGI diet alone. 
3. A LGI diet will significantly decrease appetite as measured by VAS scores. 
4.5. Significance of the problem to the Kuwaiti population 
Any clinical or dietary findings from this study will be of great significance to the health 
professionals and nutrition care providers in Kuwait as the relevant dietary data on this 
type of dietary intervention is lacking. In the attempt to manage the risk factors for CVD 
in T2 DM patients, dietary treatment is of substantial importance. Prevention and risk 
reduction are primary themes for current research in Kuwait (Al-Adsani et al., 2004; al- 
Muhtaseb et al., 1991; Mojiminiyi et al., 2006; Jackson et al., 2002; Akanji, 2002; 
Abdella et al., 1998). Thus, findings from this study will translate into future programs 
for diabetes management and in constructing procedures for nutrition education 
appropriate for the Kuwaiti population. 
The study will focus primarily on determining the best approach for the dietary 
management of CVD risk in overweight/obese individuals with T2 DM in Kuwait. To 
the best of our knowledge, this study is the first to examine dietary manipulation, both in 
terms of GI and/or energy restriction, and to examine its applicability and relevance in 
the diabetic Kuwaiti population. Outcomes from this study, therefore, enable nutrition 
professionals in the country to gain insights into the dietary intake of this population 
compared to international recommendations in order to promote more positive behaviors 
and build-up a comprehensive plan to meet the nutritional requirements of this 
population. In addition, the study will help nutrition professionals develop an awareness 
of risk management and evaluate possible strategies for CVD risk reductions in T2 DM. 
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This might require a comprehensive care approach and a shift in the way many patients 
with diabetes in Kuwait are currently being treated. 
4.6. Ethical approval 
Ethical approval was sought from the University of Surrey Advisory Committee on 
Ethics (Appendix 4). A letter of approval for conducting the study in the Ameri hospital, 
Kuwait, was also obtained (Appendix 5). The study was supervised by a panel of 
professionals at both study sites; the University of Surrey and the Ameri hospital in 
Kuwait. The panel of experts including nutrition specialists, diabetologists, research 
assistants, and dieticians were involved for guidance and research quality assurance 
especially throughout the data collection period. 
4.7. Methods 
4.7.1. Estimation of the GI of T2 DM diet in Kuwait 
Before the commencement of the study, a detailed literature review was conducted to 
search for any dietary study that might provide insights into the GI of the diet of 
Kuwaitis. This search indicated that there had been no work that defined the GI of the 
diet of Kuwaitis previously. Therefore, it was decided to undertake a pilot study in order 
to estimate the GI of the diet of T2 DM patients in Kuwait. Twenty-six subjects with T2 
DM; l1 males and 15 females, age 26 ±12.4 years (SD) and BMI= 31.7±6.7 (kg/m2) 
(SD), who attended the dietician outpatient clinic at the Ameri hospital, were interviewed 
and a 24-hour dietary recalls were collected. This was done through the corresponding 
outpatient dietician at a routine outpatient visit and the recalls were analyzed using 
WinDiet software (WinDiet, research version, Aberdeen, UK). These recalls were 
collected in both weekdays (n=17) and weekend days (n=9). The majority of subjects 
were obese with a mean BMI of 31.7±6.7 (SD). Analyses of these records indicated that 
the mean GI of the diet of subjects with T2 DM was 68% which falls in the high GI range 
for the diet. Table 4.1 summarizes the basic outcomes from this pilot study including 
anthropometric, blood pressure, and dietary information. 
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Table 4.1. Characteristics and dietary composition (per day) of patients with T2 DM in Kuwait 
(pilot study). 
Criteria N Mean SD 
Age (years) 26 53.6 12.4 
Weight (kg) 26 82.4 17.2 
BMI (kg/m2) 26 31.7 6.7 
Waist circumference (cm) 16 120.3 13.8 
Systolic BY (mmHg) 22 129.5 13.5 
Diastolic BY (mmHg) 22 82.9 15.0 
Energy(kcal/d-KJ/d)) 26 2565-1113 428-1797.6 
T. Fat (g/d) 26 113.6 37.3 
S. Fat (g/d) 26 41.1 18.5 
Protein (g/d) 26 96.9 34.4 
PUFA (g/d) 26 16.6 11.6 
MUFA (g/d) 26 38.2 16.1 
T. Cholesterol (mg/d) 26 387.5 181 
STARCH (g/d) 26 205.5 51.7 
CHO (g/d) 26 305.5 65.3 
Dietary fibre (g/d) 26 22.0 9.1 
GI (%) 26 67.9 9.8 
4.7.2. Sample size justification 
Primary Outcome Variable: Plasma triglyceride (TAG). 
Luscombe et al (1999) observed a 0.33 mmol/1 fall in TAG concentrations on a LGI diet. 
Based on these data, a common standard deviation of 0.28 was assumed. Using these 
data a sample size of 15 participants / group would be predicted to have 80% power to 
detect a difference in means of 0.33 mmol/l in the TAG concentration between groups. 
Allowing for a 25% dropout rate, 20 participants/group were recruited. 
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4.7.3. Recruitment 
Recruitment was based on existing health records held in the Ameri hospital for each 
patient. Volunteers were recruited through clinical databases by the assistance of 
diabetologist. The recruitment period lasted for three months (February-April 2006). 
Overweight and/or obese volunteers were recruited only from the Ameri health region. 
which included the primary health care centres in the area. The Ameri hospital was 
chosen for the target population because it was the most active in terms of diabetes 
management in Kuwait. 
4.7.4. Study participants 
Inclusion criteria were 
" Patient with established T2 DM according to WHO criteria (1999) 
" Aged 30-70 years 
" Overweight or obese (BMI > 27 kg/m2) 
" On stable medication for at least 6 months 
" HDL cholesterol <I mmol/l for men, < 1.2 mmol/1 for women 
" TAG > 1.3 mmol/1 
" Average GI of the diet (determined from 24 hour dietary recall) > 65 
Participants were excluded if they had a BMI of > 45 kg/m2 or if they had serious 
microvascular complications. Patients were seen by a diabetologist on a regular basis for 
at least 6 months prior to participation in the study. All patients were in good health 
except for diabetes. Medications, including, oral hypoglycaemic agents and lipid- 
lowering, were maintained at the same doses throughout the study period. 
4.7.5. Study design 
The study was a controlled, randomized parallel design with two dietary treatments and a 
control group. The duration of the intervention was 6 weeks. The dietary treatments 
were the LGI diet and the LGI combined with an energy-restricted weight reducing diet 
with a6 week dietary intervention period preceded by a2 week run in period and a6 
week follow up (Figure 4.1). The study consisted of 3 cohorts. During the run-in period. 
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participants were asked to maintain their normal diet, while in the follow up period 
participants had free choice of either continuing with the intervention diet or going back 
to their habitual diet. The dietary intervention was of an open, free living design in which 
participants purchased their own food and prepared their own meals. 
Participants were randomly assigned to one of the following groups; a control group, a 
LGI diet group or an energy-restricted LGI group. In all three groups, subjects were 
requested not to alter their level of physical activity throughout. 
30 ml blood sample 
(ý 24-hour dietary recall 
U 
24-hour dietary recall 
VAS 
Week -2 Week 0 
O Face to face interview 
M Telephone interview 
X Indicates cancellation of the follow up part 
Figure 4.1. Study design. 
30 ml blood sample 30 ml blood sample 
Q 24-hour dietary recall 24-hour dietary recall 
x 
---------------- 
VAS 
Week 6 Week 12 
98 
4.7.6. Intervention diets 
4.7.6.1. LGI diet 
The principal components of the LGI diet were based on the GI testing of some local 
breads and rice staples for the participants under study. This investigation was carried out 
before running the study (Chapter 3). In addition, the International Tables of the GI 
values (Foster-Powell et al., 2002) were utilized for modifying individuals habitual high 
GI diet to a lower GI diet, designed to be isocaloric with respect to their previous dietary 
intake. The intervention aimed to achieve large differences in the GI of the high 
carbohydrate foods with no changes in the macronutrient or fibre intakes. It was 
important throughout the study that subjects in the control and LGI diet groups 
maintained their weight as this leg of the intervention was designed to test the effect of 
LGI diet alone on plasma lipids and lipoproteins. The habitual intakes of each individual 
were identified through the first 24-hour dietary recall collected personally before the 
run-in period (Appendix 6). A diet sheet was developed to provide participants with 
detailed and practical advice on the principles of the LGI diet (Appendix 7). It included 
tips on how to reduce the GI of the diet, meal and snack ideas, as well as a substitution 
list of high GI with LGI foods. The instructions were designed by the researcher to aid 
participants on understanding the principles of a LGI diet, and in implementing them. 
Individualized dietary advice was provided through the investigator and a trained 
dietitian who was already working in the hospital and who was currently dealing with 
patients with T2 DM in the hospital outpatient clinic. Dietary advice was based on the 
habitual intake and provided through visit 2 during the second week of the intervention 
period (Figure 4.1). 
4.7.6.2 LGI combined with energy-restricted diet 
The degree of energy restriction was estimated and calculated individually for each 
participant using the Harris Benedict equation calculator available online (Cornell 
University, 2001). The calculator simply incorporates the age, gender, and weight of the 
participant into the equation and calculates the basal energy requirement. This is then 
multiplied by the activity factor to account for the physical activity of the individual as 
described previously (Ebbeling et al., 2005). A weight loss of 5-10% was targeted for 
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this group. The distribution of energy in grams of macronutrients was drawn from the 
recommendations of the American Diabetes Association (Franz et al.. 2004) for people 
with diabetes. According to these guidelines, approximately 10-20% of the daily energy 
intake should be derived from protein. Both animal and vegetable sources of protein 
should be provided in the diet. The remaining 80-90% of energy is to be distributed 
between dietary fat and carbohydrate. Less than 10% of this energy should be from 
saturated fats and up to 10% energy from polyunsaturated fats, leaving 60-70% of the 
total energy from monounsaturated fats and carbohydrates. The distribution of calories 
from fat and carbohydrate was varied and individualized based on the habitual intakes 
and nutrition goals. The carbohydrate content of the diet comprised of LGI foods. The 
diabetic food exchange list (American Diabetes Association & The American Dietetic 
Association, 2003) was then used to plan menus for each participant with emphasis on 
LGI foods. Participants were provided with menus based on preferences. Monitoring 
Glycaemic status and body weight, on any diet, is essential to assess the effectiveness of 
the nutrition plan. Therefore, participants in the energy restricted diet group were asked 
to monitor their glucose concentrations and weight regularly in order to make dietary 
modifications if necessary. 
4.7.7. Questionnaires 
Three questionnaires were utilized in this study. Dietary intakes were assessed using the 
24-hour dietary recalls method. Participants' feelings of hunger/satiety was assessed 
before and one hour after each meal during the day using 100 mm self rated visual 
analogue scales (VAS) (Rogers & Green, 1993) and the knowledge of individuals with 
T2 DM was assessed using the GI knowledge questionnaire. 
4.7.7.1.24-hour dietary recall 
The method of 24-hour recall was used to assess the dietary intake of participants and to 
measure compliance with the intervention diet as this method has been shown to be the 
most feasible to identify the quantity of food items consumed by Kuwaitis (Kamel & 
Martinez, 1984). These recalls were collected on one occasion before the stud\ 
commenced and three times during the run-in and the intervention phase of the study and 
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once more at the end of the follow-up period (Appendix 6). This method of dietary 
assessment was used as being the most appropriate for dietary researches in Kuwait, as 
participants are generally reluctant to fill in written questionnaires. The researcher 
interviewed participants and provided dietary advice for them to folloýt . All 
foods and 
drinks consumed by the respondent were reported on a standard form used in the hospital 
with the use of measurement aids and visuals, including charts and draw ings to quantify 
the foods and beverages when the interview was conducted face to face. Three dietary 
recalls were conducted in person and three were collected over the telephone. The 
dietary interview length ranged from 15-30 minutes depending on the number of foods 
reported in the dietary recall 
4.7.7.2. VAS 
A pre-post meal VAS (Appendix 8) was collected from participants on three occasions 
within the run-in and intervention period and a last one in the follow-up period of the 
study. These standardized scales are known to be easy and quick to use and do not 
involve the use of descriptive terms (Stubbs et al., 2000). Four variables, hunger, 
fullness, desire to eat, and prospective consumption were tested through the 
questionnaire. Participants were familiarized with the scale in advance in the first visit 
during the run-in period. They were requested to make a vertical mark on each line that 
best matched how they felt at the time. The dates for VAS collection were pre-scheduled 
for each patient and the dietician in the hospital reminded each participant to do so the 
night before the collection. 
4.7.7.3. GI knowledge questionnaire 
The GI knowledge questionnaire was developed by the researcher for the purpose of 
testing how much participants knew about the GI of the diet and also as a tool for 
assessing the success of the nutrition education and dietary advice directed to participants 
in both intervention groups (Appendix 9). The knowledge of participants regarding the 
GI of the diet was assessed immediately after the initial dietary advice by the dietician 
and at the end of the intervention period. The questionnaire attempted to test GI 
knowledge regarding foods that are low and high in GI. The questionnaire was 
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developed using GI values from the International Tables of GI and findings from the GI 
testing of breads and rice (Chapter 3) in order to make it more appropriate for the study 
population. 
4.7.7.4. Validity and reliability of the questionnaires 
The method of 24-hour dietary recall was used for assessing dietary intakes of the study 
subjects. The 24-hour dietary recall is a valid method for estimating the dietary intake of 
energy, macro and micronutrients in the diet (Greger & Etnyre, 1978). In order to 
increase the reliability of the 24-hour recall interview in this study, a standardized form 
was used to assure consistency for the collection of the information from each patient 
(Appendix 10). Collecting a 24-hour dietary recall by means of telephone interview is 
also considered a valid method and provides an adequate description of food intake 
(Bogle et al., 2001). In fact, the telephone interview produces acceptable estimates of the 
means and distributions of nutrient intakes and has the advantages of markedly reducing 
the cost, time, logistical, and personnel constraints associated with nutrition surveys 
(Posner et al., 1982). 
VAS rating of appetite was used to measure appetite and satiety in relation to the test 
diets. This instrument is also considered a valid method for subjectively rating appetite. 
VAS are recommended to be used within subjects, using a repeated measure designs so 
as to compare the effect of treatment under similar circumstances (Stubbs et al., 2000). 
The GI knowledge questionnaire was assessed for both face and content validity. A 
panel of four University of Surrey faculty members evaluated the validity of the 
instrument. These faculty members were chosen to be experts in the area of nutrition and 
GI of food. A description of the objectives of the study was provided to the experts along 
with the questionnaire to determine whether the instrument was capable of measuring the 
objectives specified in the study. In order to ensure the validity of the Arabic version of 
the questionnaire, two diabetologests and two dietitians who worked in the Ameri 
hospital answered the questions independently. Items that were answered the same by 
the four respondents were retained. Reliability, on the other hand, was assessed b\ 
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comparing the scores of a segment of experts to those of intermediate and limited 
knowledge in the area of GI. 
4.7.8. Data collection procedures 
Data was collected starting from the month of February, until the end of August, 2006. 
Permission was sought from the Public Authority for Applied Education and Training, 
the Investigator's sponsors, to conduct the study in Kuwait (Appendix I 
Recruitment was based on existing health records held in the Ameri hospital for each 
patient. Suitability for inclusion was assessed during patient routine visits to the clinics, 
when the GI of the diet was calculated also from the 24-hour dietary recall collected 
during this visit, along with other information, within the patient's health records. At this 
point, suitability was checked using a checklist especially designed for the study 
(Appendix 12). 
Selected participants were informed about the study design through individual interviews 
during routine clinical visits. The health care providers in the hospital always encouraged 
patients to participate in the study. Upon agreement of participation, participants were 
provided with a patient information sheet (Appendix 13) and consent forms were 
obtained from each participant (Appendix 14). The consent form included an explanation 
that participation was voluntary and that participants were guaranteed confidentiality and 
freedom to withdraw from the study at any point. Time of selection for the starting date 
for each participant was done prior to the first visit and was based on the time which was 
the least disruptive to the schedule of the patient. 
4.7.8.1. Demographics and anthropometric measurements 
A demographic as well as anthropometric questionnaire (Appendix 15) were used at 
baseline and subsequent visits. Height was measured using a wall mounted stadiometer 
("Seca" Somatometre 200 cm x 0.1 cm). Weight were measured using a calibrated dial 
scales (Healthometer Professional Scales, 148 kg x 500 g). BMI was calculated using the 
standard formula (weight [kg]/height2 [m]). Waist circumference was measured to the 
1 0- 
nearest 0.1 cm using a standard tape measure at the narrowest point between the iliac 
crest and the lowest rib. Blood pressure was measured using an electronic sphygmometer 
(Omron M4, Omron Healthcare Netherlands) with the participant sitting at rest. 
4.7.8.2. Dietary measurements 
A 24-hour dietary recall was used to calculate the food intake of participants. In order to 
assist with proper portion size recording, standard measuring utensils and common 
serving dishes were displayed when collecting the first dietary recall in each phase of the 
study. The researcher asked participants for reasonable accuracy in recalling the dietary 
intake. The dietary intakes were analyzed using WinDiets software (WinDiets, research 
version, Aberdeen, UK) to give a full nutrient analysis. Considering the cultural variation 
in the diet, specificity of the amount and combination of dishes was required to make the 
report appropriate for analysis. The number of exchanges in selected Kuwaiti composite 
dishes (Sawaya et al., 1998) was also used to calculate the macronutrient content of the 
diet. 
4.7.8.3. Fasting blood values 
Fasting blood samples were taken at baseline (week 0) and 6 weeks. They were analyzed 
for glucose, T. Cholesterol, LDL-C, HDL-C, TAG, NEFA and insulin, LDL and HDL 
subfractions. 30 ml of fasting blood was drawn by venepuncture using commercially 
available vacutainer tubes (Becton Dickinson, Oxford, UK). All blood samples were 
taken by venepuncture by trained phlebotomists who worked in the laboratory within the 
hospital. Blood was collected into flouride oxalate for glucose analyses, lithium heparin 
for insulin assay and K2EDTA for all lipid assays. Blood was immediately centrifuged at 
2000g for 20 min at 4° C in an Eppendorf centrifuge 5810R low speed centrifuge for the 
separation of the plasma. Aliquots of plasma were dispensed into appropriately labeled 
Sarsted tubes (2 ml). They were stored at -80°C in the Ameri hospital and then shipped 
to the UK on dry ice through a courier company for subsequent analyses at the University 
of Surrey. Glucose, insulin, lipids and lipoprotein measurements were dcarried out as 
described previously (Section 2.2.3). 
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4.7.9. HOMA calculation 
HOMA-IR was calculated using online calculator (Diabetes Trials Unit., 2004). The 
calculation of HOMA by this method involves measurements of both glucose and insulin 
concentrations. The calculator also provides estimates of steady state beta cell function 
(%B) and insulin sensitivity (%S) which has been shown to correlate with stimulatory 
models such as the hyperinsulinaemic clamp (Diabetes Trials Unit., 2004). 
4.7.10. Calculation of daily GI and GL 
The GI figures of individual foods were derived from the world literature with main 
reference to the international table of GI (Foster-Powell et al., 2002), and the results of 
the GI testing of local Kuwaiti breads and rice (Chapter 3). Similar foods were 
determined by ingredients breakdown (Olendzki et al., 2006) and food preparation 
methods that were described as part of the collection of the 24-hour dietary recall. Mixed 
dishes involved breaking down the ingredient of the mixed dish to consider direct or 
similar matches of individual ingredients which were then matched to foods from the GI 
recourses mentioned above. Mean GI/GL values of the day were calculated using the 
method recommended by Wolever et al (1994b). Briefly, an average GI was computed 
by summing the grams of carbohydrate per serving multiplied by its GI. All divided by 
the grams of carbohydrate per day. Average dietary GL was calculated in the same way 
but without dividing by the total carbohydrate per day. The calculation of GI used 
glucose as the reference food. The following equations summarises the calculation: 
Dietary GI = GI x CHO / CHO(g / d) 
Dietary GL - GI x CHO / 100 
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4.7.11. Statistical analyses 
Statistical analyses were performed using SPSS statistical package version 14 (SPSS for 
windows, Chicago, USA). Data were checked for normality using Kolmogorov-Smirnov 
analyses and checking both the normal and detrended normal probability plots. 
Homogeneity of the variance was assessed by Leven's statistic. Skewed parameters were 
transformed as appropriate for analyses. WC, plasma TAG, LDL-C, NEFA and insulin 
concentrations were not normally distributed therefore they were log transformed and the 
geometric means were reported. Data for plasma glucose could not be transformed to a 
normal distribution therefore they were analyzed using the non parametric Kruskal- 
Wallis test for the between groups effect. Mean daily intakes of energy and nutrients 
were calculated from an average of the three 24-hour recalls collected in each phase of 
the study. VAS were also averaged for each period of the study and repeated measure 
ANOVA was used to study the changes in VAS scores, over time. Pre versus post 
dietary effects of all the different variables within each group were assessed by a paired 
Student t-test. The effect of the GI variables across groups was assessed using ANOVA. 
Post-hoc pairwise analyses with Tukey's HSD was used when statistical differences were 
evident between groups. For categorical outcomes; HOMA-IR, groups were compared 
by using the chi-square test. Values are means±SEM unless otherwise indicated. All box 
plots were plotted using the program default option of medians and interquartiles. 
Correlations coefficients were measured to examine relationships between changes in 
different variables. Statistical significance was defined asp<0.05. 
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4.8 Results 
4.8.1 Patient recruitment 
It should be noted that due to time constraints and recruitment problems, the investigator 
was unable to conduct the third part of the study (the follow-up phase). Of the 56 
participants who started the trial, four withdrew during the run-in phase of the study. 
Reasons for these withdrawals included pregnancy of one female participant while three 
participants could not come to the clinic; one because of knee injury and the other two 
because of individual work pressures. Of the 52 participants who were allocated to 
treatment groups, 2 females withdrew; one because of long period of traveling and the 
other one no longer wished to diet. The percentage of withdrawals from the study was 
still less than expected (12% versus 25%). The flow of participants through the study is 
shown in Figure 4.2 
56 Subjects agreed to 
participate 
(24 males & 32 females) 
4 Subjects withdrawn 
(3 females &1 male) 
52 Subjects enrolled in the 
trial 
(29 females & 23 male) 
LGI diet group Control group Energy-restricted LGI 
n= 16 n= 17 diet group 
(7 females &9 males) (l O females &7 n= 19 
males) (12 females &7 males) 
2 Subjects 
withdrawn 
(2 females) 
Completed trial Completed trial Completed trial 
n=16 n =16 n =18 
(7 females &9 (9 females &7 (11 females &7 
males) males) males) 
Figure 4.2. A schematic presentation of the flow of subjects through the study. 
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4.8.2. Baseline characteristics 
The anthropometric and clinical characteristics of participants at baseline according to 
allocated groups are shown in Table 4.2. The mean age of participants did not differ 
significantly between the three groups neither did the weight, BMI, and WC. Average 
diabetes duration was 7 years±3.1 (SD) years and this did not differ between the allocated 
groups, or between men or women. HDL-C and TAG concentrations presented in Table 
4.2 were taken from the patient's health record. 
Table 4.2. Characteristics of participants in each dietary group at baseline. Values are means 
(SD). 
Control (n=16) LGI (n=16) 
Energy-restricted 
LGI (n=18) 
M/F 7/9 9/7 7/11 
Age (y) 51.9 (12.8) 55.3 (8.9) 48.2 (8.0) 
Diabetes duration (y) 7 (3.1) 8.1 (2.9) 6.6 (2.6) 
Weight (kg) 91.8 (15.1) 88.1 (12.2) 88.3 (17.3) 
BMI (kg/m2) 34.6 (4.8) 33.0 (3.0) 34.4 (5.4) 
Waist circumference (cm) 104.3 (23.5) 103.8 (7.2) 110.4 (12.9) 
Systolic BP (mmHg) 127 (7.2) 129.9 (8.7) 131.1 (11.4) 
Diastolic BP (mmHg) 81.4 (3.7) 84.7 (4.7) 82.3 (5.7) 
TAG (mmol/1) i 2.1 (0.9) 2 (0.7) 2.1 (1.0) 
HDL (mmol/1) i 0.8 (0.2) 0.9 (0.2) 0.9 (0.2) 
GI (%)* 74.0 (7.9) 73.4 (5.6) 70.7 (6.7) 
GL* 208.1 (63.9) 200 (36.1) 199.4 (49.3) 
'Values were based on last biochemical profile within 3 months before the start of the trial. 
*Values represent habitual intakes 
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4.8.3. Changes in anthropometric indices and blood pressure 
There was no significant difference in the systolic or diastolic blood pressure between the 
groups at baseline. After 6 weeks intervention, the systolic blood pressure was 
significantly different across groups (p<0.0005) with the changes in the energy-restricted 
LGI diet group being significantly lower than the control (p<0.0005) and the LGI diet 
group (p=0.001; Table 4.3). The changes in the systolic blood pressure were strongly 
associated with weight loss (rr0.766, p<0.0005). 
Weight, BMI, and WC measurements were assessed at week 0 and 6. At baseline, weight 
was not statistically different between groups (p=0.67). Only participants in the energy- 
restricted LGI diet group reduced their weight significantly (p=0.001) over the 6 week 
period. Within this group two participants gained weight (1.05 kg) and they were 
included in subsequent analyses as the trial was designed originally to represent a clinical 
situation. Mean absolute weight loss (kg) from baseline to 6 weeks was 2.3±1.6 (SD) as 
shown in Figure 4.3. The percentage of weight loss over the 6 week period within the 
weight loss group was 2.6±1.6% (SD) In this group, there was a relationship between 
baseline weight and weight loss (r=0.57, p=0.013). Also, changes in body weight were 
associated with changes in GL of the diet ( 0.312, p=0.028) but not the GI (r=-0.308, 
p=0.213). Weight loss in the energy-restricted LGI group was significantly different than 
the control group (p=0.001) and the LGI diet group (p=0.017). These results are shown 
in Table 4.3 and Figure 4.3. 
BMI was not significantly different between groups at baseline (p=0.511). The average 
BMI for the allocated groups placed them in the obese range (BMI>30). BMI for the 
energy-restricted group decreased significantly from baseline (p<0.0005). This reduction 
was significant when compared to the control (p<0.0005) and the LGI diet group 
(p=0.009) with no difference between these latter two groups (Figure 4.4). Changes in 
the BMI were strongly related to changes in total energy intake /day (x0.987, p<0.0005). 
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Table 4.3. Anthropometric measurements at baseline and at week 6. Values are means (SEM) 
Variable Control LGI 
Weight (kg) Baseline 92.8 (3.8) 88.3 (3.0) 
6 weeks 92.9 (3.9) 87.9 (2.9) 
Changes (6 weeks 0.5 (0.5) -0.3 (0.7) 
-baseline) 
BMI (kg/m2) Baseline 34.8 (1.2) 33.0 (0.8) 
6 weeks 35.1 (1.2) 33.0 (0.8) 
Changes (6 weeks 0.24 (0.6) 0.07 (0.3) 
-baseline) 
WC (cm)t Baseline 109.8 (1.0) 104.4 (1.0) 
6 weeks 110.1 (1.0) 101.2(l. 0) 
Changes (6 weeks 0.09 (0.9) -3.1 (1.1)* 
-baseline) 
Systolic BP Baseline 127 (1.8) 129.9 (2.2) (mmHg) 
6 weeks 127 (1.9) 128.4 (2.1) 
Changes (6 weeks 0.4 (0.5) -1.5 (1.4) 
-baseline) 
Diastolic BP Baseline 81.4(l. 9) 84.7 (1.2) (mmHg) 
6 weeks 81.6 (1.2) 83.4(1.2) 
Changes (6 weeks 0.2 (0.4) -1.1 (0.8) 
-baseline) 
energy- p Pairwise 
restricted LGI (ANOVA) testing 
88.3 (4.1) 
85.9 (3.9) 
-2.4 (0.4)** 
34.4 (1.3) 
33.5 (1.2) 
-0.9 (0.6)** 
110.2 (1.0) 
103.6 (1.0) 
-6.8 (6.5)** 
131.1 (2.7) 
123 (2.3) 
-7.5 (1.1)*** 
82.3 (1.3) 
80.7(1.1) 
-1.6 (0.6)* 
0.001 b, c 
<0.0005 b, c 
0.001 b 
<0.0005 b, c 
0.117 NS 
tValues are geometric means (SEM). 
*Represent within group difference of p<0.05, **p <0.005, and ***p<0.0005. 
a: significant changes between control and LGI. b: significant changes between control and energy-restricted LGI 
group. c: significant changes between LGI and energy-restricted LGI group 
NS, not significant 
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Figure 4.3 Weight changes during the trial. A: changes from baseline with different 
diet, p<0.0005. B: absolute weight loss in the LGI plus weight loss diet group. Each 
bar represent an individual participant. ***significantly different from baseline, 
p<0.0005. a: changes from baseline significantly different from the control and LGI 
group. 
WC at baseline was not different between the groups. The Average WC (cm) for the 
whole study participants at baseline was 108.9±13.1 (SD) which placed participants in a 
high risk category according to NCEP ATP-III criteria. At week 6 there was a significant 
reduction in WC in both intervention groups. Participants in the LGI diet group 
decreased their WC by 3% (p=0.01), whereas participants in the energy-restricted LGI 
group had a 6% reduction from baseline (p<0.0005) with no changes in the control group 
(p=0.926). The energy-restricted LGI group showed a decrease in their WC relative to 
the control (Figure 4.4, p=0.001). Changes in the WC for the participants in the 
intervention groups was associated with changes in the GI of the diet (r=0.404, p=0.004). 
4.8.4. Composition of the diet 
Dietary information was obtained from all participants by 24-hour recall before the trial 
(habitual diet) and then on the 1st, 7th, and on day 15 during the run-in period. The 
recalls were also collected three times within the intervention period; in week 2,4, and 6. 
An average of the three days for each phase of the study was taken for analysis. It should 
be clarified here that the habitual dietary intakes were included in the figures only for 
comparisons with the run-in diet in order to show that the latter was representative of the 
habitual intake and not confounded by mis-reporting as a result of inclusion in a trial. 
There were no changes in the habitual diet relative to the run-in diet. Changes between 
diets were subsequently assessed using only the difference between the run-in and the 
intervention diets. 
4.8.4.1. Energy content of the diet 
The overall average habitual energy intakes (kcal/d-KJ/d) for participants was 
2430.7±70.6-10209±296.5 (mean±SEM). There was no differences in energy intake 
between groups or between males and females. Over the dietary intervention period, 
mean energy intake was reduced within all dietary groups (2%, 1%, and 19% for the 
control, LGI and energy-restricted LGI groups respectively), but with a significant 
reduction only in the energy-restricted LGI diet group when compared to the control and 
the LGI diet group (p<0.0005; Figure 4.5). 
I12 
A decrease of 3500 kcal/week (14700KJ/week) can be estimated to achieve a weight loss 
of approximately 0.5 kg/week. Therefore a 3290 kcal (13818 KJ) decrease (470`7) of 
calories in the energy-restricted LGI diet group was estimated to achieve a weight loss of 
0.47 kg/week. In the present study, subjects in the energy-restricted group had a mean 
weight loss of 2.4 kg (SD-I. 4) over a6 week period. This is equivalent to a weight loss 
of 0.4 kg/week. 
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Figure 4.4. Changes in A: BMI (kg/m2) and B: WC (cm) between groups over 6 weeks. 
*significantly different from baseline, p<0.05 and **p<0.005. Different letters indicate 
that changes from baseline on the different diets differed significantly, p<0.005. 
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4.8.4.2 Macronutrient composition of the diet 
Macronutrient intakes of participants in the three groups are shown in Table 4.4. At 
baseline, there was no significant difference in the total energy intake or the percentage 
energy from CHO, protein, T. Fat, S. fat, MUFA or PUFA between the groups. The 
energy-restricted LGI group decreased their intake of CHO significantly (p=0.004) 
relative to the control but not the LGI group. Total fat intakes also decreased 
significantly for the energy-restricted LGI diet group compared to both the control and 
the LGI diet group. Therefore the decrease in total energy intake in the energy-restricted 
LGI group was brought about by a decrease in both the CHO and the total fat of the diet 
but with no changes in the overall contribution of these macronutrient to the total 
energy/day (Figure 4.6 and 4.7). Consumption of dietary fibre was not different between 
groups at baseline. The mean intakes of fibre for the whole sample was 24.0g±5.6 (SD) 
at baseline. This did not change for any of the groups over the intervention period (Table 
4.4). 
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Control LGI Energy-restricted LGI 
Figure 4.5. Changes in total energy (kcal/d) between groups over 6 weeks. 
***significantly different from baseline, p<0.0005. a: changes from baseline significantly 
different than control and LGI group, p<0.0005. 
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4.8.4.3. GI and GL of the diet 
The average GI of the habitual diet for the whole sample was 73%±6.8 (SD). There was 
no significant difference in the mean dietary GI between groups at baseline. After six 
weeks, both the LGI and the energy-restricted LGI group decreased their dietary GI 
significantly compared to the control group (p<0.0005) with no statistical differences 
between these two groups. The percentage reduction in the GI of the LGI diet group was 
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12.5% (1.5), while the percentage reduction in the GI of the diet of the energy-restricted 
LGI group was 10% (1.5). The average GI intakes of participants is presented in Table 
4.4, whilst changes between baseline and the end of the study are shown in Figure 4.8 
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Figure 4.8. Changes in A: GI and B: GL of the diet. **significantly different from 
baseline, p<0.005, ***p<0.0005. Different letters indicates that changes from 
baseline on different diets differed significantly, P<0.0005. 
Baseline GL for the participants in the three groups was similar (Table 4.4). Over the 
intervention period, the energy-restricted LGI group decreased their GL significantly 
compared with the control (p<0.0005), and the LGI diet group (p<0.005). Changes in the 
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GL were positively associated with changes in total carbohydrate intakes (r=0.412. 
p=0.003), but not changes in the GI of the diet (r=0.233, p=0.103). 
Participants' knowledge within the intervention groups improved significantly over time 
(p<0.05) as measured by the correct number of responses in the GI knowledge 
questionnaire with no significant difference between the two intervention groups 
(p=0.487). Changes in the GI of the diet were not associated with improvement in GI 
knowledge (r=-0.08, p=0.647). 
4.8.5. Changes in glycaemic control 
4.8.5.1. Changes in fasting glucose 
Plasma glucose was not normally distributed even after log transformation. Therefore 
data was analyzed using Kruskal-Wallis test. Analysis revealed no significant change in 
glucose concentrations between the groups (p=0.366; Figure 4.9. ), despite the observation 
that plasma glucose concentrations were lower by 10% in the LGI group compared to 3% 
in both the control and the energy-restricted LGI groups. 
4.8.5.2. Changes in fructosamine concentrations 
Baseline concentrations for fructosamine were higher in the LGI group compared with 
the control and the energy-restricted LGI groups (p<0.008). ANOVA for the differences 
in the concentration of fructosamine within each group was used to compare between 
groups and a comparison within each group was made to study the changes using a paired 
sample t-test. Analyses revealed that there was no significant change in the concentration 
of plasma fructosamine in the control group but a significant decrease in both the LGI 
(p<0.005) and the energy-restricted LGI groups over time (p<0.0005). Comparison 
between the groups showed that the LGI group had a significantly lower fructosamine 
concentration relative to the control (p=0.011) but not the energy-restricted LGI group 
(p=0.752). There was also a tendency for plasma fructosamine to decrease in the energy- 
restricted LGI group compared with the control group (p=0.055). These results are 
shown in Table 4.5 and the changes within each group are presented graphically (Figure 
4.9). 
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4.8.5.3. Changes in insulin concentrations and HOMA-IR 
At baseline, there was no statistical difference between the three groups. There was a 
23% reduction in plasma insulin in the LGI diet group (p=0.005) and a 13% reduction in 
the energy-restricted LGI group (p=0.036) but no change in fasting concentrations in the 
control group (p=0.652). After 6 weeks, there was no statistical difference in plasma 
insulin between the intervention groups (Table 4.5) but the difference between the control 
and LGI group was of borderline significance (p=0.066). 
Baseline HOMA-IR between groups was significantly different for the three groups 
(p=0.029). A between group comparisons of the changes in HOMA-IR in each group 
indicated no significant difference between groups (Table 4.5). There was also no 
association between changes in HOMA and weight loss (r=-0.163, p=0.259). 
A HOMA-IR index of >2 was taken to indicate IR (Balkau et al., 1999). A chi-squared 
test of independence (Table 4.6) indicated that there was no significant changes in the 
number of participants with insulin resistance in the control group (p=1.00), LGI group 
(p=0.149), or the energy-restricted LGI group (p=0.70), although decreases in the number 
of participants with HOMA-IR were seen in the latter two intervention groups. 
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Table 4.6. Chi square test of independence for HOMA-IR. 
Group HOMA-IR>2 
n% 
HOMA-IR<2 
n% 
Control (n=16) Baseline 9 56.3 7 43.7 
6 weeks 9 56.3 7 43.7 
LGI (n=16) Baseline 9 56.3 7 43.7 
6 weeks 4 25 12 75 
Energy-restricted LGI Baseline 8 44.4 10 55.6 
(n=18) 
6 weeks 6 33.4 12 66.6 
4.8.6. Changes in the features of an ALP 
4.8.6.1. Changes in plasma TAGs 
At baseline there was no significant difference in plasma TAG between the three groups. 
After 6 weeks of intervention there was a 12% increase in plasma TAG within the control 
group (p=0.037), whilst plasma TAG in the LGI and the energy-restricted LGI group 
decreased by 12% (p=0.006) and 16% respectively (p<0.0005). When the groups were 
compared, both the LGI and the energy-restricted LGI group showed decreased plasma 
TAG (p<0.0005) relative to the control. These results are shown in Figure 4.10 and 
Table 4.7. Changes in plasma TAG were associated with changes in WC (rr0.261, 
p=0.068). Other correlations are shown in Figure 4.11 
4.8.6.2. Changes in T. Cholesterol and LDL-C 
At baseline, participants in each group were similar in terms of their T. Cholesterol and 
LDL-C concentrations. Over time, there were no significant changes in the concentration 
of T. Cholesterol within or between groups, but there was a reduction in plasma LDL-C 
concentration in all three groups (p=0.001). Decreases of 5%, 9%, and 10% were 
observed for the control, LGI, and the energy-restricted LGI groups respectively. 
However, the percentage reduction was significant for both the LGI (p=0.006) and the 
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energy-restricted LGI group (p=0.003) when compared with the control group with no 
significant difference between the two intervention groups. The ratio of LDL: HDL after 
6 weeks dietary intervention was also lower than at baseline (p<0.0005). 
4.8.6.3 Changes in HDL-C 
The three groups had similar concentrations of plasma HDL-C at baseline. After 6 
weeks, the concentration of HDL-C increased significantly from baseline in the LGI diet 
group (p<0.001) and the energy-restricted LGI group (p<0.005). ANOVA indicated a 
significant difference between groups in HDL-C concentration (p<0.0005). Post-hoc 
analyses indicated that there was a significant increase in HDL-C concentrations in the 
LGI and the energy-restricted LGI diet groups relative to the control group (p=0.006 and 
p=0.003 respectively), but no significant difference between the two intervention groups 
(Table 4.7 and Figure 4.10). 
4.8.6.4. Changes in plasma LDL and HDL subclasses 
The majority (92%) of the participants expressed a predominance of sdLDL 
('%AUCB>50%; LDL subclass pattern B). Of the remaining participants, 4% had a 
predominance of larger, buoyant LDL (Pattern A; sdLDL<40, a predominance of LDL- 
11) and 4% were of an intermediate pattern I (Pattern I; 50>sdLDL>40). By the end of 
the intervention period, one participant had switched from pattern B to pattern I. The 
proportion of sdLDL was significantly associated with plasma TAG at the beginning 
(r=0.35, P=0.013) and the end of the trial (r=0.34, p=0.018) in the control, LGI, and LGI 
plus energy restricted diet groups. Pattern B subjects had a mean plasma TAG and HDL- 
C concentration of 2.1±0.9 (SD) and 0.83±0.2 respectively at the beginning of the trial 
and 1.9±0.9 (SD) 0.92±0.2 respectively at the end of the trial. Participants with pattern A 
had a TAG and HDL-C concentration of 1.5±0.4 and 1.02±0.2 at the beginning of the 
trial and 1.4±0.2 and 1.0±0.2 respectively after 6 weeks intervention. 
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The percentage of the larger HDL2 subclass increased significantly in the t« o 
intervention groups after 6 weeks of intervention compared to the control (p=0.047 and 
p=0.013 for the LGI and the energy-restricted LGI diet group respectively) with no 
significant differences between the two intervention groups. An example of the increase 
in HDL2 subclass in one subject as shown by a computer generated densitometric scan is 
presented in Figure 4.14. Mean values for the LDL peak density, %AUCB and % HDL, 
are shown in Table 4.8, whilst changes in these values across time are presented 
graphically in Figure 4.12. A strong association was observed between weight loss and 
the change in the %AUCB (r----51, p=0.032) in the energy-restricted LGI diet group. 
Changes in sdLDL were also associated with changes in the WC (rr0.387, p=0.006). 
At baseline apo B and apo A-I were not significantly different between groups. Plasma 
apoproteins did not change significantly either within or between the dietary intervention 
groups after 6 weeks. HDL-C and apo A-I were shown to be positively related 
(p<0.0005) at baseline (r=0.64) and at 6 weeks (r=0.67). 
4.8.7. Changes in NEFA 
There was no significant difference in the concentration of plasma NEFA between groups 
at baseline. After 6 weeks intervention, there were a significant changes in plasma NEFA 
in all groups; NEFA concentrations fell in both the LGI (p=0.033) and the energy- 
restricted LGI group (p<0.0005) but there was a significant increase in the control group 
(p=0.023). Both the LGI and the energy-restricted LGI diet groups had decreased NEFA 
concentrations significantly relative to the control group. 
4.8.8. Changes in subjective appetite rating 
VAS data were collected in 33 participants; 11 in the control group, 10 in the LGI diet 
group, and 12 in the energy-restricted LGI diet group. At baseline there was no 
significant difference between groups in scores for hunger (p=0.161), desire to eat 
(p=0.288), fullness (p=0.223), or prospective food consumption (p=0.119). A 2-way 
ANOVA for the scores after 6 weeks indicated a significant effect of time (p<0.0005). 
and a significant interaction between time and treatment (p=0.006, p=0.019. p=0.065, 
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p=0.018 for the hunger, desire to eat, fullness, and prospective consumption scores 
respectively), with no difference between groups. These results are shown in Figure 
4.15. 
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Figure 4.12 Changes in A: % HDL2 and B: sdLDL. Values are means±SEM. 
*Significantly different from baseline, p<0.05, **p<0.005, ***p<0.0005. Different 
letters indicate changes from baseline on the different diets. p<0.05. 
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Figure 4.13 Changes in sdLDL (%AUCB) in one participant A: before and B: after 6 
weeks of dietary intervention with LGI diet (a reduction from 29.6% to 21.8%). 
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Figure 4.14 Changes in %HDL2 in one participant A: before and B: after 6 weeks of 
dietary intervention with LGI diet (an increase from 28.2% to 36.9%). 
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4.9. Discussion 
The present study was undertaken to investigate the effect of a LGI diet on CVD risk in a 
sample of overweight/obese T2 DM patients in Kuwait, with special attention given to 
outcomes related to ALP. A secondary objective was to investigate the efficacy of a LGI 
diet compared to a LGI, energy-restricted, weight-losing diet in improving diabetic 
dyslipidaemia known as an ALP in overweight/obese T2 DM patients in Kuwait. Due to 
time constraints and recruitment problems, the investigator was unable to conduct the 
third part of the study (the follow-up phase). 
4.9.1. Dietary intakes and GI 
The GI of the diet was calculated as a mean of three GI values obtained from 24-hour 
recalls collected in each phase of the study. The calculation of GI from food records by 
others (Wolever et al., 1994) has resulted in normally distributed values, and thus was 
considered to be appropriate for parametric statistical analyses. Estimation of the GI/GL 
from 24-hour dietary recalls was also possible and has been used previously to assess the 
association between these dietary parameters and body weight and outcomes from 
chronic diseases (Olendzki et al., 2006). The average GI of the three groups at baseline 
was 73%; this corresponds to a GI that has been previously reported for a diabetic 
population (Wolever et al., 1994b). The average GI of the diet of T2 DM patients in 
Kuwait was successfully reduced from 73% at baseline to 61% in 6 weeks; a reduction of 
12 units. A similar reduction was reported by others in diabetics and in patients with 
CHD (Brand et al., 1991; Collier et al., 1988; Frost et al., 2004; Tsihlias et al., 2000; 
Frost et al., 1994). On average, studies reported a GI reduction of 16 units (Brand-Miller 
et al., 2003a). Overall, a reduction of 12-14 units (Brand-Miller et al., 2003a; Collier et 
al., 1988; Fontvieille et al., 1992) has been associated with improved glucose control, 
serum cholesterol, and TAG concentrations in diabetics. In the present study no 
significant differences in the changes in GI was observed between the LGI group (12±1.5 
units reduction) and the energy-restricted LGI diet group (10±1.7 units reduction). 
Both the International Tables of GI (Foster-Powell et aL, 2002) and the results of the GI 
testing of commonly consumed breads and rice in Kuwait (Chapter 3) were used as tools 
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to construct the LGI diet. The main approach used to lower the GI of the diet for the mo 
intervention groups was the substitution of LGI foods for those with a high GI content. 
In order to decrease the potential effects of the variations in dietary fibre, dietary GI was 
changed mainly through altering the physical structure of the starchy foods (whole vs. 
ground beans or seeds), bread types, and substituting pasta for rice and potatoes in the 
intervention groups. Both intervention diets were constucted in accordance with the 
dietary recommendations for patients with diabetes (Franz et at., 2004). The dietary 
manipulation was carried out in a free living situation where participants had free access 
to food with no supply of specific LGI foods. Therefore the results should be more 
reflective of outcomes from a clinical setting rather than a metabolic ward. The finding 
that the GI of the diet was significantly decreased in the two intervention groups, 
suggests both palatability of the diet and applicability of the GI concept to the dietary 
management of T2 DM in Kuwait. 
Patient's GI knowledge of foods improved significantly over time in both intervention 
groups. This was measured through the GI questionnaire which was also used as an 
educational tool where any deviation from the correct responses was used to reinforce the 
nutritional message. Interestingly, changes in GI knowledge were not related to changes 
in the GI of the diet. This suggests that dietary programs for T2 DM patients in Kuwait 
should also aim at behavioural changes and not only be directed towards improving 
dietary knowledge. 
In comparison to the ADA recommendations for people with diabetes (Franz et al., 
2004), participants in the current study had a baseline percentages of energy from protein 
(16%), CHO (51 %), and T. Fat (3 3%) that were comparable with these recommendations. 
The percentages of S. Fat, PUFA, and MUFA, as a percentage of total energy, were also 
in-line with the recommendations of the ADA (10%, 6%, and 10% respectively) and did 
not change significantly over the intervention period. These intakes were also close to 
those reported in other countries including 9960 diabetics in the US (Banini et al., 2003). 
132 diabetics in the UK (Eeley et al., 1996), 164 diabetics in Australia (Barclay et al.. 
2006) and 342 diabetics in Canada (Wolever et al., 1994b). The consumption of CHO 
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and total fat (g) in the energy-restricted LGI diet decreased significantly compared with 
the control and the LGI diet groups, whilst the overall percentage contribution of these 
macronutrients to total energy remained constant. 
4.9.2. Changes in blood pressure and anthropometry 
The reduction in systolic blood pressure that accompanied a reduction in the GI in the 
current study is of great importance since the UKPDS recognize hypertension (and 
hyperglycaemia) as an independent and additive risk factor for diabetic complications 
(Stratton et al., 2006). This reduction was achieved only in the energy-restricted LGI diet 
group compared with the control and the LGI diet group. Changes in the systolic, but not 
diastolic, blood pressure were significantly related to weight loss (r=0.766, p<0.0005). 
Blood pressure control and lower blood pressures in hypertensive T2 DM patients has 
been recommended by the ADA (American Diabetes Association, 2004a) as an important 
strategy to prevent the progression of CVD morbidity and mortality. 
The intention was to keep the weight of the individuals in the control and the LGI diet 
groups constant during the 6 weeks study, while decreasing the weight of those in the 
energy-restricted LGI diet group. This was achieved in the study through a reduction in 
the total amount of energy/day in the energy-restricted LGI group while maintaining the 
GI of the diet similar to people in the LGI diet group. Participants in the energy- 
restricted LGI group lost a significant amount of weight compared with the control 
(p=0.001) and the LGI diet group (p=0.017). Mean weight loss for this group was 
2.4±1.6 kg (SD). However, this finding should not be overemphasized as the average 
weight loss in this group was only 3% and mainly achieved by four participants. Studies, 
in T2 DM patients, have reported metabolic improvement in glycaemic control, insulin 
sensitivity and CVD risk factors with a modest weight reduction of 5-10% (Blackburn, 
1995; Ditschuneit et al., 2002; Wing et al., 1987a). In contrast, a minimum weight loss 
of 10%, from baseline body weight, was needed to demonstrate significant improvements 
in the risk profile (Bosello et al., 1997). Wing and colleagues (1987a) reported that a 
weight loss of less than 5% in diabetics was not associated with any significant changes 
in the risk profile. The level of weight loss achieved in the current study through energy 
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restriction was similar to that which has been shown to accompany the consumption of 
LGI foods in energy balance studies (Livesey, 2007). The amount of weight loss in this 
study therefore makes it possible to analyse the effects of LGI separately from the 
potentially confounding effect of weight loss, mediated through increased satiety 
(Dumesnil et al., 2001). In the energy-restricted group, no association between weight 
loss and changes in dietary GI was found. Instead, changes in the BMI were strongly 
associated with changes in total energy intakes (Kcal/d; r=0.987, p<0.0005). This 
finding, in addition to the observation that participants in the LGI diet group did not lose 
weight, suggests that weight loss in this study was produced by decreased energy 
intake/day and was not related to decreased appetite as a result of the consumption of the 
LGI diet. This finding was consistent with other studies that have tested dietary GI with 
respect to weight changes and reported negative outcomes (Kabir et al., 2002; Sloth et 
al., 2004). It should be emphasised that the changes in some scores of the VAS 
questionnaire were initially due to difference in the scores for the groups at the start of 
the study. Therefore it seems that the LGI diet in the current study did not produce 
significant changes in the hunger or satiety among groups who consumed the LGI diet. 
A significant reduction in WC was observed within both the LGI and the energy- 
restricted LGI diet groups. The reduction of WC within the LGI diet group is of 
particular interest. The importance of this arises from the finding that the decrease in WC 
within this group was achieved without energy restriction or weight loss. This is 
certainly of relevance since weight loss in obese individuals represents a serious 
challenge, especially in T2 DM as a result of their poor dietary compliance (Wing et al., 
1987b). This is also important as a reduction in central abdominal fat has been shown to 
be related to a less atherogenic lipid profile (Markovic et al., 1998; Sharp et al., 2003). 
Changes in WC in the current study were associated with changes in the GI of the diet 
(r=0.404, p=0.004). It seems, therefore, that the LGI diet in the current study, whilst not 
affecting weight loss, had the potential to decrease abdominal fat not through regulation 
of appetite but rather through other mechanisms that might involve the lowering of 
hyperinsulinaemia (Dumesnil et al., 2001). Increased abdominal fat tissue is often 
associated with increased lipolysis and elevated plasma concentrations of NEFA which 
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elevates hepatic TAG synthesis as a result of increased substrate availability (Frayn. 
2001). Thus, the decreased WC in the LGI diet group is consistent with the lowering of 
circulating NEFA concentrations. In light of this finding, the conclusion drawn by the 
European Group for the Study of Insulin Resistance that WC and BMI are equally strong 
indicators of the risk of insulin resistance is important. In addition McLaughlin et al. 
(2004) found that insulin resistance might exist in a significant proportion of the normal 
weight population. This highlights the importance of the LGI approach in decreasing 
markers of insulin resistance, not only in obese people, but also in centrally obese insulin 
resistance individuals. 
4.9.3. Effects of GI on glycaernia and insnlinaernia 
When obese T2 DM patients consumed a LGI meal, the overall glycaemic response was 
40% lower and the peak glucose concentration was 25% lower in the LGI meal group 
compared to an isoenergetic high GI meal (Cohen et al., 1990). Additionally, studies 
have also suggested that a high concentrations of fasting plasma glucose may be reduced 
by decreased dietary GI (Heilbronn et al., 2002). The increased risk of CVD with the 
habitual consumption of high GI meals is believed to be partly related to hyperglycaemia 
induced oxidative stress (Ludwig, 2002). Although participants in the current study had a 
high concentration of fasting glucose at baseline (9.7 mmol/l ± 3.7 SD), no changes were 
observed in these concentrations on the intervention diets. However, the lack of 
significance, whilst not expected, was in agreement with many previous studies (Brand et 
al., 1991; Collier et al., 1988; Jenkins et al., 1985; Jenkins et al., 1987; Wolever et al., 
1992). A meta-analysis of eleven studies by Brand-Miller (1994), eight of them in 
diabetics, reported an average reduction of only 5% in mean plasma glucose 
concentrations after a LGI diet. For the most part, the reduction was associated with 
weight loss (Wolever et al., 1992). In contrast, weight loss, in the present study, did not 
affect glucose concentrations in the energy-restricted LGI group, as changes in these 
values did not show any relationship with changes in weight, possibly because of the low 
amount of weight lost. 
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Glycaemic control, as measured by fructosamine concentrations, improved significantly 
within both intervention groups but only significantly in the LGI group when compared 
with the control group (p=0.011). Measurement of fructosamine concentrations are 
favoured as a short term marker in studies that last for 6 weeks as the effect is reported to 
change maximally in 4-6 weeks (Jones et al., 1983). There is compelling evidence that 
postprandial glycaemia is an important risk factor that needs to be controlled in both type 
I (Diabetes Prevention Program Research Group, 2002) and T2 DM patients (UKPDS, 
1998). Studies are conclusive on the effect of a LGI diet on glycaemic control in T2 DM 
patients. In a recent meta-analyses by Opperman et al. (2004), seven randomized control 
trials that measured fructosamine concentrations were included. Mean fructosamine 
concentrations were reduced significantly on a LGI diet compared with high GI diets (- 
0.1 mmol/l, p=0.05) over a period of 4.6 (SD 3) weeks. Previous to this , another meta- 
analysis, of 10 studies that investigated the effect of LGI diet on glycaemic control in T2 
DM patients (Brand-Miller et al., 2003a), showed that over a4 week period, mean 
fructosamine concentrations were 0.2 mmol/l lower than baseline (range 0.04-0.35). 
Improvement in glycaemic control with the consumption of LGI diets has been achieved 
even in a very short term study that lasted for only two weeks (Jenkins et al., 1988a). 
Indeed, the longer the consumption of a LGI diet, the larger the decreases in fructosamine 
concentrations (Brand-Miller et al., 2003a). These studies, with others that were not 
included in the meta-analyses mentioned above (Salmeron et al., 1997a; Salmeron et al., 
1997b), all reported an improvement in glycaemic control with a LGI diet. Even when 
the improvement in glycaemic control was not significant, such as in the study of 
Heilbronn et al. (2002), HbA 1c was reduced by -2.8%; two-fold more in subjects 
consuming a LGI energy-restricted diet when compared to subjects consuming a high GI, 
energy restricted-diet. A LGI diet may improve glycaemic control by lowering early 
postprandial hyperglycaemia and decreasing the risk of postabsorptive hypoglycaemia 
(Ludwig, 2002). Only a few studies have reported negative results with the use of LGI 
diets in diabetics (Cohen et al., 1990; Tsihlias et al., 2000; Luscombe et al., 1999). most 
probably because the GI was not reduced sufficiently, or due to the small sample size. 
Therefore the use of LGI in the dietary management of T2 DM in Kuwait would seem to 
be advantageous. 
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It is important to note that even when fasting glucose concentrations were unchanged in 
the LGI group, a fall in the concentration of fructosamine, as an index of overall 
glycaemic control, was apparent in this group (p<0.0005). This suggests that changes in 
the fructosamine are not necessarily due to a decreased glucose response postprandially 
(Jenkins et al., 1988a). In addition, diet may influence protein glycation by other 
mechanisms such as the rate of protein turnover or antioxidant status (Davie et al., 1992). 
However, the uncoupling between the concentrations of fructosamine and fasting 
glucoses with the use of LGI has been previously reported (Wolever et al., 1992; 
Fontvieille et al., 1992; Wolever & Mehling, 2003; Jenkins et al., 1987). The selection 
of participants in the present study was not based on well controlled diabetes, as 
participants were recruited mostly from the out-patient clinic in the Amiri hospital where 
most of the patients are referred from primary clinics as a result of poor diabetic control. 
Therefore it could be argued that changes in the glycaemic control due to dietary 
modifications are not referred to those associated with less well controlled diabetes. 
However, studies on diabetic subjects with obesity, high fasting plasma glucose, and 
dyslipidaemia showed similar and sometimes more favourable outcomes (Fontvieille et 
al., 1992; Dumesnil et al., 2001). 
All participants in the current study had elevated fasting insulin concentrations at baseline 
(129.6±16.9 pmol/l (SEM)). When tested individually, there was a significant reduction 
in these concentrations both within the LGI diet group (p=0.005) and the energy- 
restricted LGI diet group (p=0.036). The percentage reduction in the insulin 
concentration observed in the LGI diet group was almost double the reduction of the 
concentration in the energy-restricted LGI group (23% vs. 13% reduction). However, 
whilst this did not reach significance, and the changes in the former group was of 
borderline statistical significance when compared to the control group (p=0.066). an 
association between the GI of the diet and insulin concentrations is well documented; 
decreased hyperinsulinaemia and increased insulin sensitivity is often associated with a 
LGI diet (Rizkalla et al., 2004; Miller, 1994; Jarvi et al., 1999; Liese et al., 2005; Frost et 
al., 1998). On the other hand, a high GI diet may stimulate more insulin secretion than a 
LGI diet because of the relative postprandial hyperglycaemia and increased incretin 
139 
levels (Ludwig, 2002), such as glucose-mediated insulinotropic polypeptide (GIP). 
Although weight-reducing diets have a powerful insulin sensitizing effect (Wing et al., 
1987a; Wing et al., 1994), in the present study this was not different from the LGI or the 
control group, as weight loss, whilst statistically significant, was not clinically significant 
(Blackburn, 1995; Ditschuneit et al., 2002; Wing et al., 1987a). Moreover, the lack of 
significant insulin reduction in the energy-restricted group might be due to the reduced 
intake of carbohydrate during energy restriction which could potentially reduce the 
insulin sensitizing ability of the LGI diet (Heilbronn et al., 2002). Wing and co-workers 
(1994) noted that the amount of energy restriction and weight loss has independent 
effects on glycaemic control and insulin sensitivity in T2 DM patients. Insulin resistance 
in the current study was defined by HOMA-IR >2 (Balkau et al., 1999). 31% of the 
insulin resistant subjects in the LGI diet group in the present study became more insulin 
sensitive as compared to 11% in the energy-restricted LGI group with the number of 
participants with insulin resistance in the control group remaining constant (56%). These 
findings suggest that the number of individuals with insulin resistance was decreasing in 
the intervention groups but the study was probably underpowered for this measure. 
4.9.4. Effects of GI on an ALP 
4.9.4.1. Effect on plasma TAGs 
One of the main findings of the current study was the favourable effects produced on 
plasma TAG in overweight/obese T2 DM patients by using a dietary approach that placed 
emphasis on the use of LGI foods. This finding extends data from previous short term 
studies that showed a beneficial reduction of TAG concentrations with the use of LGI 
diets in subjects with elevated baseline plasma TAG and/or T2 DM (Dumesnil et al., 
2001; Fontvieille et al., 1992; Frost et al., 1994; Jenkins et al., 1985; Wolever et al., 
1992; Jenkins et al., 1987). Reductions in plasma TAG have reached 20% in one study 
(Wolever et al., 1992) compared to a control diet and 35% (from 2.0 to 1.3 mmol/l) in 
only 6 days in T2 DM patients in another study (Dumesnil et al., 2001). Studies have 
clearly shown that elevated plasma TAG is an independent risk factor for CVD (Austin et 
al., 1998). Nonetheless, some studies have shown negative outcomes with respect to 
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TAG concentrations (Sloth et al., 2004; Kabir et al., 2002; Frost et al.. 2004; Jimenez- 
Cruz et al., 2003). 
A meta-analysis of over 70 studies concluded that reduction of a kilogram in body weight 
is associated with a 0.015 mmol/l decrease in plasma TAG (Dattilo & Kris-Etherton. 
1992). Although there was a 16% fall in TAG concentrations in the energy-restricted 
LGI group compared to a 12% reduction in the LGI diet, the difference did not reach 
statistical significance and there was no additive effect of weight loss on TAG 
concentrations. This finding might suggest that the amount of weight loss achieved by 
participants in this study was not enough to substancially affect TAG concentrations. As 
mentioned previously, the study was designed to decrease the weight of subjects in the 
energy-restricted LGI group by 5-10%. However, this was not achieved successfully and 
only a 3% reduction was obtained. This is further supported by a lack of association 
between weight loss and changes in TAG concentrations in the energy-restricted group 
(p=0.78). 
Changes in TAG concentrations were associated with changes in the GI of the diet 
(r-0.35, p=0.01.5). One of the possible explanations for a LGI-induced lowering of 
plasma TAG is through a decreased production of VLDL by the liver as a result of 
increased insulin sensitivity, limiting the availability of NEFA for VLDL production 
(Martins & Redgrave, 2004). It is also possible that an increase in insulin sensitivity that 
is associated with LGI diet could increases the rate of clearance of TAG concentrations 
through stimulation of LPL. There is evidence for a decrease in the rate of TAG 
clearance as a result of decreased LPL activity in T2 DM patients (De Man et al., 1996). 
Decreased TAG clearance is also known to have a detrimental effect on LDL 
heterogeneity (Griffin & Fielding, 2001). Moreover, the LGI diet is expected to contain 
larger amount of resistant starch. Resistant starch is fermented by the colonic microflora 
producing short chain fatty acids which have been shown to exert metabolic effects on 
lipids through the reduction of VLDL production (Marcil et al., 2002). It appears that 
central adiposity is more relevant, within the context of GI, than body weight in inducing 
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favourable changes in plasma TAG as indicated by the trend in the relationship between 
changes in TAG concentrations and changes in WC (rr0.261, p=0.068). 
Despite the fact that the participants in the control group received no intervention, an 
unexpected increase in plasma TAG was observed within this group. This finding was 
surprising given that the lipid profiles for these participants were stable as compared with 
the previous lipid profile (6 months). However, individual biological variation in plasma 
TAG concentrations has been previously reported and may explain this result (Nazir et 
al., 1999). This finding emphasises the importance of a RCT design that is able to 
accommodate such changes. It is consistent with the rapid progression of macrovascular 
complications within this population in Kuwait, suggesting the relevance of this study to 
the Kuwaiti population in the context of diabetes risk management. In Kuwait, about 
75% of patients with T2 DM had either mixed hyperlipidaemia or predominant 
hypertriglyceridaemia (Akanji, 2002) a major CVD risk factor. Additionally, in 108 
Arabic diabetic patients, the only significant difference in lipid concentrations between 
diabetic patients with and without CAD was for plasma TAG (Daghash et al., 2007). In 
the present study, two participants in the control group had hyperchylomicronaemia 
manifested by the presence of visibly lipaemic plasma both in baseline and post trial 
samples. Most of these patients have an underlying lipid disorder, such as LPL 
deficiency, that is usually exacerbated by diabetes (Julien et al., 1997). The plasma TAG 
of these two subjects made a significant contribution to the overall change in the control 
group. 
4.9.4.2. Effect on T. Cholesterol and LDL-C 
There were no changes within or between diets with respect to plasma total cholesterol 
concentrations. This finding was not surprising given that some of the largest 
epidemiological studies to date, such as the Survey of British Adults (Frost et al., 1999) 
and the Zutphen Elderly Study (van Dam et al., 2000) failed to show any relationship 
between LGI diet and total plasma cholesterol. Even in a long term study of 6 months 
(Tsihlias et al., 2000) there was no effect of LGI breakfast cereal consumed by T2 DM 
patients on total plasma cholesterol compared to high GI cereal. Studies which have 
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reported a reduction in the concentration of T. Cholesterol in T2 DM patients with a LGI 
diet achieved a reduction of 19 GI units (Opperman et al., 2004). with a larger decreases 
in cholesterol being reported in patients with elevated baseline concentrations 
(T. Cholesterol>5.2 mmol/1). Others have shown a significant reduction in total 
cholesterol with an even greater reduction of 26 GI units (Fontvieille et al., 1992). 
Therefore, the lack of significance might be explained by the smaller reduction in GI 
achieved in the current study. Moreover, mean baseline cholesterol concentrations in 
participants were below the 5.2 mmol/l cut-off for high cholesterol concentration. It 
should also be remembered that total cholesterol concentration is now recognised to be 
only a weak predictor of CHD risk within populations (Fruchart & Packard, 1997). 
A pronounced reduction in LDL-C in subjects with T2 DM has been previously reported 
when the GI of an energy-restricted diet was reduced (Heilbronn et al., 2002). This study 
involved 45 male and female subjects who were followed over 12 weeks of energy 
restriction. A 13.2% reduction of LDL-C was found, with the LGI diet lowering LDL-C 
to a greater extent than the high GI diet (p = 0.02). In weight maintenance studies (Jarvi 
et al., 1999; Jenkins et al., 1985), LGI diets have been shown to reduce LDL-C compared 
to high GI diets in subjects with raised plasma TAG concentrations and in T2 DM 
patients with poor glycaemic control. 
The majority of participants (92%) in the current study had a predominance of sdLDL 
(pattern B) at baseline. After 6 weeks intervention, while only one participant switched 
from pattern B to 1, a significant reduction in the concentration of sdLDL, in the 
intervention groups compared to the control group (p=0.001) was evident with no 
difference between the intervention groups. A raised plasma TAG concentration is a 
critical determinant of LDL particle size (Griffin, 1997) therefore, a reduction in sdLDL 
can only be observed when TAG decreases concomitantly (Halle et al., 1999). Baseline 
plasma TAG concentrations were elevated; TAG>1.5 mmol/l. This concentration of 
TAG promotes the transfer of plasma TAG from TAG rich lipoproteins to LDL and HDL 
in exchange for cholesteryl esters leading to the formation of sdLDL (Griffin, 1997) and 
increased HDL clearance (Lamarche et al., 1999). A reduction in plasma TAG reduces 
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CVD risk by redistributing LDL toward larger, less dense, and thus less atherogenic LDL 
particles (Griffin, 1997). In the current study, no changes in the number of LDL 
particles, as indicated by plasma apo B, was found between or within diets. Previous 
studies have reported a reduction in apo B concentrations in response to LGI diets 
(Rizkalla et al., 2004; Jarvi et al., 1999). A predominance of sdLDL and raised LDL 
particle number (raised plasma apo B concentration) frequently co-exist in the 
dyslipidaemia found in T2 DM (Tan et al., 1995). In the present study, none of the study 
population presented with hyper-apo B (apo B>l. 3 g11) at the beginning or at the end of 
the intervention period. This was an unexpected finding since most of the subjects were 
pattern B with a predominance of sdLDL. However, this uncoupling between the 
quantity and quality of LDL particles was previously reported in free living groups with 
an ALP when TAG concentrations increased over 2.5 mmol/l (Griffin et al., 1999). This 
observation led the author to suggest that there might be a distinct mechanisms for the 
regulation of LDL particle number and the distribution of LDL particle size. It should, 
therefore, be emphasised that the effect of the diet on CHD risk in at least 16% of the 
study population be interpreted with caution as CVD risk may be overestimated in these 
individuals (Griffin et al., 1999). In the current study, despite the reduction in WC within 
the intervention groups, no changes were detected in the concentration of apoB in these 
groups. Apolipoprotein B was previously shown to be very sensitive to the accumulation 
of abdominal fat (Despres & Lamarche, 1993). This could be due to the fact that baseline 
apo B was not originally elevated and that a longer period of time was needed for these 
changes to take place. 
4.9.4.3. GI and the effect on HDL-C 
The plasma concentration of HDL-C is well known to be inversely associated with CHD 
in T2 DM (Leelawattana et al., 2003). A low plasma HDL-C concentration is associated 
with an increased rate of HDL clearance (Brinton et al., 1991), which in turn is increased 
when HDL is enriched in TAG (Lamarche et al., 1999). HDL-C is claimed to be a better 
discriminator of CHD than LDL-C and for every 0.026 mmol/1 increase in HDL-C. CHD 
is reduced by 3% (Castelli, 1988). In the current study, the mean HDL-C concentration 
increased significantly in both the LGI and the energy-restricted LGI groups compared to 
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the control group, with no difference between these two groups. This increase was 
consistent with results found in the 1987 survey of British adults (Frost et al., 1999) and 
the study of US adults (Ford & Liu, 2001). The latter study clearly showed a significant 
reduction of HDL-C of -0.06 mmol/l per 15 unit increase in GI, after adjusting for 
gender, BMI, smoking, alcohol intake and physical activity, after the consumption of 
high GI foods. In the former study, a 29% reduction in CHD morbidity in women and 
7% in men was associated with a difference between the lowest and highest quintiles of 
GI. An increase in HDL-C was expected in these studies because LGI foods are 
associated with decreased hepatic gluconeogenesis and a prolonged suppression of NEFA 
release for VLDL synthesis (Rizkalla et al., 2002). Studies that did not show an increase 
in the concentration of HDL-C compared to high GI diets (Heilbronn et al., 2002; Jarvi et 
al., 1999; Jenkins et al., 1988a) were usually of short duration (Opperman et al., 2004). 
More importantly, the proportion of HDL2 in the present study increased significantly in 
both of the intervention groups compared to the control group. This is important as 
studies indicated that any benefit underlying elevated HDL cholesterol concentrations 
could be mainly attributed to the HDL2 subfraction (Salonen et al., 1991). The increase 
in % HDL2 observed within the intervention groups compared to the control group with 
the consumption of LGI diet might be a consequence of decreased VLDL production and 
CETP-mediated exchange of lipid. It could also be attributed to enhanced HL activity in 
these individuals with LGI diet, as a result of insulin sensitivity (Martins & Redgrave, 
2004). While overweight/obese diabetic men and women showed changes in both HDL- 
C and HDL particle profile (%HDL2), there were no significant changes in plasma apo A- 
I in the intervention groups, despite associations between the HDL-C and apo A-I 
particles both at baseline and after intervention. With many key metabolic factors 
participating in the reverse cholesterol transport, it is difficult to conclude which 
mechanism is specifically involved with respect to apo A-I. Overall, the correlation 
between changes in TAG concentrations with changes in LDL size (r--0.280, p=0.049) 
and HDL size (trend in the correlation; r=-0.239, p=0.094) were consistent with the 
$ concept that lipoprotein changes are driven by changes in plasma TAG concentrations. 
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4.9.5. Implications of the findings for the Kuwaiti population 
One important outcome that might be of particular interest to the health professionals and 
nutrition care providers in Kuwait is that lowering the GI of the diet produced a 
favourable improvement in the diabetic risk profile that might be easier to implement in 
terms of compliance than dietary manipulations designed to cause weight loss. To the 
best of our knowledge this study was the first to involve any dietary manipulation in 
Kuwait both in terms of GI and/or energy restriction. A dietary factor is considered 
beneficial, only if the changes produced by such a diet do not adversely affect other risk 
factors. The fact that the LGI diet, in the present study, favourably altered many of the 
risk factors associated with the atherogenic profile of overweight/obese T2 DM patients, 
without adversely affecting other risk factors appears promising. The reduction of risk 
amongst participants with two dietary manipulation; LGI diet and LGI with energy 
restricted diet was equivalent for most of the risk parameters. Lowered systolic blood 
pressure, however was only significant in the energy-restricted diet group. Therefore, 
energy restricted diets should be considered for hypertensive T2 DM patients. It should 
be emphasised that many factors in the design of the study were successful. Among these 
factors was the maintenance of dietary fat and fibre consumption throughout the study 
thereby controlling some confounders that could affect the validity of the GI. In addition, 
measurements of sdLDL added strength to the study as this measure is considered to be 
one of the hallmarks of diabetic dyslipidaemia (Krauss, 1994). The monitoring and 
additional attention given to subjects who were clearly suffering from a lack of dietary 
advice and counselling, was shown to successfully increase compliance. The targeting of 
the nutritional messages should get further attention. Beside dietary modifications, 
nutritional plans should be directed toward behavioural changes as the improved GI 
knowledge in the current study did not reflect lower GI intake. The possibility that the 
LGI diet approach might not produce favourable changes in risk profile in non-obese 
individuals should be tested, as hypertriglyceraemic subjects are known to be more 
responsive to the type of diet. 
146 
4.10. Conclusions 
The present study showed that modest changes of dietary GI in overweight/obese T2 DM 
patients in Kuwait produced a favourable reduction in plasma TAG that was associated 
with other potentially beneficial changes in lipid and lipoprotein markers of an ALP such 
as increased HDL-C, and decreased LDL-C. The LGI diet was also associated with 
favourable changes in the composition of LDL and HDL particles. In addition, diabetic 
control was improved by lowering dietary GI. These changes in response to a LGI diet 
were of an equal magnitude to that achieved when weight reduction was less than 5% 
compared to baseline. In conclusion, these two dietary manipulations resulted in 
equivalent improvements in CVD risk profile in overweight /obese T2 DM patients. 
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CHAPTER 5 
The two intervention groups and the control group all had similar mean LDL peak 
densities, %AUCB, and HDL2 at baseline. There was no significant changes in the levels 
of LDL peak density in any of the intervention groups. However, sdLDL in both the LGI 
and the energy-restricted LGI group decreased significantly relative to the control group 
(p=0.005 and p=0.003 respectively). There was no significant difference between the 
intervention groups. These results are presented in Table 4.8 and Figure 4.12. An 
example of the decrease in sdLDL in one subject as shown by computer generated 
densitometric scan is presented in Figure 4.13. 
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Figure 4.11 Correlation between changes in A: sdLDL, B: %HDL2, C: NEFA and D: 
%G1 and changes in plasma TAG. The strength and direction of correlation is 
individually presented in the Figure as correlation coefficient (r). 
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Chapter 5 
A STUDY OF THE EFFECTS OF LOW CARBOHYDRATE ATKINS DIET, 
WITH AND WITHOUGHT MODERATE EXERCISE, ON THE EXPRESION OF 
AN ATHEROGENIC LIPOPROTEIN PHENOTYPE. 
5.1. Overview 
Obesity is a major modifiable risk factor for CVD. It increases the risk of developing 
conditions, such as T2 DM, dyslipidaemia and hypertension that, in turn, increase CVD 
risk (Abate, 2000). More importantly, evidence is accumulating that the distribution of 
fat in the body, and especially abdominal fat, is more highly associated with the risk of 
CVD (Diabetes Prevention Program Research Group, 2002). Although obesity itself 
does not form part of an ALP, visceral obesity has been linked with increased plasma 
TAG concentrations (Sharp et al., 2003) and a predominance of smaller, dense LDL 
particles (Blackburn et al., 2003), both of which are major components of an ALP. 
Therefore, since the accumulation of abdominal fat may underlie the development of an 
ALP, weight loss may be an important factor for the management of this high risk 
dyslipidaemia. Interest in low carbohydrate (LC) diets has grown, largely on the strength 
of evidence that they can effectively reduce weight (Stern et al., 2004; Seshadri et al., 
2004; Samaha et al., 2003; Foster et al., 2003). However, the role of LC diets in 
reversing the lipid and lipoprotein abnormalities associated with an ALP is not well 
understood, and is controversial, as these diets derive a large proportion of their energy 
from fat; a macronutrient with a potentially detrimental impact on CVD risk (Lovejoy et 
al., 1998). In addition, the combined effects of a LC diet with other lifestyle 
modifications, such as moderate exercise, is an area where evidence is lacking. 
Therefore, the present study aimed to investigate the effect of a LC diet on an ALP in 
overweight/obese individuals, and to examine how moderate exercise may influence any 
dietary effects. 
149 
5.2. Aims of the study 
The aims of this study were two-fold: 
1. To investigate the effect of a 6-month, ]ow-carbohydrate, Atkins diet on the 
expression of an ALP and fasting insulin concentrations, as markers of CVD risk 
in overweight/obese men. 
2. To compare the efficacy of a low-carbohydrate Atkins diet, with and without the 
inclusion of moderate exercise, on the expression of an ALP, to establish the 
most effective approach for reducing CVD risk in overweight/obese men. 
5.3. Study hypotheses 
1. A low carbohydrate diet will produce significant improvements in fasting insulin 
and the expression of an ALP in overweight/obese men. 
2. A low carbohydrate diet combined with exercise will further enhance 
improvements in fasting insulin and the expression of an ALP in 
overweight/obese men as compared to low carbohydrate diet alone. 
5.4. Methods 
5.4.1. Participant selection 
Participants were selected for the study based on the following inclusion criteria: 
" Males 21-65 years of age. 
" BM I 27-40kg/rn2 . 
" Not on any weight reduction regimen or currently losing weight. 
" Living in close proximity to Guildford. 
" Ability to exercise to a moderate intensity. 
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Exclusion criteria were: 
9 History of heart disease, renal disease, liver disease, gout, clinical depression. 
anorexia, and /or drug or alcohol abuse. 
" TI DM or T2 DM. 
" Currently using weight loss drugs. 
9 Uncontrolled thyroid disease. 
9 Treated with lipid-lowering or anti-hypertensive medication. 
Methods of subject recruitment were based on media advertising, and posters and flyers 
within the Guildford area, utilizing the university webpage and adverts placed inside the 
`Dr Atkins New Diet Revolution' book in bookstores. Selected participants were 
randomized to their dietary intervention groups using computer generated random 
numbers (GraphPad Software Inc, USA) 
5.4.2. Sample size justification 
The sample size was originally estimated by the collaborators (Dr. Helen Truby, Dr. Kath 
Heart, and Mrs Rebecca Hiscutt) and was calculated on the primary outcome measure of 
plasma insulin (pmol/1). The calculation was based on that used in a previous study at the 
University of Surrey; The BBC Diet Trials; (Morgan et al., 2004). In order to detect a 
40pmol/l difference in pre to post change in fasting insulin concentrations between 
groups with an 80% power and significant at p=0.05,20 subjects per group were 
required. A standard deviation of 45.2 was assumed. Therefore, the study included a 
total of 60 participants distributed between the two intervention groups to withstand an 
estimated drop-out rate of 50%. 
5.4.3. Study design 
The study was a randomised trial of parallel design, with two intervention groups; a LC 
diet group and a LC diet plus exercise group (Figure 5.1). The study was a collaborative 
project that involved other investigators who were responsible for the recruitment and 
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management of the volunteers, and collection and analyses of dietary and fitness data. 
My principal role was to undertake all the biochemical analyses for the study. The trial 
was part of a larger, 12 months randomised trial on the effect of LC diets on CVD risk 
factors in overweight and obese men. 
Low carbohydrate diet 
30 participants 
60 Participants vv 
Male, 2I-65 years 7 day diet diary 7 day diet diary 
27<BMI<40 kg/M2 AA 
Low carbohydrate diet 
+ exercise program 
30 participants 
Anthropometric Anthropometric Anthropometric Anthropometric 
Baseline 2 months 4 months 6 months 
50 ml blood 35 ml blood 35 ml blood 50 ml blood 
Figure 5.1. Study design. 
5.4.4. Intervention groups 
5.4.4.1. LC diet group 
The dietary principals of the LC Atkins diet were based on the Dr Atkins Diet Revolution 
book (Atkins, 2003), with modifications to make the diet as nutritionally balanced as 
possible. Dietary advice and diet sheets were provided to ensure compliance. Diet sheets 
were constructed for each phase of the study; an induction phase, ongoing weight loss, 
pre-maintenance, and maintenance phases. Participants in the LC group were instructed 
to maintain their baseline levels of activity. 
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5.4.4.2. LC diet and exercise group 
All efforts were made to make the dietary intervention in this group identical to that of 
the first group. In addition, participants were asked to perform three moderate exercise 
sessions of 30 minutes duration per week. The exercise session included brisk walking, 
use of an exercise bike, or gym achieving 50-70% maximum heart rate as assessed by 
heart rate monitors which were provided for the participants. Exercise bikes and gym 
passes were provided for the duration of the study. Participants who were already 
exercising at baseline, were asked to increase their exercise level. 
5.4.5. Measures 
5.4.5.1. Anthropometric measurements 
Anthropometric measures were taken as described in section 2.2.5.1. 
5.4.5.2 Dietary and fitness measurements 
A 7-day quantified diet diary was used to calculate the food intake of participants at 
baseline and 6 months intervention. In order to assist with proper portion size recording, 
the diaries contained pictures of portion sizes. The dietary intakes were analyzed using 
WinDiets software research version (The Robert Gordon University, Aberdeen, 
Scotland). 
Fitness was assessed using the Aerobic Adaptation Test (AAT) developed by Church and 
co-workers (2001). This test utilises an exercise bike to detect changes in submaximal 
work capacity with minimal participant discomfort. Participants were asked to maintain 
a constant speed (60 rpm), and then work load (wattage) was gradually increased each 
minute until 70% of maximum heart rate was achieved. Improved fitness, or otherwise, 
was then assessed by changes in the final wattage at baseline, 2 months, 4 months and at 
the end of the study. 
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5.4.5.3. Blood samples 
Blood samples were taken and treated as described in section 2.2.1 at baseline, 2,4, and 6 
months. 
5.4.5.4. Laboratory measurements 
Total plasma TAG, T. Cholesterol, HDL-C, LDL-C, apo A-I, apo B, NEFA, and glucose 
were measured as described in Section 2.2.2.1. Plasma insulin concentrations were 
measured as described in Section 2.2.4. Small, dense LDL (sdLDL) and HDL subclasses 
were measured by techniques described in Sections 2.2.3.2 and 2.2.3.1 respectively. 
5.4.6. Statistical analyses 
Data was coded and entered into SPSS statistical software, version 14 (SPSS for 
windows, Chicago, Illinois). Data was analysed for normality using the Kolmogorov- 
Smirnov test. The following variables were not normally distributed and were therefore 
log transformed before analyses; weight, plasma insulin, and plasma TAG. The 
characteristics of the study participants were expressed using descriptive statistics. Data 
were analysed for both between (treatment) and within (time) group effects. As 
participants in the LC and exercise group did not increase their activity level significantly 
over time compared to the LC diet alone group, it was decided to combine the analyses 
inorder to examine the effect of LC diet alone on CVD risk. The effect of LC diet in each 
group on all measured variables was assessed by one-way repeated measure ANOVA for 
those variables with interim measurements. A Tukey post-hoc test was then applied to 
locate individual differences. Variables that were assessed only at baseline and at the end 
of the study were examined for within group differences by paired sample t-test. The 
between group differences were tested using the unpaired Student t-test for the changes 
from baseline. A two-way ANOVA, with treatment and time as factors was conducted to 
test the differences between different groups with time. Only complete sets of data were 
used for analyses. Pearson correlations coefficients (r) were determined to examine the 
relationship between variables. Ap <0.05 was considered statistically significant. 
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5.5. Results 
5.5.1. Study progression 
The flow of participants through the study is outlined in Figure 5.2. Out of 56 
participants recruited, 12 withdrew at different stages of the study for various reasons 
(21% attrition rate). The reasons for withdrawal included inability to tolerate the 
intervention diet, loss of interest in the diet, inability to attend appointments or medical 
reasons unrelated to the diet. 
56 Participants 
4 Participants 
withdrawn before 
randomisation 
52 Participants 
LC group LC + exercise group 
n=26 n=26 
Q* No longer wish 
to diet (n=4) 
*Not able to *Medical 
tolerate diet reason (n=1) 
(n=11 
*Did not attend 
appointments 
cc Completed the trial Completed the trial < 
Q n=21 n=23 
* Represents reasons for withdrawal. 
Figure 5.2. Flow of participants through the trial. 
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5.5.2. Baseline characteristics of participants 
All participants who started the trial were overweight or obese as defined by increased 
weight and elevated BMI (>27 kg/m2). Baseline anthropometric measurements are 
shown in Table 5.1. There was no significant difference in age, weight, BIM, or waist 
circumference between the two groups at baseline. Out of 42 participants with baseline 
lipid and lipoprotein data, 7 (17%) initially presented with a predominance of sdLDL and 
were therefore classified as Pattern `B'. Twenty one (50%) of the participants had raised 
plasma TAG (TAG>1.5 mmol/1), and 12 (29%) had low HDL-C (HDL-C<lmmol/1). 
Table 5.1. Baseline characteristics of study participants. 
Mean (SD) 
LC LC + exercise 
p (t-test) 
Age (years) 45.7 (7.6) 48.1 (9.7) 0.318 
Weight (kg) 102.1 (13.1) 105.5 (13.2) 0.332 
BMI (kg/m2) 31.4 (3.1) 33.1 (3.4) 0.050 
WC (cm) 108.9 (6.8) 112.4 (10.6) 0.158 
Fasting glucose (mmol/1) 6.2 (0.5) 6.2 (0.6) 0.783 
Fasting insulin (pmol/l)§ 58.4 (1.8) 63.3 (2.0) 0.797 
Values represent means (SD), § values represent geometric means. 
5.5.3. Prevalence of metabolic syndrome 
The NCEP ATP-III criteria (2001) for the identification of the metabolic syndrome (MS) 
were applied to detect the presence of MS in the study participants at baseline and upon 
completion of the trial. The presence of three features of MS shown in Table 5.2 was 
taken as being indicative of the MS. The most common combination for the syndrome in 
the study participants was increased waist circumference combined with low HDL-C and 
raised plasma TAG concentrations. 
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Tabe 5.2. Prevalence of metabolic syndrome in study participants at baseline (b) and 
at 6 months (6 m) based on the NCEP ATP-III criteria (2001). 
Subjects Waist 
circumference > 
102 cm 
b 6m b 6m 
Fasting plasma 
glucose > 6.1 
mmol/l 
HDL-C <1 Fasting Metabolic 
mmol/I Plasma Syndrome 
TAG>1.5 
mmol/l 
b 6m b 6m b 6m 
All 46 25 25 18 12 7 20 11 14 4 
Diet 22 11 96647442 
Diet + exercise 24 14 16 12 63 13 7 10 2 
5.5.4. Changes in nutrient intakes 
Nutrient intakes were analysed at baseline and after 6 months intervention by averaging 
the intakes recorded in the 7-day food diaries. For all participants, the average energy 
intake/day was reduced significantly (p<0.0005) from 2628±156 kcal/d-l 1038±655 KJ/d 
(SEM) at baseline to 1760±111 kcal/d-7392±466 KJ/d at 6 months; an energy deficit of 
868 kcal/day (Figure 5.3). There was a significant difference in mean energy intake/day 
between groups, as a result of a greater decrease in energy intake in the exercising group 
versus the diet alone group (Table 5.3). 
Changes in the macronutrient composition of the diet in grams are presented in Table 5.3. 
At baseline, the percentage of total energy from macronutrients was not significantly 
different between groups (Figure 5.3 and 5.4). After 6 months, there was a significant 
increase from baseline in the percentage of daily energy from total fat (p<0.0005), 
saturated fat (p<0.0005), PUFA (p=0.002), MUFA (p<0.0005), and protein (p<0.0005), 
while there was a significant reduction in the percentage of energy from carbohydrate per 
day (p<0.0005) for the whole sample. Comparisons between groups indicated that the 
only significant difference between the intervention groups with respect to macronutrient 
composition of the diet was in protein as a fraction of total daily energy intake, with this 
percentage being significantly increased in the exercise group compared with the LC diet 
alone group (p=0.044; Figure 5.3 ). 
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Figure 5.4 Average ± SEM of A: T. Fat, B: S. Fat, C: PUFA, and D: MUFA at baseline 
and after 6 months of intervention. *Within group difference of p<0.05, **p<0.005, and 
***p<0.0005 from baseline. 
5.5.5. Changes in anthropometric measures 
5.5.5.1. Changes in weight 
Weight was measured at baseline and thereafter once every 2 months until the end of the 
trial. At baseline there was no significant difference in the weight between the 
intervention groups (p=0.332). After 6 months, there was a significant reduction in the 
weight of participants in both groups (p=0.001; Figure 5.6). The percentage of weight 
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* ** 
loss in the LC diet group was 6.4% which was not significantly different from the 
percentage of weight reduction in the LC plus exercise group (6.3% reduction). Also, the 
percentage of weight change was not statistically different between the two groups at any 
point during the intervention. Participants achieved rapid weight loss during the first two 
months of the trial (4.8% ±3.3 (SD) and 5.7%±3.8 for the LC diet group and the LC plus 
exercise group respectively). Weight loss then slowed down in both groups. Mean 
absolute weight loss from baseline to 6 months for the whole sample was 6.6+6. l kg 
(SD). By the end of the trial, there was a mean reduction of 6.4%±5.6 (SD) from the 
initial body weight in all subjects. Two participants, one in the LC diet group and one in 
the LC plus exercise group, regained weight at 6 months (1.20 kg and 0.40 kg 
respectively). The absolute weight loss for all subjects from baseline to 6 months is 
presented in Figure 5.5, while the average weight changes from baseline for the 
intervention groups are presented in Figure 5.7. 
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Figure 5.5. Absolute changes in weight after 6 months of intervention with A: low- 
carbohydrate diet and B: low-carbohydrate with moderate exercise. Each bar represents 
one subject. 
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5.5.5.2. Changes in BMI 
The BMI for all the participants following a LC diet decreased significantly from 
32.3±3.3 kg/m2 (SD) to 30.2±3.6 kg/m2 (p<0.001; Figure 5.6). Participants in both 
groups showed a decrease in their BMI compared to baseline (p<0.001). While the LC 
diet group had a significantly lower BMI than the LC plus exercise group at baseline 
(p<0.05), 2-way ANOVA showed no significant effect of diet on BMI (p=0.078). or any 
time and group interaction (p=0.309). 
5.5.5.3. Changes in the waist circumference (WC) 
WC was significantly reduced in all participants as a whole (p=0.001; Figure 5.6) from 
110.6±9.1 cm (SD) at baseline to 104.1±10.1 at 6 months, with a significant decrease in 
this measure for the whole cohort over time. At baseline, 43 participants (97.7%) 
presented with WC in excess of 102cm. After 6 months intervention, only 25 participants 
(56.8%) had a WC >102 cm. At the end of the trial, there was no significant difference 
between the two groups (p=0.259) or any significant interaction between time and group 
(p=0.548) in changes in the WC. Figure 5.7 shows a comparison between groups with 
respect to WC. 
162 
102 
.ý1 
9; 
3: 
E 
31 
3( 
25 
1 
1 
v 
1 
1 
Figure 5.6. Average ± SEM of A: weight, B: BMI, and C: waist circumference for study 
participants as a whole at 0 (baseline), 2,4, and 6 months of intervention. ***Significantly 
different from baseline, p<0.001. 
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Figure 5.7. Average ± SEM of A: weight, B: BMI, and C: waist circumference at 0 
(baseline), 2,4, and 6 months of intervention in the LC diet and the LC plus exercise 
group. *Within group difference ofp<0.05, and ***p<0.001 from baseline. 
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5.5.6. Changes in fitness 
Changes in fitness were defined by differences in the final exercise work load (wattage) 
based on the aerobic adaptation test (Church et al., 2001). The level of fitness from 
baseline to 6 months was only increased significantly within the LC plus exercise group 
(p<0.05; Figure 5.8). There was a significant effect of time (p=0.006) and a trend 
towards greater fitness level in the LC plus exercise group compared with LC diet group 
(p=0.05) but no interaction between time and treatment (p=0.383). The only time that a 
significant increase in the fitness level was observed within the exercise group was 
between the second and forth month of the intervention (p<0.011). At this time point, 
there was a trend towards increased fitness in LC group alone (p=0.060) and therefore no 
significant difference between groups in fitness at this time point was evident. 
+* 
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Figure 5.8. Average ± SEM of fitness at 0 (baseline), 2,4, and 6 months of intervention 
in the LC diet and the LC diet plus exercise group. **Within group difference ofp<0.01 
from baseline. 
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5.5.7. Changes in glycaemia 
Mean fasting glucose concentrations for the whole cohort throughout the study can be 
seen in Figure 5.9. No significant effects of time were seen on fasting plasma glucose in 
the whole cohort (p=0.097). Although there was a 6.4% reduction in plasma glucose 
concentration in the LC plus exercise group from baseline (from 6.2±0.1 mmol/l (SEM) 
at baseline to 5.7±0.4 mmol/l at 6 months), comparison between groups indicated no 
significant effect of time (p=0.10, Figure 5.10), group (p=0.524) or significant interaction 
between time and group (p=0.090). 
5.5.8. Changes in plasma insulin and HOMA-IR 
Mean fasting plasma insulin for the two groups at baseline was not different (p=0.797). 
After two months, there was a tendency towards lower plasma insulin in the LC plus 
exercise group relative to baseline (p=0.058), but there were no significant changes 
within any of the groups (p=0.473 and p=0.501 for the LC diet and the LC diet plus 
exercise group respectively; Figure 5.10). At the end of the trial there was a 5% 
reduction of insulin concentrations in the LC diet group and 12% reduction in the LC diet 
plus exercise group. However, these changes did not reach significance (p=0.501). The 
changes in a surrogate marker of insulin sensitivity, HOMA-IR, were not significant 
either within or between groups after 6 months of intervention (Figure 5.9 and 5.10). 
166 
A 
6.2 
- 
E 
6.0 
5.8 
ö 
8 
n. 
c 
ö 
a 
ýG 
.. Q 
O 
Z 
Months 
Figure 5.9. Average ± SEM of A: fasting glucose, B: fasting insulin, and C: HOMA-IR 
for the study participants as a whole at 0 (baseline), 2,4, and 6 months of intervention. 
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Figure 5.10 Average + SEM of A: glucose, B: insulin, and C: HOMA-IR at 0 
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5.5.9. Changes in feasures of an ALP 
5.5.9.1. Changes in plasma TAGs 
The mean concentration of plasma TAG for the whole cohort decreased significantly 
(Figure 5.11) from 1.5±1.1 (SEM) mmol/l at baseline to 1.1±1.1 mmol/l at 6 months 
(p<0.005). The LC diet without exercise group showed reductions in plasma TAG at 4 
(p<0.01) and at 6 months (p<0.05) compared with baseline values. The exercise group 
showed significant reductions in plasma TAG within the first two months (p<0.05) of 
intervention which was maintained at 6 months. Although there were reductions in 
plasma TAG of 15% and 19% in the LC and LC plus exercise groups respectively, there 
was no significant effect of treatment (p=0.131; Figure 5.12) or interaction between time 
and treatment (p=0.358) but a significant effect of time (p=0.003). The ratio of 
TAG: HDL-C decreased significantly in the overall cohort (p=0.001) but there was no 
significant difference between groups (p=0.649). 
5.5.9.2. Changes in T. Cholesterol and LDL-C 
There was no significant difference in total plasma cholesterol or LDL-C during any 
period of the trial in the LC group (Figure 5.11) but a significant decrease in total plasma 
cholesterol after two months in the LC plus exercise group (p<0.05). The concentration 
of LDL-C within the latter group also decreased significantly after two months relative 
to baseline (p=0.016) but then increased between two and four months (p=0.022). By the 
end of the interventions, there was no significant difference in these lipids in either group 
compared to baseline. Between group comparison indicated there was no significant 
effect of time (p=0.079 and p=0.449) and no significant interaction between time and 
treatment (p=0.291 and p=0.385) for total cholesterol or LDL-C (Figure 5.12). Full 
details on the concentrations of plasma lipids and lipoproteins are provided in Appendix 
16. 
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5.5.9.3. Plasma HDL-C 
The overall cohort had a significantly (p=0.047) higher plasma concentration of HDL-C 
at 6 months (1.4±0. lmmol/l (SEM)) compared with baseline (1.3±0.1 mmol/1); Figure 
5.11). There was no significant change in the concentration of HDL-C from baseline to 6 
months in the LC diet group (p=0.197) or the LC plus exercise group (p=0.136). 
However, an increase in HDL-C was evident between the second and sixth months in the 
LC plus exercise group (p<0.01). There was a significant effect of time (p=0.011) but no 
significant effect of group (p=0.972) or interaction between time and treatment 
(p=0.834). These changes are shown in Figure 5.12. The ratio of total cholesterol: HDL- 
C decreased significantly for the whole cohort at 6 months compared with baseline 
(p=0.004). 
5.5.9.4. Changes in NEFA concentrations 
The whole cohort showed a tendency (p=0.060) towards lower plasma NEFA 
concentrations at 6 months (0.68±0.04 mmol/l (SEM)) compared with baseline 
(0.76±0.05 mmol/1). There was no difference in plasma NEFA between groups at 
baseline. A within group analysis of the concentration of fasting NEFA indicated a 
tendency (p=0.059) towards decrease in this concentration in the LC diet plus exercise 
group but not the LC alone diet group (p=0.442). There was no significant changes in 
plasma NEFA between groups after 6 months of intervention (p=0.477). Changes in 
NEFA within and between groups can be seen in Table 5.4. 
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Figure 5.11. Average ± SEM of A: TAG, B: HDL-C, and C: LDL-C for study 
participants as a whole at 0 (baseline), 2,4, and 6 months of intervention with low- 
carbohydrate diet. *Significantly different than baseline at p<0.05 and **p<0.01. and 
***P<0.001. 
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5.5.9.5. Changes in LDL and HDL subclasses and LDL particle number 
The overall cohort had a significantly (p<0.0005) higher percentage of the larger, more 
lipid-rich HDL2 subclass and higher concentration of plasma apoA-I (p=0.026). The 
proportion of small, dense LDL (sdLDL), as well as peak LDL density, was significantly 
reduced within the whole cohort at 6 months compared with baseline (p<0.0005 for each 
group), but this was not accompanied by any significant change in total plasma apo B (a 
surrogate for the number of LDL particles in fasting plasma) (p=0.440). Within group 
analyses revealed that HDL2 increased in both the LC diet alone (p=0.056) and LC diet 
plus exercise groups (p=0.002) after 6 months relative to baseline (Figure 5.13). The 
proportion of sdLDL, as measured by the percentage AUC representative of subclass 
pattern `B' was decreased in both the LC diet (p=0.002) and LC plus exercise group 
(p=0.055) after 6 months (Figure 5.13). A reduction in LDL peak density was also 
evident in both intervention groups (p=0.014 and p=0.001; LC diet and the LC diet plus 
exercise groups respectively). There was also evidence of an increase in plasma apoA-I in 
the LC diet group (p=0.066), but no changes in plasma apo B in any of the groups. When 
the groups were compared, there was no significant difference in any of the above 
lipoprotein subclass profiles. Changes in lipoprotein subclasses and plasma apoproteins 
can be seen in Table 5.4. 
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Figure 5.13. Changes in A: sdLDL and B: HDL2 in each group. * represent within group 
trend in the changes from baseline. ** Significantly different from baseline, p<0.005. 
5.5.10. Correlation analyses 
Changes in plasma TAG correlated significantly with changes in body weight (1--0.459, 
p=0.003) within the whole cohort. Plasma insulin (r=0.388, p=0.010), sdLDL (r--0.430, 
p=0.008) and LDL peak density (x-0.385, p=0.019) all correlated significantly with 
weight loss. Improvements in fitness for the whole sample were significantly and 
negatively associated with changes in sdLDL (r=-0.507, p=0.002) and LDL peak density 
(r=-0.465, p=0.006) but not with changes in weight (r=0.032, p=0.822). Changes in 
fitness was not associated with changes in plasma TAG (rr0.142, p=0.563). Changes in 
HOMA-IR were significantly associated with changes in plasma TAG (r=-0.311, 
p=0.048) for the whole cohort. Alterations in the principal macronutrient content of the 
diet did not appear to account for the relationship between changes in lipoproteins and 
BMI (Appendix 17). 
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5.6. Discussion 
The aims of the present study were to investigate the effects of two lifestyle approaches 
on surrogate markers of CVD risk. These approaches were a low carbohydrate diet alone 
and a low carbohydrate diet with moderate exercise. These aims were based on the 
hypothesis that a low carbohydrate diet will increase insulin sensitivity and decrease the 
expression of the ALP, and that moderate exercise, when combined with a low 
carbohydrate diet, will further enhance improvement in these CVD risk markers as 
compared to a low carbohydrate diet alone. 
5.6.1. The effects on weight, BMI, and waist circumference 
The amount of weight loss in this trial (6.6 kg) was expected given that this magnitude of 
weight loss has been frequently demonstrated in low carbohydrate diet trials (Volek et 
al., 2004b; Samaha et al., 2003; Truby et al., 2006; Foster et al., 2003). The percentage 
of weight loss achieved in the present study (6.4%) would be expected to confer health 
benefits in obese individuals in terms of CVD risk (Wing et al., 1987a). A favorable 
improvement in markers of CVD risk was evident in the cohort as a whole and within 
both intervention groups. This improvement was also evident with respect to the number 
of participants meeting the ATP-III criteria for metabolic syndrome. By the end of the 
trial, the number of participants expressing 3 or more features of the metabolic syndrome 
had decreased from 14 to 4. Generally, the metabolic syndrome increases CHD risk by 
3.7 fold in men (Sattar et al., 2003). 
Weight loss has profound effects on lipid metabolism and this is perhaps the most likely 
mechanism to explain how a low carbohydrate diet exerts favorable effects on plasma 
TAG. Weight loss in both groups was evident from the reduction in total energy 
achieved in the sample as a whole (from 2471 kcal/d-10378 KJ/d to 1760 kcal/d-7392 
KJ/d) in addition to the macronutrient composition of the diet, which suggested that 
participants were compliant with the expected macronutrient goals of the diet (27±5.4% 
(SD) %, 55±9.4%, and 14±9.4% energy from protein, fat, and carbohydrates 
respectively). Although the dietary advice for participants in both groups was to restrict 
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intake of carbohydrate, but not energy, and despite the speculation that a low 
carbohydrate diet facilitates weight loss by promoting adipose tissue metabolism (Atkins, 
2003), weight loss in both groups, in the present study, appered to result from decreased 
energy intake. This reduction in energy might be attributable to several factors including 
limited food choices in a low carbohydrate diet, the simplicity of the diet or as a result of 
a greater effect on satiety with the higher consumption of protein. 
When the intervention groups were compared with respect to weight loss and BMI, the 
low carbohydrate diet and the low carbohydrate diet plus exercise groups showed no 
significant differences after the intervention. This finding was quite unexpected as the 
role of exercise in assisting and maintaining weight loss has been well established by 
others (Wing, 1999; Avenell et al., 2004a; Blair, 1993). Studies have found that the 
combined effects of a low carbohydrate diet with exercise is additive on improving body 
composition (Layman et al., 2005). The lack of difference between groups could 
therefore be related to a difference in the total energy intakes. Although men tend not to 
upregulate their energy intake in response to exercise (Stubbs et al., 2002), men in the 
exercise group in the present study may have increased their consumption of food after 
exercise to compensate for their increased energy expenditure. After 6 months 
intervention the exercise group had a lower estimated average energy intake compared 
with the diet alone group (p=0.019). However, under-reporting of food intake during 
exercise programs have been previously reported, and evidence from previous studies 
indicates that self-reported food intake during transitions from one level of energy 
expenditure to another is a major source of error in recording dietary intake (Ambler et 
al., 1998). In the current study, changes in fitness were not associated with weight loss. 
The absence of this association is consistent with other reports (Jakicic et al., 1999; Ross 
et at., 2000) in which weight loss produced by exercise required more than 30 minutes of 
daily activity. Therefore, it is probable that while participants in the low carbohydrate 
diet plus exercise group had a small but significant increase in their fitness compared to 
baseline, the intensity, duration, and frequency of exercise utilised by these individuals 
was insufficient to decrease weight in relation to the low carbohydrate diet alone. Indeed. 
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these three exercise components are important determinants of the clinical outcomes of 
any exercise program (LaFontaine & Roitman, 2002). 
In hindsight, when fitness was analysed, the lack of significance between groups in terms 
of weight loss at 6 months was not surprising given the fact that there was no significant 
difference between groups in fitness at that point in time (6 months). The increase in 
fitness observed within the exercise group was only significant at four months of 
intervention when compared with baseline but was not significantly different from the 
low carbohydrate diet alone group. It seems that the latter group was possibly highly 
motivated and may have sought out other healthy lifestyle options such as increased 
physical activity, although 86% of participants in the low carbohydrate diet group 
complied with instructions not to alter their exercise levels over the course of the study. 
This is a common confounding feature in studies that examine the effect of lifestyle 
changes on CVD risk (Petrella et al., 2005). The proposed assumption is further 
supported by the tendency towards an increased level of fitness level in the low 
carbohydrate diet alone group between the second and fourth month of intervention 
(p=0.06); when the exercise group had maximum changes in fitness. After this period, 
fitness waned and eventually the groups re-attained their baseline fitness levels. The 
reason as to why participants in the exercise group have ceased exercise is not clear. It is 
probable that participants within this group exercised intensely during the first months of 
the trial which led them to exhaustion and therefore decreased compliance. A low 
carbohydrate diet has been associated with a higher heart rate and increased exertion in 
one study (Haub et al., 2006) compared with a control diet. The practical implications of 
this finding therefore deserve some address. Participants in the exercise group were able 
to comply with a low carbohydrate diet, but not an exercise program, this finding in itself, 
is an interesting outcome since dietary compliance is one of the main factors that might 
compromise the success of any nutritional therapy. It also highlights the difficulty obese 
individuals face in following a regular exercise program with minimal supervision. 
Centrally obese individuals are known to have a greater risk of developing diabetes and 
CVD (Diabetes Prevention Program Research Group, 2002). The reduction in waist 
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circumference for the overweight/obese participants in this study (from 110.7 cm at 
baseline to 104.1 cm after 6 months) therefore represents an important outcome in terms 
of CVD risk reduction. A major risk associated with abdominal obesity is the insulin 
resistance of metabolic syndrome. Among the factors that promote insulin resistance in 
central obese individuals is increased lipolysis of abdominal fat and the exposure of the 
liver to elevated concentrations of NEFA (Bjorntorp, 1992). Elevated plasma NEFA can, 
in theory, lead to the increased production of VLDL by the liver. Increased NEFA 
concentrations have been identified as a major metabolic defect in many diseases 
including T2 DM (Frayn et al., 2005). Consequently, the trend towards reduction of 
NEFA concentrations in the overall cohort after 6-months represents another important 
outcome from the study in terms of CVD risk reduction. 
5.6.2. Effect on markers of insulin resistance 
Impaired fasting glucose (fasting plasma glucose > 6.1 mmol/1) is one of the NCEP ATP- 
III (2001) criteria for the clinical diagnosis of insulin resistant patients with the metabolic 
syndrome. Of the 25 participants who had a baseline glucose concentration that exceeded 
6.1 mmol/l in the current study, seven had lowered their plasma glucose concentration 
below this value by the end of the trial. However, no changes in mean fasting plasma 
glucose over 6 months was evident for the cohort as a whole or between the intervention 
groups. Consistent with this finding, a weight loss of a similar magnitude as in the 
present study was not associated with significant changes in glucose concentrations in 
another trial of a low carbohydrate diet that also lasted for 6 months (Samaha et al.. 
2003). In general, the reduction in glucose concentrations that is associated with the 
consumption of low carbohydrate diets is limited to individuals with diabetes (Samaha et 
al., 2003), although it is also related to the magnitude of weight loss. 
Measurements of fasting insulin represent a more useful way to identify individuals with 
insulin resistance since hyperinsulinaemia is highly correlated with insulin resistance 
(Reaven, 1988). In the present study, subjects showed characteristics of insulin 
resistance with raised insulin concentrations together with evidence of increased visceral 
fat (waist circumference > 102 cm). Although it is expected that fasting concentrations 
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of insulin would decrease after 6 months after a significant reduction in ww eight, and more 
relevantly, reduction in waist circumference, no significant changes in fasting 
concentrations of insulin were evident in the study sample after 6 months. Ho«ever, a 
trend towards lower insulin concentrations between baseline and 2-months of 
intervention in the low carbohydrate plus exercise group (p=0.058) was evident when 
there was maximum weight loss, though this effect was transient and had disappeared by 
the end of the trial. The lack of significance with respect to insulin concentrations might 
be attributable to the nutrient composition of the diet. Participants at the end of the trial 
had a higher percentage of saturated fat and protein intakes compared with baseline, 
therefore it is possible that this higher intake had an adverse effect on insulin 
concentrations, as high fat and high protein diets are known to increase plasma 
concentrations of insulin (Lovejoy et al., 1998). In addition, participants in the exercise 
group had a greater increase in the percentage of protein as total energy when compared 
with the LC diet alone (p=0.044) which might have counteracted the effect of exercise 
within this group. Overall, studies on the effect of low carbohydrate diets on markers of 
insulin resistance are controversial. While some studies (Samaha et al., 2003; Brehm et 
al., 2003; Meckling et al., 2004) showed an increase in insulin sensitivity with the 
consumption of low carbohydrate diet, others showed no significant difference between 
low carbohydrate and low fat, energy restricted diets (Meckling et al., 2002; Foster et al., 
2003; Stern et al., 2004) on insulin concentrations. 
5.6.3. The effect on markers of ALP 
5.6.3.1. Effects on plasma TAG 
The findings in the present study are in agreement with that of many other studies that 
have investigated the effects of low carbohydrate diets on lipids and lipoproteins, and 
showed that these diets generally reduce plasma TAG (Volek et al., 2004b: Sharman et 
al., 2002; Volek et al., 2000; Foster et al., 2003). Interestingly, the reduction in plasma 
TAG in the present study was apparent in both intervention groups, with there being no 
significant difference between them. A kilogram reduction in body weight is associated 
with a 0.015 mmol/1 decrease in plasma TAG (Dattilo & Kris-Etherton, 1992). 
Reductions in plasma TAG ranging from 11.4% to 60.4% of baseline concentrations have 
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been reported to result from weight loss in response to a low carbohydrate diet (Brehm et 
erl., 2003; Sondike et al., 2003; Volek et al., 2003; Westman et al., 2002). Elevated 
plasma TAG is known to predispose to CHD (Grundy, 1999), and studies clearly indicate 
that elevated plasma TAG is an independent risk factor for CVD (Austin et al., 1998). 
Although weight loss beneficially affects TAG concentrations, changes in TAG on loýý 
carbohydrate diets are usually greater than those associated with weight loss alone 
(Wood, 2006). A possible mechanism for the reduction in plasma TAG induced by a low 
carbohydrate diet is through increased TAG clearance by LPL or decreased VLDL / TAG 
production by the liver in response to decreased carbohydrate substrate delivery. 
Consequently, VLDL particle quantity, but not size, is reduced (Volek & Feinuran. 
2005). In addition, a low carbohydrate diet will also be lower in GL as a result of the lmti 
carbohydrate consumption per day. The findings in Chapter 4 and from others (Bellisle 
et al., 2007; Colombani, 2004) indicate that this type of diet decreases TAG 
concentrations in hyperlipidaemic subjects as it stabilises plasma glucose concentrations 
and reduces the availability of NEFA for VLDL production. 
Exercise has been consistently shown to decrease plasma TAG. In the largest controlled 
exercise trial to date, the Health Risk Factors, Exercise Training, and Genetics 
(HERITAGE) study, plasma TAG was decreased by 2.7% in 299 normolipidaemic men 
who participated in 5 months of exercise training (Leon et al., 2000). In the present 
study, TAG concentrations after the intervention were shown to be similar between the 
diet alone and diet plus exercise groups. The lack of a significant difference in fitness 
between these groups no doubt contributed to this finding, so that plasma TAG 
concentrations may only have been affected by weight loss. The changes in plasma TAG 
were associated with changes in weight loss therefore since the latter was also not 
different between groups, this may explain why plasma TAG was unaffected by the 
interventions. This is further supported by the lack of association between changes in 
plasma TAG with changes in fitness in the exercise group. 
A surrogate marker of insulin resistance is the ratio of TAG: HDL-C (Bloorngarden. 
2003). Many studies have shown a significant reduction in this ratio in response to a lov, 
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carbohydrate diet (Sharman et al., 2002; Volek et al., 2004b; Westman et al., 2002: 
Meckling et al., 2004). The present study was in agreement with these studies in that this 
ratio was decreased with the consumption of the low carbohydrate diet (p=0.001) for 6 
months but with no significant difference between groups. 
5.6.3.2. Effects on T. Cholesterol and LDL-C 
There was no overall increase in total plasma cholesterol by the end of the 6 months 
intervention compared with baseline values. While studies that have examined blood 
lipid responses to low carbohydrate diets have generally reported small increases in total 
cholesterol (Westman et al., 2002; Larosa et al., 1980; Volek et al., 2000), one earlier 
study reported increases in total cholesterol and LDL-C of 6% and 18% respectively in 
normolipidaemic subjects after 8 weeks (Larosa et al, 1980). 
One of the main concerns of consuming low carbohydrate diets is that they are relatively 
high in total and saturated fat. Diets high in saturated fat, in particular, are well known 
to increase plasma concentrations of LDL-C which is an established risk factor for CHD 
(Turner et al., 1998). An increase in LDL-C has been shown when dietary saturated fat 
was increased at the expense of other macronutrients in hyperlipidaemic subjects 
(Sondike et al., 2003). In the present study, plasma LDL-C was similar at 6 months to 
baseline values within groups, and the changes in LDL-C did not differ significantly 
between the groups. The lack of any significant effects on LDL-C is important given the 
popular concern over low carbohydrate diets raising this lipoprotein. Other studies have 
also reported no significant changes in LDL-C with the consumption of a low 
carbohydrate diet (Howell et al., 1997; Samaha et al., 2003). It has been suggested that a 
low carbohydrate diet might be more appropriate for the treatment of individuals with 
obesity and dyslipidaemia related to raised TAG and low HDL and inappropriate for 
individuals with high baseline LDL-C concentrations (Sondike et al., 2003). The Atkins 
diet has been associated with favorable effects on lipids and LDL-C (Dashti & Al-A«adi. 
2001; Volek et al., 2004b; Wood, 2006; Foster et al., 2003). This finding would suggest 
that any adverse effect of increased total and saturated fat on LDL-C is offset by ýN eight 
loss. 
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5.6.3.3. Effect on HDL-C 
The majority of studies have shown a beneficial increase in HDL-C in response to a loci 
carbohydrate diet (Volek et al., 2000; Yancy et al., 2004; Volek & Feinuran. 2005; 
Krauss et al., 2006; Foster et al., 2003). This increase in HDL-C is believed to be as a 
consequence of a decrease in plasma TAG and CETP-mediated neutral lipid exchange 
and resultant remodelling of HDL or through the down regulation of hepatic scavenger 
receptor BI concentrations (Hatahet et al., 2003). This receptor binds HDL-C and 
facilitates reverse cholesterol transport of HDL cholesterol to the liver. Recently, the 
activity of CETP was found to be unchanged with the intake of a low carbohydrate diet 
(Wood et al., 2006) suggesting that the mechanism behind the elevation of HDL-C might 
result from peripheral cholesterol removal and estrification and reduced incorporation of 
TAG into HDL particles (Wood, 2006). Moreover, a greater increase in HDL-C after 
training program may occur in individuals with elevated plasma TAG at baseline 
(Couillard et al., 2001) . The present 
findings were in agreement with the above studies 
in that HDL-C concentrations significantly increased with the consumption of the low- 
carbohydrate diet in both groups but with no significant difference between them. 
Usually manoeuvres which reduce serum TAG tend to increase HDL-C (Garg, 1998), it 
is therefore reasonable to find that as weight-loss in this study did not affect plasma TAG 
differentially, changes in HDL-C concentrations were also equivalent between groups. 
Among overweight, insulin resistant individuals, hyperinsulinemia, hypertriglyceridemia, 
low HDL-C concentrations, and a net increase in the daily energy expenditure produced 
by regular endurance exercise may eventually induce mobilization of body fat and weight 
loss. In turn, this may ultimately reduce the amount of abdominal fat, improve insulin 
action, lower plasma TAG, and increase plasma HDL-C concentrations (Despres & 
Lamarche, 1994). HDL-C in the current study increased significantly within the exercise 
group between the second and the forth month of the trial which was concomitant with 
the significant increase in fitness during this period. In the present study, although there 
was no change in total cholesterol concentrations over time for the whole sample. a 
significant reduction in the ratio of total: HDL-C from baseline was evident. 
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5.6.3.4. Effects on LDL and HDL size and particle number 
The majority of men in the current study did not express a predominance of small, dense 
LDL i. e. they expressed LDL subclass pattern `A', which was unexpected since they had 
BMIs of 27 and over. Only seven participants were classified as LDL pattern B' at the 
start of the study. Of those, two were in the diet group and five were in the diet plus 
exercise group. Individuals exhibiting higher concentrations of sdLDL have a greater 
than three-fold increased risk of CVD (Austin et al., 1988). Interestingly, all subjects 
with pattern `B' switched to pattern `A' after 6 months on a low carbohydrate diet. The 
reduction in sdLDL seen in the current study was in agreement with other studies that 
examined the effect of carbohydrate consumption on LDL particle size (Dreon et al., 
1994; Sharman et al., 2002; Krauss et al., 2006; Wood et al., 2006). The reduction in 
sdLDL was seen even when participants were normolipidemic, normal weight men who 
consumed a low carbohydrate diet for 6 weeks (Sharman et al., 2002). Those with a 
predominance of sdLDL particles had significant increases in mean and peak LDL 
particle diameter and the percentage of larger and lighter LDL particles after the 
consumption of a low carbohydrate diet, while those with pattern 'A' remained pattern 
`A' by the end of the intervention. Reduction in sdLDL can only be observed when 
plasma TAG decreases concomitantly (Halle et al., 1999). These dietary-induced 
changes in sdLDL have been attributed to reductions in VLDL and IDL particles. In the 
present study, participants on both diets experienced an increase in the proportion of large 
LDL and decrease in sdLDL. This change is associated with reduced plasma TAG and 
hence decreased neutral lipid exchange of TAG for cholesterol esters into the LDL 
particle by CETP. The resulting lower concentration of TAG, compared with cholesterol 
esters in LDL particles, would lead to the production of larger LDL (Griffin, 1997). In 
the present study, changes in fitness were significantly associated with changes in sdLDL 
(rr-0.507, p=0.002) and LDL peak density (r---0.465, p=0.006) emphasizing once more 
the importance of increasing exercise among obese individuals for the reduction of CVD 
risk. 
The concentration of plasma apo B is an alternative measurement for LDL particle 
number because one apo B is present per particle of LDL. Plasma apo B constitutes an 
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independent risk factor for CHID (Vega et al., 1991). Plasma concentrations of apo B 
have been shown to decrease by 4.1% after 10 weeks on a low carbohydrate diet (Lofgren 
et al., 2005). In the present study, despite the reduction in TAG concentrations and 
energy intake seen in both groups, there was no reduction in apo B over time or between 
groups. In theory, the lower energy intake might have been expected to decrease the 
availability of TAG in the liver for VLDL synthesis leading to an increase in apo B 
degradation and a decrease in VLDL secretion. Reductions in apo B usually result from a 
decrease in VLDL secretion or an increase in hepatic clearance of VLDL or a 
combination of these two processes (Sniderman et al., 2001). The present findings might 
suggest that a low-carbohydrate diet has differential effects on the regulation of LDL 
particle size (sdLDL) and particle number (apo B concentration). 
There is a strong inverse relationship between the large HDL2 subclass and CAD 
(Johansson et al., 1991). In the present study, both intervention groups experienced a 
significant increase in the proportion of HDL2. However, since there was no significant 
difference between groups in the reduction in plasma TAG, the increase in HDL2 was 
also predictably similar between groups. It is possible that low carbohydrate-induced 
reductions in plasma TAG might not always be coupled with increases in HDL2 (Seshadri 
et al., 2004). The results in this study were in agreement with other reports (Seshadri et 
al., 2004), in that HDL2 increased in the low carbohydrate diet group. Others have 
reported a significant increase in large HDL particles with no change in the quantity of 
small HDL particles (Wood et al., 2006). Apo A-I concentrations, on the other hand, 
increased significantly at 6 months compared to baseline (p=0.026) which was 
concomitant with the increase in HDL-C observed in this study. 
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5.7. Conclusions 
Taken together, the findings of the present study demonstrated that a 6-month low 
carbohydrate diet had some beneficial effects on markers of an ALP. in particular 
decreasing plasma TAG, increasing HDL-C and decreasing the proportion of sdLDL. 
The results also indicate that the high consumption of fat and protein during a low 
carbohydrate diet might offset or counteract any beneficial effects of a low carbohydrate 
diet on hyperinsulinaemia. Furthermore, most of the favourable changes seen with the 
low carbohydrate diet were associated with the weight loss as a result of decreased 
energy intake. This study was unfortunately unable to differentiate between the effect of 
exercise and the low carbohydrate diet on an ALP, probably because of the difficulty that 
obese individuals faced in undertaking a regular exercise program, under minimal 
supervision. 
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CHAPTER 6 
Chapter 6 
GENERAL DISCUSSION 
This research project focused on four different lifestyle strategies for ameliorating an 
ALP in a population at increased risk for CVD either because of the presence of T2 DM 
and/or being overweight or obese. Three of the tested lifestyle modifications were based 
on dietary interventions, while the last approach combined both dietary and activity 
factors. A dual approach was used to examine the impact of modifying the quality of 
dietary carbohydrate on an ALP, using low GI and a low GI / hypo-energetic diets in 
overweight/obese T2 DM patients. The effects of the quantity of carbohydrate on an 
ALP was also examined in a dual approach, in a comparison of a low carbohydrate 
Atkins diet with or without a moderate exercise program in obese subjects. These dietary 
combinations were designed to provide informative, multiple comparisons in two 
extremely different populations of overweight and/or obese UK Caucasians, and patients 
with T2 DM from Kuwait. 
6.1 Measurements of glycaemic index 
In the scientific literature, there is a considerable body of evidence on the therapeutic 
potential of LGI diets in patients with T2 DM (Wolever et al., 1992; Brand-Miller et al., 
2003a; Brand-Miller, 2004; Franz et al., 2004; Ludwig, 2002; Meckling et al., 2004; 
Salmeron et al., 1997b; Schulze et al., 2004; Tsihlias et al., 2000; Willett et al., 2002; 
Wolever et al., 2003). However, it was not possible to address any dietary intervention 
aimed at modifying the GI of the diet in Kuwait without first testing some local foods for 
their GI, as data regarding this was lacking. Moreover, many researchers (Aston et al., 
2007; Miller et al., 1992; Foster-Powell et al., 2002) have indicated the importance of 
measuring the GI of specific foods rather than applying GI values to groups of similar 
foods. Before determining the GI of some carbohydrate-rich staples in Kuwait, it was 
necessary to establish the pattern of intake of carbohydrate-rich foods in this country by 
undertaking an initial pilot study. This provided a valuable insight into some of the 
nutritional habits and dietary intakes of T2 DM patients in Kuwait. 24-hour dietary 
recalls were collected, together with anthropometric and blood pressure measurements in 
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26 T2 DM patients. After careful examination of dietary recalls, it was decided to 
examine the GI of the most commonly consumed, carbohydrate-rich foods. The food 
diaries also provided an estimate of the average dietary GI of foods being consumed by, 
these patients. 
Seven types of bread plus a type of rice that is commonly consumed by T2 DM patients 
were selected as staples for GI testing, and examined for their physiological effects and 
nutrient composition (Chapter 3). Six of these breads were shown to have GI values that 
fell within an intermediate GI range (56-68 for the tested breads) which was comparable 
to the GI values of similar foods reported in the literature (Foster-Powell et al., 2002; 
Henry et al., 2005). The exception to this was a brown pita bread which gave a high GI 
value of 76. Only one UK study has reported the GI of brown pita bread as being lower 
than in the present study (Henry et al., 2005). The difference in GI in this case is likely 
to be due to differences in the processing or baking of these breads. This again 
emphasised the importance of testing GI locally, and brand by brand, as it was impossible 
to predict from the literature where local differences in GI may have occured. On the 
strength of this finding, it was recommended that Kuwaiti T2DM patients replace the 
high GI brown pita bread with one of the other breads tested, preferably with light white 
pita or white pita breads. The importance of this finding lies in the evidence to suggest 
that even small changes in the GI of the diet can produce significant reductions of CVD 
risk (Liu et al., 2000). Although the insulinaemic response to the selected staples was 
relatively higher than expected in relation to the GI values, it correlated well with GI. It 
was concluded that additional testing of these staples in T2 DM patients is required to 
firmly establish their total glycaemic effect. 
6.2 The effects of low GI diet in T2 DM patients in Kuwait 
The effects of two low GI diets, with and without energy restriction, were examined for 
markers of CVD risk in T2 DM in Chapter 4. Kuwait has one of the highest prevalence 
rates of T2 DM and its associated risk factors (Abdella et al., 1996; Al-Adsani et al.. 
2004; al-Muhtaseb et al., 1991; Jackson et al., 2002; Akanji, 2002: Abdella et al., 1998). 
The intake of a low GI diet in this population was associated with multiple, favourable 
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effects on CVD risk markers without adversely affecting any of the other risk markers 
that were examined. This finding was generally consistent with a wealth of literature 
from similar studies (Augustin et al., 2002; Kabir et al., 2002: Leeds, 2002; Luscombe et 
al., 1999; Miller, 1994; Rizkalla et al., 2004; Wolever et al., 1992: Fontvieille et al., 
1992; Frost et al., 2004; Opperman et al., 2004; Wolever, 2006), and included improved 
glycaemic control, decreased plasma TAG and LDL-C concentrations, and increased 
HDL-C. In addition, both LDL and HDL particle size were increased in response to a 
reduction in dietary GI. Despite the observations of others that plasma apo B, a marker of 
LDL particle number (Marcovina et al., 1988; Van Lennep et al., 2000), is decreased by 
lowering the GI of the diet (Rizkalla et al., 2004; Kabir et al., 2002), neither plasma apo 
B or apo A-I changed in the present study, perhaps as a result of the small sample size, as 
the study was powered primarily to detect a change in plasma TAG. 
A number of mechanisms have been proposed to explain how GI may influence lipid 
metabolism (Augustin et al., 2002). These include: insulin-mediated effects on the rate- 
limiting enzyme in cholesterol synthesis (HMG-CoA reductase) because of slow 
carbohydrate absorption; decreased bile acid and cholesterol absorption from the ileum as 
a result of the fibre content of low GI foods; inhibition of cholesterol synthesis by the 
short chain fatty acid propionate due to colonic fermentation of fibre; and finally, a 
reduced inflammatory response mediated by HDL which blocks the interaction of T cells 
and thereby inhibits TNF-a and IL- I P. 
Both intervention groups, the low GI and the hypo-energetic low GI, showed significant 
reductions in their waist circumference. This reduction was related to the decrease in 
dietary GI achieved in both group (r=0.404, p=0.004). This finding within the low GI 
diet group, that was not energy restricted, is of particular importance for two reasons. 
First, the reduction in waist circumference within this group was achieved without energy 
restriction or weight loss, and secondly reduction in central abdominal fat is correlated 
with a lower atherogenic lipid profile (Markovic et al., 1998; Sharp et al., 2003). 
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This study was surprisingly unable to show any difference in the effects of a LGI diet. 
with or without energy restriction, on modifying the expression of an ALP, possibly 
because of the limited amount of weight loss that was achieved by participants in the 
energy restricted group. Studies in T2 DM patients have reported metabolic 
improvement in glycaemic control, insulin sensitivity and CVD risk factors with a 
modest weight reduction of 5-10% (Blackburn, 1995; Ditschuneit et al., 2002; Wing et 
al., 1987a). However, below this level of weight loss, no significant changes in the risk 
profile were found by others (Wing et al., 1987a). It is reasonable then to draw two 
conclusions regarding these findings. Firstly, in view of the drop in the systolic blood 
pressure in the energy-restricted low GI group in the current study. energy-restricted diets 
appear to be appropriate for the management of CVD risk in hypertensive T2 DM 
patients. Secondly, dietary manipulations aimed at reducing the GI of the diet are more 
acceptable to the participants and therefore easier to achieve in terms of compliance than 
dietary manipulations aimed at weight loss. Although compliance with the energy 
restricted diet was poor, as indicated by the very limited amount of weight loss in this 
group, compliance with the LGI diet in both of the intervention groups was considerable. 
Indeed, the LGI foods were highly acceptable to the study participants as proven by the 
fact that they, like others (Miller, 1994), indicated a preference to continue the LGI diet 
after the completion of the trial. It can therefore be postulated that dietary manipulation 
to achieve a lower GI was, at least in practical terms, easier to achieve than an energy 
restricted diet and did not present any adverse effects on markers of CVD risk. Despite 
this, weight loss should continue to be recommended in overweight /obese T2 DM 
patients, since weight loss has been shown consistently to have a potent effect in 
enhancing insulin sensitivity in overweight individuals (Avenell et al., 2004a; Yoshida et 
al., 2004), increasing diabetes control in T2 DM patients (Wing et al., 1987a), and 
improving lipid and lipoprotein profiles in both of these populations (Dashti et al.. 2003; 
Dumesnil et al., 2001; Fernandez et al., 2004). Therefore, different weight loss strategies 
should be considered in order to increase dietary compliance. Instead of using a single 
dietary regimen for weight loss, such as the low energy diets that have been used for the 
study of T2 DM, a broad spectrum of dietary options to accommodate individual food 
preferences and lifestyles should be considered (Dansinger et al., 2005). In other words. 
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a single type of diet is not the best for everybody. When the efficacy of four commercial 
weight loss programs (Atkins, Weight Watchers, Slim-Fast, and Rosemary Conle\) in the 
UK were compared in the BBC Diet Trials (Truby et al., 2006), there was no significant 
difference in the amount of weight loss between the four diets, but certain diets produced 
more favourable effects on CVD risk factors than others. This indicates that while a 
variety of popular diets can be used to reduce body weight, dietary effects on CVD risk 
factors are more specific to the individual diet. 
The duration of the LGI study in Kuwait was moderate (6 weeks) in relation to other LG I 
studies (Dumesnil et al., 2001; Frost et al., 2004; Heilbronn et al., 2002; Jarvi et al., 
1999; Rizkalla et al., 2004), but the dietetic advice and support was regular and intensive. 
The practical implementation of this diet and attainment of its health benefits might 
therefore be difficult to achieve in a free-living population without this nutritional 
support. 
Although knowledge can produce changes in behavior and decision making (Ford & 
Jones, 1991) and provides cues for action (Becker et al., 1977), the results of the present 
study indicate that knowledge alone was insufficient to produce behavioral changes. The 
results point clearly to a need to develop intensive educational programs for diabetics that 
aims to increase knowledge and thus promote behavioral modifications. 
A major limitation, as with any dietary intervention, was the method of dietary 
assessment, which had a strong bias towards underestimating habitual energy intakes 
(Black et al., 1991). Accurate dietary analysis was further hindered in Kuwait by the lack 
of validated nutritional analysis software specific for the Kuwaiti population. 
Establishing a food analysis database specific for the Kuwaiti population is required. 
There was also no dietary follow-up of participants after 6 weeks of intervention, making 
it difficult to draw conclusions about the sustainability and acceptability of the diet in the 
longer term. 
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The study of the effects of low GI diets in T2 DM patients was the first to involve dietary 
manipulations in Kuwait, both in terms of GI and/or energy restriction. Although 
participants in this study did not achieve the desired amount of weight loss (5-10%) by 
energy restriction, dietary compliance among Kuwaiti T2 DM patients is well knoten to 
be generally very poor (Akanji, 2002) making a weight loss of as little as 3% in this 
population not only a unique achievement but also a highly successful outcome 
(Dr. Mojiminiyi & Dr. Akanji, personal communication, 2007). Individual variations in 
lipoprotein response to changes in dietary composition have been linked, at least in part, 
to genetic differences amongst individuals (Dreon & Krauss, 1997). Therefore, outcomes 
of the current study cannot be generalized beyond an overweight /obese T2 DM Kuwaiti 
population. 
6.3 The effects of low-carbohydrate Atkins diet 
Another approach that was used to study the impact of diet on an ALP was to examine 
the effects of a low carbohydrate, Atkins diet for the management of overweight/obese 
subjects (Chapter 5). The effect of a low carbohydrate diet either alone or in combination 
with an exercise program was examined to provide evidence for the influence of physical 
activity in modulating the effects of this type of diet. A low carbohydrate diet (Brehm et 
al., 2003; Dashti et al., 2003; Jarvi et al., 1999; Samaha et al., 2003; Wood et al., 2006) 
and exercise (Anderson & Hoie, 2005; Blair, 1993; Fahlman et al., 2002; Petrella et al., 
2005; Ross et al., 2000) has been shown to be beneficial in reducing some of the risk 
factors associated with CVD in overweight/obese individuals. 
Dietary compliance in this study was measured by dietary records and supported by other 
measures. For example, the nutrient intake in the low carbohydrate and the low 
carbohydrate plus exercise group was analysed at baseline and at 6 months by averaging 
the intake of 7-day food diaries. For all participants, the average energy intake/day was 
reduced significantly (p<0.0005) from 2628±156 kcal/d-11038±31 KJ/d (SEM) at 
baseline to 1760±111 kcal/d-7392±466 KJ/d at 6 months, an energy deficit of 868 kcal/d- 
3646 KJ/d. An energy deficit of this magnitude for one week (868 x7= 6076) would be 
expected to produce a weight loss of 0.87 kg per week. Mean weight loss for all 
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participants together was 6.6 kg over 6 months, indicating a ýý eight loss of 0.26 kg/« eel:. 
Although the food diaries indicated that the participants adhered to the low carboh\ drate 
diet, these diaries might not accurately reflect real consumption, as under-reporting in 
obese individuals is common (Barkeling et al., 1990). 
The outcome of the low carbohydrate study is consistent with others (Brehm et al.. 2003; 
Dansinger et al., 2005; Dashti et al., 2003; Samaha et al., 2003) in showing beneficial 
reductions in plasma TAG and increases in plasma HDL-C in the whole sample. The 
low carbohydrate diet in both groups, however, was not associated with decreased 
insulinaemia. This was an unexpected finding. Other studies that achieved a similar 
weight loss have shown significant reductions in plasma insulin (Brehm et al., 2003; 
Volek et al., 2004b; Foster et al., 2003), and confirmed tha association between weight 
loss wand decreased insulin concentrations and improved insulin sensitivity. It is 
possible that the relatively high proportion of fat and protein in the low-carbohydrate diet 
in the current study had an adverse effect on insulin concentrations. At the end of the 
study participants had a higher percentage of saturated fat and protein intakes compared 
to baseline. High fat and high protein diets are known to increase plasma concentrations 
of insulin (Lovejoy et al., 1998; Nuttall et al., 1984). However, it seems that the effects 
of these macronutrients were counter balanced by weight loss and therefore the overall 
effect of diet on insulin concentrations was neutral. 
One of the main concerns in consuming low carbohydrate diets is that they are relatively 
high in total and saturated fat. Diets high in saturated fats with 12-16 carbons are well 
known to increase plasma concentrations of LDL-C (Summers et al., 2002). an 
established risk factor for CHD (Turner et al., 1998). Findings from the current stud} 
would suggest that any adverse effect of increased total and saturated fat on LDL-C is 
offset by weight loss. Nonetheless, blood lipid concentrations should be regularly 
monitored in individuals following the Atkins diet, since LDL, though not significantly 
changed in the present study, might increase with the continued consumption of such a 
diet (Sondike et al., 2003). 
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The recommendation to increase exercise levels was clearly not met by the participants. 
While 86% of participants on the low carbohydrate diet alone complied with the 
instructions not to alter their exercise levels over the course of the study, only 63% of 
subjects in the low carbohydrate and exercise group complied with instructions to 
increase their exercise levels from baseline (Rebecca Hiscutt, personal communication, 
2007). As a consequence, it is not surprising that there was no difference in markers of 
CVD risk factors between the dietary interventions, with and without exercise in the 
present study. Despite this, the recommendation to increase exercise as a strategy for the 
secondary prevention of CVD should be maintained because the role of exercise in 
assisting and maintaining weight loss has been well established by others (Wing, 1999; 
Avenell et al., 2004a; Blair, 1993). Moreover, there is evidence to suggest that the 
combination of exercise and energy restriction is favorable for altering the distribution of 
weight loss, increasing the loss of fat mass more than the fat-free mass (Ross & Janssen, 
1999; Ross et al., 2000). Lastly, assessment of CVD risk in the Atkins study was based 
on a limited number of biomarkers of CVD risk that were chiefly lipid in origin. There 
are other CVD risk factors that play an initiating event in atherosclerosis that could be 
potentially improved by exercise. One of these risk factors is endothelial dysfunction. 
Individuals with endothelial dysfunction have a 3-4 fold increased risk of coronary events 
that is independent of traditional risk factors (Al Suwaidi et al., 2002). Exercise may 
improve endothelial function and enhance coronary blood flow in individuals at risk of 
CVD, thus reducing the overall risk of atherosclerosis (LaFontaine & Roitman, 2002). 
In general, physical activity levels are reported to be low both in the UK (National Centre 
for Social Research, 2004) and in Kuwait (Al-Asi, 2003). 
6.4 Optimising a dietary approach for CVD risk reduction 
The study of the low carbohydrate Atkins diet in Chapter 5 was of relatively short 
duration (6 months). Whether subjects will comply with such a diet over the long term is 
questionable (Foster et al., 2003). Therefore, a low GI/GI, diet with a large amount of 
whole grains, fruit and vegetables such as the one used in the GI study in Kuwait 
(Chapter 4) might represent a potentially more flexible dietary approach for CVD risk 
reduction. The low carbohydrate diet was associated with a 17% reduction in plasma 
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TAG concentrations (Chapter 5), whilst T2 DM patients showed a reduction in plasma 
TAG of between 12%-16% on a low GI diet. In light of the increased association 
between raised plasma TAG and increased CVD risk, these two approaches might appear 
equally efficacious. However, a generalization of the findings should not be made as 
both studies involved relatively small subject numbers. 
In a comparison of methods for assessing dietary intake, the use of diet diaries in the 
Atkins study was associated with more under-reporting than the 24-hour dietary recalls 
from T2 DM patients in Kuwait, (estimated weight loss from diet recalls =0.47 kg/week, 
actual weight loss =0.40 kg/week versus estimated weight loss from food diaries =0.87 
kg/week, actual weight loss =0.26 kg/week for the GI and the Atkins study respectively). 
Despite the fact that the food diary method is considered to be more accurate for 
assessing dietary intake on an individual basis, since it directly measures portion sizes 
and does not depend on memory of the subject (Wrieden et al., 2003), the 24-hour recall 
used in the GI study seemed to better reflect actual intakes of overweight/obese T2 DM 
patients in Kuwait. While this finding does not necessarily support the superiority of the 
latter method over diet diaries in overweight/obese populations in the UK, it might 
indicate a possible confounding effect of cultural differences between the two groups 
(Harrison et al., 2000). 
Findings from the energy restricted low GI study in T2 DM patients in Kuwait indicated 
a need for effective methods to promote healthy weight loss in this population. The 
Atkins diet that was tested in the present study in a UK overweight / obese population 
may represent an option for increasing dietary compliance for weight loss in T2 DM 
patients in Kuwait. Beneficial effects of the Atkins diet have been shown in T2 DM 
(Samaha et al., 2003). The Atkins Diabetes Revolution: the ground breaking approach to 
preventing and controlling type 2 diabetes book (Vernon & Eberstein, 2004) might be a 
useful dietary alternative to the Atkins diet for diabetics. The plan presented in this book 
is similar to the Atkins weight loss diet except that the intake of carbohydrates is 
progressively increased in relation to glycaemic control. 
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In diabetics, the adoption of multiple healthy habits has been definitively associated with 
a better health-related quality of life, even after adjustment for demographic and 
socioeconomic characteristics, diabetic complications and severity, and the related co- 
morbidities (Li et al., 2007b). Therefore, if weight loss is successfully achieved in 
overweight or obese individuals, then a maintenance diet would be a low GI diet 
combined with an exercise program. This might offer the optimal choice between loci fat 
and low carbohydrate diets, since low fat diets may lead to increased glycaemia and 
insulinaemia (Ludwig et al., 1999). The metabolic benefits of such an approach in 
decreasing CVD risk might be significantly greater than those obtained from either a low- 
fat or low-carbohydrate diet alone. 
An ALP consists of a collection of high risk abnormalities in plasma lipoproteins that 
cannot be measured by routine laboratory analyses. This is mainly because of technical 
difficulties in the measurement of lipoprotein subclasses (Rizzo & Berneis, 2006b). 
However, because of their strong link with CVD risk (Griffin, 1997; Griffin et al., 1994; 
Grundy, 1997; Gardner et al., 2000; Salonen et al., 1991; Ahmad et al., 2007), and 
potential value as therapeutic targets (NCEP ATP 111,2002), it has been suggested that 
measurements of LDL and HDL subclasses in high risk individuals (such as participants 
in the current studies) should be encouraged (Rizzo & Berneis, 2006b). Indeed, 
measurement of both LDL and HDL subclasses in the studies herein has strengthened 
evidence for the beneficial effect of the different dietary treatments used. 
6.5 Concluding remarks 
This thesis has examined multi-factorial lifestyle approaches for the reduction of CVD 
risk in overweight/obese T2 DM patients, with a focus on the modification of an ALP in 
overweight / obese individuals. The effects of these approaches on an ALP in each study 
were similar, in that they all showed favourable effects, to varying degrees, on lipids and 
lipoproteins. Both of the intervention studies resulted in reductions in metabolic risk 
factors for CVD, including a decrease in plasma TAG and increase in the HDL-C 
concentrations across the two studies. Because of poor compliance to the energy - 
restricted diet in the low GI study in Kuwait and to exercise regimens in the Atkins study, 
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no additional benefits of these approaches were shown. Despite this, weight loss and a 
high level of exercise should continue to be recommended for CVD risk reductions in 
high risk individuals with T2 DM and obesity. A low GI diet for T2 DM and a low- 
carbohydrate diet for overweight/obese individuals with an ALP would seem to offer a 
simple and acceptable approach for reducing CVD risk. 
6.6 Future work 
The outcome from these studies has generated questions that could represent principal 
objectives for future investigation. Future work could encompass the following: 
Essential work that needs to be done as a priority would be to complete the low GI diet 
trial in T2 DM patients in Kuwait by conducting a follow-up phase. This should be done 
in order to reach a definite conclusion about the acceptability of the tested diet and the 
long term effects in these individuals. In addition, the measurement of gut hormones 
(CCK, PYY3-36, leptin, and ghrelin), as originally intended, would provide evidence for 
the effects of the low GI diet on energy metabolism and appetite regulation. 
The GI of other carbohydrate-rich foods that are commonly used in Kuwait must also be 
determined. Indeed, establishing a GI database that is specific for Arabian foods should 
be a theme of future national (Kuwaiti) research, as the International Tables of GI values 
provide only a limited amount of information. 
The staples that were examined in this thesis are seldom eaten alone. Therefore it would 
be worth examining the effects on the overall glycaemic response of adding fat and /or 
protein to these staples. 
A multi-factorial intervention study for the reduction of an ALP, not only in T2 DM 
patients but also in otherwise healthy overweight/obese individuals in Kuwait. should be 
undertaken. In addition to dietary changes, this should also include the examination of 
changes in behavior and physical activity as major lifestyle components that influence 
and frequently confound dietary effects. 
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Appendix 2 Mean (SEM) of glycaemic and insulinaemic indices for tested foods. 
Food type 
GI (%) 
n=10 
Mean 
(SEM) 
II (%) 
n=10 
Mean 
(SEM) 
White pita 58.6 (3.5)*** 82.4 (13.4)a 
Light white pita 56.2 (2.7)***a 77.3 (11.1) a 
Brown pita 76.4 (5.0)**b 152.5 23.6 b 
Light brown pita 67.7 (5.2)*** 99.6 (19.1) 
White bread 67.8 (3.1)*** 125.7 (16.4) 
Brown bread 64.3 (3.9)*** 98.1 (14.4) 
Iranian bread 66.9 (6.8)*** 139.5 (15.6) 
vvrr«e rice OL. J (4. /)--- 96.5 (16.3) 
Glucose 100 100 
*Significantly different from the glucose load, p<0.05, **p<0.005, ***p<0.0005 
Different letters within each column represents significant difference, p<0.05. 
236 
Appendix 3. Mean plasma glucose at 0,15,30,45,60,90,120 min elicited b\ 
eight Kuwaiti foods in 10 healthy subjects. 
Mean blood glucose concentration (mmol/1). n=10 
Food 
0 min 15 min 30 min 45 min 60 min 90 min 120 min 
White Pita 
Mean 5.1 6.0 7.0 6.9 6.9 6.2 5.8 
SEM 0.2 0.3 0.4 0.5 0.6 0.5 0.4 
Light White Pita 
Mean 5.2 6.0 6.9 7.0 6.6 6.3 6.0 
SEM 0.2 0.3 0.3 0.4 0.5 0.5 0.4 
Brown Pita 
Mean 5.3 6.2 7.6 7.4 7.1 6.2 5.8 
SEM 0.3 0.3 0.5 0.4 0.5 0.3 0.2 
Light Brown Pita 
Mean 5.2 6.3 7.4 7.3 6.9 6.4 5.9 
SEM 0.2 0.2 0.5 0.6 0.7 0.6 0.4 
White Bread 
Mean 5.1 5.8 7.4 8.0 7.2 5.9 5.6 
SEM 0.2 0.3 0.5 0.6 0.7 0.5 0.4 
Brown Bread 
Mean 5.3 5.9 7.3 7.5 7.1 6.2 5.9 
SEM 0.2 0.2 0.4 0.5 0.6 0.4 0.3 
Iranian Bread 
Mean 5.2 6.1 7.4 7.3 6.8 6.2 5.6 
SEM 0.2 0.3 0.5 0.5 0.5 0.4 0.2 
White Rice 
Mean 5.3 6.4 7.7 6.8 6.3 6.1 5.8 
SEM 0.2 0.2 0.4 0.4 0.4 0.3 0.2 
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Appendix 4. Ethical approval for the LGI study from the University of Surrey. 
Unis 
Ethics Committee 
06 July 2007 
Professor Linda Morgan 
SEMS 
Dear Professor Morgan 
Influence of glycaemic index diet and a low glycaemic combined with weight loss diet on 
atheogenic risk in type 2 diabetics (ECJ2005194JSBMS) 
On behalf of the Ethics Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the submitted protocol and supporting documentation, 
Date of confirmation of ethical opinion: 06 October 2005 
The list of documents reviewed and approved by the Committee is as follows: - 
Document Type: Application 
Dated: 20/08/05 
Received: 31/08/05 
Document Type: Insurance Proforma 
Received: 31/08/05 
Document Type: Research Protocol 
Received: 31/08/05 
Document Type: Appendix 1- 24 Hour Dietary Recall 
Received: 31/08/05 
Document Type: Appendix 2- Suitability Checklist 
Received: 31/08/05 
Document Type: Appendix 3- Patient Information Sheet 
Received: 31/08/05 
Document Type: Appendix 4- Consent Form 
Received: 31/08/05 
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Appendix 5. Approval letter to conduct the LGI study in the Amiri hospital, Kuwait. 
!l4 
Diabetes Unit 
Department of Medicine 
AM)R1 HOSPITAL - KUWAIT 
Date: 28 September 2005 
Dear Sir/ Madam 
This is to confirm that we, the diabetic team at AlAmiri hospital in Kuwait, had 
reviewed the protocol that Mrs Radriyah Al-jazaf presented to us regarding the study 
of the influence of the low glycemic index and a low glycemic; index combined with 
weight loss diet on cardiovascular disease risk associated with Type 2 diabetes 
mellitus. We have no objection over conducting this study in the hospital and using 
our patients as study subjects. 
Should you have any other questions regarding this please contact team members in 
AlAmeri hospital, telephone & fax +965 246 8874 
Di A[-itNtkkhi MD cony; d tnt diahetoloui, t 
{º t_ 
Dr. M At-Arot MD, consultant diabetologist 
Dr. A Alattar lam; con tantdiabetologist 
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Appendix 7. LGI diet sheet 
Soya Bread 
Plums 
LQntilas 
grapes 
Rice 
Spaghetti 
Yom 
Table sugar 
baked potatoes 
carrots 
cornf lakes 
bananas 
Instant rice 
Rice Coke 
French Bread 
0 20 40 60 30 100 120 140 
Glycemic Index 
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Low Glycaemic Index Diet Sheet 
Soya Broad 
Plums 
Lon-tiles 
grapes 
R ice 
Spaghetti 
Yom 
Table sugar 
baked potatoes 
carrots 
cornflakes 
Bananas 
Instant rice 
Rice Cake 
French Bread 
0 20 40 60 80 100 120 140 
Glycomic Index 
Your Dietary Guide to a Low GI 
Diet 
ýA; O 
How to reduce the GI of the diet 
ý Step 1- Make a list of 
the main carbohydrates (vegetables, fruits, 
breads, grains, cereals, pasta, rice, juices, beans, soups, baked 
goods, etc. ) in the diet and note the number of times a week that 
particular food is eaten. 
d Step 2- Look up the Glycemic Index for each food on the list. If you 
can't find a particular food listed, consider the foods ingredients. If 
they are all highly processed (refined white flour, sugar, corn syrup) 
rank the food HIGH. If the food has some processed and some 
unprocessed ingredients, rank it a MEDIUM. If almost all the 
ingredients are in their natural state, rank the food as LOW. This is a 
good rule of thumb, but it's not exact. Also, overcooked foods will 
tend to have a higher GI than undercooked foods. This is especially 
true for pasta, vegetables, grains, and cereals. 
d Step 3- Identify the high glycemic foods in the diet, foods with a G. I 
over 70, and try to eliminate as many as you can. Pick out some of 
the medium GI foods (GI between 55 and 70) you can do without. 
d Step 4- Substitute foods that are enjoyed and start working them 
into every day diet. If eating out and have to select a high GI food 
try to offset it by ordering something with a very low GI. Or, consider 
ordering a vinaigrette dressing on a salad to bring the average GI 
of your meal lower. Remember, this isn't an "all or nothing" diet. No 
one eats perfectly all the time. Just do the best you can and watch 
what happens 
Step 5- Encourage the habit of testing blood glucose to prove it 
works. This will help people knowing the effect of various 
carbohydrates on their blood glucose level. 
2i 
Meal Ideas 
Breakfast 
A low-GI breakfast includes whole-grain breads or toasts, oat based 
cereals, and lots of fresh fruits. Avoid syrups and stay away from 
instant hot cereals. 
1 Cup of tea or coffee 
Brown bread with Low fat cheese 
+ Light yogurt with fresh fruit and bran 
Low-GI cold cereal with skim milk and fruit 
Whole wheat pita bread stuffed with scrambled egg 
French toast with diabetic maple syrup and fruit 
All-bran muffin with diabetic jam and fruit 
t Brown toast with melted low-fat cheese and fruit 
Rye toast and egg-white omelette and fruit 
Lunch 
At lunch time, stay away from processed white bread and rolls. 
Instead, make a sandwich using wholegrain rye bread. Try salads 
made with lots of varied fresh vegetables and vinaigrette dressing. 
Fish is also a good protein addition 
Homemade soups: vegetable, lentil, minestrone, or barley 
(you can add extra vegetables) 
F Sandwiches made with lean meats on whole-grain wheat, rye, 
pita bread, along with vegetable and fruit salad 
0 Pasta salad with vinaigrette dressing and assorted fresh 
vegetables 
and reduced-fat cheese 
t Mixed salad, hummus, with grilled chicken and vinaigrette 
dressing (toss in some beans) 
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Dinner 
Base your meal on a low-GI carbohydrate, with generous amounts of 
non-starchy vegetables and plenty of fresh salads. Eat lean meats, 
poultry, and fish. End your balanced meal with a serving of fresh fruit. 
I Pasta, grains, rice, beans, whole grain breads 
0 Fresh vegetables and salads 
4 Lean meats, chicken, and fish 
t- Substitute beans, peas, or lentils for protein sources if you 
prefer 
Snack (choose 2 from the list) 
By choosing snacks with a low GI or low-fat desserts, you can help 
prevent some of the symptoms and complications associated with 
gusher foods. 
Fresh or dried fruits 
41 Nuts (small serving) 
Low-fat ice cream with fresh fruit 
0 Apple 
i Oatmeal biscuits 
t, Sugar free chocolate bar (small serving) 
0 Baked tortilla chips 
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Starting a low GI diet 
The Glycemic Index (GI) is a measure of how fast after eating a food 
glucose gets absorbed into the bloodstream. Foods high on the GI 
contain carbohydrates that are rapidly absorbed into the bloodstream 
and, foods with low GI values take relatively longer to release sugars into 
the bloodstream. 
The GI uses a scale from 0 to 100. As you move up the scale, Towards 100, 
the quicker the food source will elevate your blood sugar levels. At the 
top of the scale (100) is normally pure glucose. 
The significance of the glycaemic index 
Low GI means a smaller rise in blood glucose levels after meals 
Low GI diets can improve the body's sensitivity to insulin 
Low Gl can improve diabetes control 
Low GI foods keep you feeling fuller for longer 
High GI Foods Moderate GI Foods Low Glycemic Foods 
Glucose 100 Orange juice 157 
JApple 
36 
Baked Potato 85 White Rice 56 Pear 36 
Corn Flakes 84 Popcorn 155 Skim Milk 32 
Cheerios 74 Corn 55 Green Beans 1 30 
Graham Crackers 74 
Brown 
Rice 55 Lentils 29 
Honey 73 Sweet Potato 54 Kidney Beans 27 
Watermelon 72 (Ripe) Banana 
150 
Grapefruit J25 
White Bread 70-72 
[Orange 
43 Barley 1_25 
Table Sugar Apple Juice 141 
Raisins 
J_65 
64 Basmati Rice 60 
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FHigh GI Breakfast Low GI Breakfast 
{Cranberry Juice Cocktail 68 Orange Juice 46 1 
Cantaloupe 65 Grapefruit 25 
Raisins 64 Peach 28 
Corn flakes 92 All-Bran 38 
Cherrios 74 Muesli, toasted 43 
Plain Bagel 72 Sourdough Toast 54 
English Muffin 77 Pumpernickel Toast 41 
White Toast 70 j Stone Ground Whole Wheat Toast 53 
Waffles 76 Oatmeal Buttermilk Pancakes 56 
Pancake Syrup 76 J Diabetic maple Syrup J 19 J 
Strawberry Preserves 74 Diabetic fruit Spread 7 
Huh GI Lunch Food Low GI Lunch Food 
Chicken Rice Soup 53 Minestrone Soup 39 
Sandwich on white bread 73 Sandwich on Whole Wheat Pita 57 
Bread 
Peanut Butter and Jelly 61 Peanut Butter and Diabetic fruit 39 
Sandwich on White Bread spread on Whole Wheat Bread 
Potato Salad 68 Macaroni Salad 44 J' 
Watermelon 72 Apple 40 
High GI Dinner Food Low GI Dinner Food 
Instant Rice 87 Basmati Rice 44 
Baked Potato 94 Boiled, New Potato 57 
Instant Mashed Potatoes 86 Sweet Potato 54 
French Fries 75 Yams 51 
White Rice 72 Spaghetti Cooked Al Dente 38 
Bread Stuffing 74 Pearled Barley 25 
Taco Shell 68 Lima Beans 32 
Hamburger Bun 61 Sour Dough Roll 54 
Macaroni and Cheese 64 Ravioli with Meat 39 
Hi&h GI Snack Food Low GI snack Food , v{ 
Pretzels 83 Peanuts 15 
Corn Chips 42 Popcorn j 55 
_ Graham Crackers 74 Diabetic Chocolate Chip Cookies 34_J 
Rice Cakes 82 Cherries 22 1 
Wat a-t 
-er. 
Craackern ckers 
- 
78 Low Fat ice Cream 50 
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The Low Glycemic Index Traffic Light System 
You can determine if a food has a High or low Glycemic Index by 
Referring to the stoplight list of foods: 
Green means low - eat these foods every day 
" Yellow means moderate - eat these foods sometimes-about three 
times a week 
9 Red means high - eat these foods rarely 
If the food is not on the list, find a food that is similar to one that is on the 
list-the glycemic index will probably be similar 
FOOD 
GROUP 
Green 
often (every day) 
Red 
Once a week or 
less 
Breads, Whole grain products White bread 
Grains and without Breads with 
Cereals dextrose, maltose, added sugar 
honey, molasses, brown Cereals with 
sugar or added sugar 
corn syrup White rice 
Whole Grain Breads Cookies or other 
Whole Grain Pasta baked goods 
Whole grain brown rice, with added 
Oatmeal sugar 
Bran and Whole Grain Crackers 
cereals with no sugar added 
Whole grain crackers 
Stone Ground whole wheat 
bagels or Pitas 
Bran muffins 
sweetened with fruit juice, 
fructose or artificial 
sweeteners 
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Fruits Apples watermelon 
Apricots pineapple 
Berries Dates 
Cantaloupe/honeydew Canned fruits 
melons with added 
Cherries, Grapes sugar or 
Grapefruit, Kiwis in syrup 
Mangos, Oranges Frozen fruits with 
Peaches added sugar 
Pears, Plums 
Tangerines 
Vegetables Artichokes, Asparagus Mashed 
Dried Beans (all Potatoes 
kinds), Broccoli, Cabbage French Fries 
Cauliflower, Celery, Baked Potatoes 
Cucumbers Potato Chips 
Eggplant, Green Beans Corn 
Green Onions Popcorn 
Lentils, Mushrooms Turnips 
OnionsPeas Parsnips 
Spinach, Squash and Sweet pickles 
Zucchini 
Sweet potatoes and yams 
Tomatoes, Peppers 
Meats, Lean Beef Sugar cured 
Eggs, Chicken meat, 
Beans, Nuts Turkey Cold cuts 
Fish processed with 
Shellfish sugar 
crabmeat, shrimp, scallops) 
Lamb 
Beans, Lentils, Nuts 
Milk and Cheese Regular Ice 
Dairy Low fat milk Cream 
Yogurt (no added sugar) Chocolate milk 
Eggs 
Butter 
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Cottage Cheese 
Cream Cheese 
Fats & Olive oil/canola oil Jam/Jelly 
Condiments vinegar Syrup 
Mustard, mayonnaise Honey 
Soy sauce Molasses 
salsa 
Spreadable fruit (no added 
sugar) 
Tomato sauce 
Snack Most fruits (not bananas or Cookies, candy 
Foods watermelon) Cakes, pies 
Yogurt (no sugar added) Regular ice 
cheese cream 
Peanuts, Doughnuts 
Nuts Potato Chips 
Celen' Corn Chips, 
Cheetos, etc. 
Beverages Low fat milk Regular Soda 
Uns,, A/eetened tea Sports drinks 
Chocolate milk 
Juices with 
added sugar 
Fruit Drinks 
o Preparation Makes a Difference 
" Adding fat will make a yellow choice a green or red choice a 
" Extra sugar or sweetened sauces will make a green or 
food a red choice. 
o Understand that most fruits and many vegetables have a low 
glycemic index. 
2c) 8 
o Most starchy foods like potatoes, carrots, breads, cereals, crackers, 
have a high glycemic index. 
o Foods that are low in carbohydrate like meats, eggs, milk, cheese 
and other dairy products have a low glycemic index, but the 
portions of these need to be moderate, since too much fat and too 
many calories can overcome the benefits of the low glycemic 
index diet. 
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VAS 
Name: 
ID: 
Date: 
Meal: 
Please place a vertical mark through the line for each question. Mark the 
line according to how you feel at this moment. Regard both ends of the 
lines as indicating the most extreme sensations you have ever felt. 
Immediately before meal...... .. 
Time 
..................... 
Not hungry at all 
Very week 
Not at all full 
Nothing at all 
How hungry do you feel? As hungry as I've ever 
How strong is your desire to eat? 
Very strong 
How full do you feel? 
Extremely full 
How much food do you think you could eat? 
A large amount 
1 hour after Meal ........................................ .... 
Time 
How hungry do you feel? 
Not hungry at all 
How strong is your desire to eat? 
Very week 
How full do you feel? 
Not at all full 
Nothing at all 
How much food do you think you could eat? 
As hungry as I've ever f 
Very strong 
Extremely full 
large amount 
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Appendix 9. GI 
knowledge questionnaire Name: 
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Name: 
ID: 
Q#: 
Glycaemic index Knowledge Questionnaire 
As part of your participation in the study of the influence of a low GI diet on the metabolic risk profile in 
type 2 diabetes, we have created this questionnaire for you. Tick one of the boxes opposite to the 
appropriate answer to each question. Your responses will be completely confidential but will help us to find 
out how much you know about the glycaemic index. 
Which type of bread has relatively a lower GI 
White pita bread 
" Wholemeal bread. 
" Don't know. 
2. If you think about eating a low GI snack it is better to have 
" Digestive biscuits. 
Marie biscuits. 
Don't know. 
3. This food is a better choice for breakfast since it has a lower GI 
Cornflakes. 
" All-Bran. 
" Don't know. 
4. Which of these has a lower GI 
" Mango. 
" Apples. 
Don't know. 
5. Some foods tend to raise glucose levels rapidly. Such foods include 
" White rice. 
" Beans. 
" Don't know. 
6. This type of salad has a lower GI 
" Potato salad with low fat mayonnaise. 
" Pasta salad with low fat mayonnaise. 
" Don't know. 
7. Basmati rice has a ............. 
GI than short grain rice 
" Lower. 
" Higher. 
" Don't know. 
8. As a dinner item, it is better to choose 
" Lentil soup. 
" Pasta soup. 
" Don't know. 
9. Which of these foods have a relatively lower GI 
" Mashed potatoes. 
Pasta. 
Don't know. 
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10. The main idea of eating a low GI diet is to 
" Control glucose level. 
" Lose weight. 
Don't know. 
11. It is better to replace wholemeal bread with 
" White bread. 
" Sourdough bread. 
Don't know. 
12. The GI of jam when combined with wholegrain bread become 
+ Higher than that of the jam alone. 
Lower than that of the jam alone. 
" Don't know. 
When you have completed filling out the above form please hand it over to the dietitian. Thank you for 
your contribution of time and effort. 
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Appendix 10 Standard interview form for collection of 24-hour dietary recall 
24-hour dietary interview 
24-hour dietary interview format to collect detailed information about all foods and 
beverages. 
The interview will include the following: 
1) Quick List: Respondent will be asked to recall all foods and beverages consumed in a 
24-hour period the day before the interview without interrupting. 
2) Time, Occasion and Place: Respondent will be asked to report the time and place each 
food was eaten and what they would call the eating occasion for the food. Afterwards, a 
list of frequently forgotten foods will be shown to probe the respondent for any forgotten 
foods or drinks. 
3) Food Details: Specific food probes will be used to collect detailed information for 
each food reported. This includes a complete description of each food and the amount 
eaten. 
4) Final Review: The reported foods will be reviewed with the respondent in 
chronological order. Any additional foods remembered during the process will be added 
to the record as well as modifications for reported foods. 
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Appendix 12. Suitability checklist 
Suitability Checklist 
Clinic Name 
Patients Name Phone #: 
Suitable 
YES NO 
Type 2 diabetes F] 7 
Age years 7 7 
BMI kg/m2 Q Q 
Microvascular complication 
F-I F-I 
HDL-C mmOI/I 
F] 
TAG mmol/I Fý F-I 
Name: 
.................................... Signature:................................. 
Date:....... 
(Medical supervisor) 
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Appendix 13. Patient information sheet. 
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Patient Information Sheet 
The effect of low GI foods on decreasing the risk of heart disease in patient with 
diabetes 
Introduction 
Thank you for agreeing to consider taking part in this study. Before you decide whether 
to participate it is important for you to understand why research is being done and what it 
will involve. Please take time to read the following information carefully and discuss it 
with others if you wish. Please ask us if there is anything that is not clear or if you would 
like further information, and please take time to decide whether or not you wish to take 
part. 
What is the study about? 
Diet is the cornerstone in the treatment of diabetes. For many years we have 
recommended a high carbohydrate, low fat diet for people with type 2 diabetes, but there 
has been concerns recently that this may not be ideal, and that, in particular, it may have 
an adverse effect on some blood fat abnormalities that are seen in people with diabetes, 
and which may be among the factors which increase the risk of heart disease in diabetes. 
One solution for the problem has been the introduction of diets containing foods with a 
low glycemic index (GI). The GI is a measure of the rise in blood glucose after eating a 
particular food; foods with low GI produces less of a rise in blood glucose; carbohydrate 
in foods like pasta, fruits and vegetables is absorbed slowly as compared to carbohydrate 
in white rice potatoes that is absorbed rapidly, giving these foods a low and high GI 
respectively. Low GI foods are beneficial to diabetes and appear to have favorable effect 
on blood lipids, especially the TAG, a lipid that has been pertinently associated with heart 
disease risk. A low GI foods combined with a weight loss diet may have an even more 
beneficial effect on blood lipids. However studies comparing the relative effect of low GI 
diets alone and combined with weight loss are lacking. 
Why have you been invited to participate? 
We plan to carry out the study in overweight people with type 2 diabetes who have been 
on stable medication for at least 6 months and who are currently eating a high GI diet. As 
far as we understand you fit these criteria. 
Do you have to take part? 
Absolutely not. There is no pressure on you to participate in this study, and it is entirely 
up to you to decide whether to do so or not. If you decide to take part, you will be asked 
to sign a consent form. If you decide to take part you are still free to withdraw from the 
study at anytime. I you decide not to take part or if you withdraw from the study, this will 
in no way affect the standard of care which you will continue to receive. 
What will the study involve? 
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This is a dietary intervention study which will involve a2 week run-in phase followed by 
a6 weeks period of dietary modification and another 6 weeks period of follow up. The 
study will not involve a change in your medication unless advised by your diabetologest. 
Visit 1 (week 0) 
This will be done during your routine visit to AlAmeri hospital. You will be interviewed 
by your diabetologest to make sure that you are qualified to participate in the study. 
She/he will outline the details of the study and the type of dietary modification which you 
would be asked to implement. If you agree to take part, you will be asked to sign a 
consent form and you will also be interviewed by the study dietitian (whom you may 
have seen before) and asked to recall all the foods/drinks consumed within the day 
before. 
You will then be asked to follow your usual diet and activity level for two weeks. During 
this period you will be asked also to fill a questionnaire rating your appetite in 3 
predetermined dates. Your dietitian will give you a phone call the night before to remind 
you to do so. 
Visit 2 (week 2) 
You will be asked to come in having fasted overnight. Prior to the meeting with the study 
dietitian, a blood sample for measuring blood lipids, glucose, and glucose control will be 
taken. Your weight, height, and waist circumference will be measured. After this you will 
be allowed tea or juice and will be able to take your regular medication as appropriate. 
For the next 6 weeks you will be assigned to one of three groups. You will be asked to 
eitherl. Follow your usual diet. 2. A low GI diet or 3. A low GI with a weight reducing 
diet. You will be given advice by the study dietitian on what foods to consume and 
suggestions for menus. During the six week period, you will be getting phone calls from 
the study dietitian to provide help and answer your questions regarding the study diet and 
also to collect 2 dietary recalls. You will also be asked to fill a questionnaire rating your 
appetite on 3 dates within this period. 
Visit 3 (week 6) 
You will be asked to come in having fasted overnight. Prior to the meeting with the study 
dietitian, a blood sample for measuring blood lipids, glucose, and glucose control will be 
taken. Your weight, height, and waist circumference will be measured. After this you will 
be allowed tea or juice and will be able to take your regular medication as appropriate. 
You will be also interviewed by the study dietitian and asked to recall all the foods/drinks 
consumed within the day before. You can ask any question and talk about your concerns 
also during this visit. 
Visit 4 (week 12) 
As in visit 2. After that you will be free to continue following the intervention diet for 6 
more weeks or get back to your habitual intake. 
Are there any adverse effects of either dietary intervention? 
The risks to you are very low since you will be asked to consume only foods which are 
readily available in supermarkets. Low GI diet usually contains high dietary fiber and 
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may occasionally cause minor abdominal discomfort when the diet is started, but these 
effects soon pass as you get used to the diet. We do not anticipate any other adverse 
effects. 
What are the possible benefits of taking part? 
We hope that the study will provide information on which to base future 
recommendations for diet in people with diabetes. If the dietary modification which w\ e 
are studying is beneficial you will have had the opportunity to try the diet and to have 
done so under instruction with a considerable amount of useful information given to you. 
At the end of the study we will let you know how you responded to the diet. 
Confidentiality 
Any information which we obtain about you and the results of your blood tests will be 
held in confidence by members of the study team. During the study, you and your results 
will be identified by a code number. You will be informed of any results obtained which 
may affect your future treatment. 
Expenses 
We are unable to offer you any remuneration for participating in the study. However, 
transportation will be available in the event that a lift to/from study sites is needed during 
the study period. 
Contact for future information 
Should you require any further information or have any concerns now or at any time 
during the study please contact 
Mrs Badriya Al-jazaf 9718936 
Dr. Tahani Al-niama 9752209 
Mrs. Layla Abdulghafoor 9715691 
Thank you for your time and for considering to participate in this study 
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Appendix 14, Consent form 
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Consent Form 
I the undersigned voluntarily agree to take part in the study on the effect of low glycemic index food 
decresing the risk of heart disease in patients with diabetes 
I have read and understood the Information Sheet provided. I have been given a full explanation by the 
investigators of the nature, purpose, location and likely duration of the study, and of what I will be 
expected to do. I have been advised about any discomfort and possible ill-effects on my health and well- 
being which may result. I have been given the opportunity to ask questions on all aspects of the study and 
have understood the advice and information given as a result. 
I agree to comply with any instruction given to me during the study and to co-operate fully with the 
investigators. I shall inform them immediately if I suffer any deterioration of any kind in my health or 
well-being, or experience any unexpected or unusual symptoms. 
I agree to the investigators contacting my hospital about my participation in the study, and I authorise 
AlAmeri hospital to disclose details of my relevant medical or drug history, in confidence. 
i understand that all personal data relating to volunteers is held and processed in the strictest confidence, 
and in accordance with the UK Data Protection Act (1998). 1 agree that I will not seek to restrict the use of 
the results of the study on the understanding that my anonymity is preserved. 
understand that I am free to withdraw from the study at any time without needing to justify my decision 
and without prejudice. 
"I confirm that I have read and understood the above and freely consent to participating in this study. I 
have been given adequate time to consider my participation and agree to comply with the instructions and 
restrictions of the study. 
Name of volunteer ........................... ................................. (BLOCK CAPITALS) 
Signed ........................................................................... 
Date 
........................................................................... 
Name of researcher ........................................................................... 
(BLOCK CAPITALS) 
Signed 
........................................................... ............ 
Date 
.......................................................................... 
Appendix 15. Demographic and anthropometric questionnaire 
I 
Date QC! ýýJý/fin. 
Participant Name 
Gender 
Age 
Nationality 
Male 
11 
Female 
QQ years 
Kuwaiti others/specify 
Height metres 
Weight kg 
Waist cm 
BMI - kg/m2 
Systolic (mmHg) Diastolic (mmHg) Heart Rate (b/min) 
BP/HR 
Medication 
Cigarette smoking Yes How many/day No 
Investigator Signature 
.................. 
Date ........................ ............................................... 
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Appendix 16: Changes in lipids and lipoprotein values over the intervention period. 
Mean Mean (SEM) P 
(SEM) P paired Diet (n=20) 
Diet + exercise unpaired 
All t-test (n=2 1) t-test 
TAG 1.5 1.3 (0.4) 1.6 (0.4) 
(mmol/l)§ Baseline (1.1) 
2 months 
1.1 
(1.1) 
1.0 (0.4) 1.1 (0.4) 
4 months 
1.1 
(1.1) 
0.9(0.4) 1.2(0.4) 
6 months 
1.1 
(1.1) 0.9(0.4) 1.1 (0.4) 
6 months-baseline (% change) 
1.3 
<0.0005 (1,1) 0.3 
(0.2)* 0.4 (0.8)** 0.873 
T. Cholesterol 5.9 5.9 (0.2) 6.1 (0.3) 
(mmol/1) Baseline (0.2) 
5.7 5.9 (0.3) 5.6 (0.2) 
2 months (0.2) 
5.8 5.9 (0.2) 5.8 (0.2) 
4 months (0.1) 
6.0 6.0 (0.3) 6.3 (0.3) 
6 months (0.2) 
-0.1 0.633 0.1 (1.0) 0.1 (1.4) 0.904 
6 months-baseline (% change) (0.2) 
HDL-C 1.3 1.4 (0.1) 1.3 (0.1) 
(mmol/1) Baseline (0.1) 
1.2 1.2 (0.1) 1.2 (0.1) 
2 months (0.0) 
1.3 1.3 (0.1) 1.3 (0.1) 
4 months (0.1) 
1.4 1.5 (0.1) 1.5 (0.1) 
6 months (0.1) 
-0.12 0.047 0.1 (0.4) 0.1 (0.3) 0.954 
6 months-baseline (% change) (0.1) 
LDL-C 3.5 3.5 (0.2) 3.6 (0.2) 
(mm01/1) Baseline (0 1) 
3.3 3.6 (0.2) 3.1 (0.1) 
2 months (0.1) 
3.5 3.6 (0.2) 3.5 (0.2) 
4 months (0.1) 
3.5 3.8 (0.2) 3.5 (0.2) 
6 months (0.1) 
-0.02 0.849 0.1 (0.7) 0.1 (0.7) 0.297 
6 months-baseline (% change) (0.1) 
§Values are geometric means. 
*Represent wi thin group difference ofp<0.05 and **p<0.005. 
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Appendix 17. Correlations between dietary changes and changes in BMI and lipids and 
linonroteins. 
Changes in 
TAG 
(mmo/1) 
Changes 
in HDL 
(mmol/1) 
Changes 
in 
%LDL3 
Changes 
in %HDL2 
Changes 
in BMI 
(kg/rn ) 
Changes in R -. 164 . 320 -. 
207 -. 157 -. 314 T. Fat (g) 
P . 514 . 195 . 
426 . 562 . 155 
N 18 18 17 16 22 
Changes in R -. 068 . 121 -. 
024 -. 348 -. 199 S. Fat (g) 
P . 789 . 
632 . 927 . 
186 . 374 
N 18 18 17 16 22 
Changes in R -. 237 . 083 -. 
361 . 052 -. 
160 
PUFA(g) 
P . 343 . 
744 . 155 . 
849 . 476 
N 18 18 17 16 22 
Changes in R -. 164 . 
323 -. 198 -. 038 -. 259 MUFA (g) 
P . 517 . 
191 . 447 . 
888 . 245 
N 18 18 17 16 22 
Changes in R -. 001 . 
243 -. 002 -. 228 -. 394 
protein (g) 
P . 998 . 
332 . 995 . 
395 . 069 
N 18 18 17 16 22 
Changes in R -. 135 -. 350 -. 045 . 
066 -. 009 
CHO (g) 
P . 593 . 
154 . 
865 . 807 . 
967 
N 18 18 17 16 ?? 
R; Correlation coefficient, P; p-value, N; sample size 
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